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Summary
The RecQ DNA helicases are highly conserved from bacteria to man and are required
for the maintenance of genomic stability. All unicellular organisms contain a single RecQ
helicase, whereas the number of RecQ homologues in higher organisms can vary. Mu-
tations in the genes encoding three of the five human members of the RecQ family give
rise to autosomal recessive disorders called Bloom syndrome, Werner syndrome and
Rothmund-Thomson syndrome. These diseases manifest commonly with genomic in-
stability and a high predisposition to cancer. However, the genetic alterations vary as
well as the types of tumours in these syndromes. Furthermore, distinct clinical features
are observed, like short stature and immunodeficiency in Bloom syndrome patients or
premature ageing in Werner Syndrome patients. Also, the biochemical features of the
human RecQ-like DNA helicases are diverse, pointing to different roles in the mainte-
nance of genomic stability.
The goal of my thesis was to explore the functions of the human RecQ homologues
BLM, WRN and especially the so far biochemically uncharacterised RECQ5, with a
focus on the identification of functional domains of these proteins, their biochemical
properties and modes of action.
To characterise the domain organisation of the BLM protein, Janscak et al. (1) purified
from E. coli and biochemically characterised a deletion variant of BLM, encompassing
amino acids 642-1290. This truncated version contained the DEAH, the RecQ-Ct and
the HRDC domains. This fragment was proficient in DNA-stimulated ATPase and DNA
helicase activity displaying the same substrate specificity as the full-size protein. Gel-
filtration experiments revealed that it exists as a monomer in solution both free and in its
DNA-bound form, even in the presence of Mg2+ and ATPγS. With a λ Spi- assay, it could
be shown that BLM642-1290 is able to partially suppress the illegitimate recombination
in E. coli recQ- strains. Furthermore, the RecQ-Ct domain was identified as a region
essential for activity of the protein, and the HRDC domain as an auxiliary DNA binding
domain.
With my work on RECQ5β (2), I could show the first biochemical characterisation
of this RecQ DNA helicase. After overexpression in E. coli, I purified the protein to
high homogeneity and subjected it to various biochemical assays. The protein showed
the predicted ATP-dependent 3’-5’ helicase activity and was also able to promote the
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migration of Holliday juntions. Surprisingly, RECQ5β displayed a DNA strand-annealing
activity residing in the C-terminal half of the protein. This activity was strongly inhibited
by RPA. Inhibition of the annealing activity could also be observed in the presence of the
poorly hydrolysable ATPγS, which was alleviated by mutations in the ATP binding motif
of RECQ5β, indicating an inability of RECQ5β to anneal DNA strands in the ATP-bound
form.
BLM and WRN are classified as SF2 helicases and show ATPase activity with single
and double stranded DNA as effectors, indicating that translocation along the DNA is
mediated by contacts with the phosphodiester backbone. SF1 helicases like the PcrA
from B. stearothermophilus make contacts with the bases of the DNA, which is depen-
dent on the rotational flexibility of the DNA backbone. I have shown that DNA unwinding
by BLM and WRN was inhibited by vinylphosphonate internucleotide linkages in the
DNA that reduce the rotational flexibility of the phosphodiester backbone; an effect also
observed with PcrA (3). However, in contrast to PcrA, a single stranded DNA bind-
ing protein RPA could alleviate the inhibitory effect of these modifications on BLM and
WRN-mediated unwinding, pointing to mechanistic differences between SF1 and SF2
helicases.
One of the functions of BLM is to act together with Topoisomerase IIIα to process re-
combination intermediates containing double Holliday junctions using a strand-passage
mechanism that prevents the formation of cross-over products (4). Wu et al. (5) have
shown that this dissolution reaction is highly specific to BLM amongst the human RecQ
helicases and that it requires the HRDC domain of BLM. The HRDC domain is essen-
tial for the efficient binding to and unwinding of double Holliday junctions by BLM. The
unwinding of simple duplexes is not an activity of the protein that is required for this
reaction. The lysine 1270 of BLM located in the HRDC domain is required for efficient
dissolution and is predicted to majorly contribute to the interaction with DNA.
Cheok et al. have shown that, in addition to the highly conserved DNA unwinding
activity, BLM also contains a strand-annealing activity that does not require Mg2+, is
inhibited by ssDNA binding proteins and ATP, and is dependent on DNA length. Through
deletion analysis we have shown that a 60 amino acid stretch in the C-terminal part of
BLM is important for strand annealing (6).
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Zusammenfassung
Die RecQ DNS Helikasen sind hochkonserviert in Bakterien bis zum Menschen und sind
wichtig fu¨r die Bewahrung genomischer Stabilita¨t. Alle unizellula¨ren Organismen bein-
halten eine einzige RecQ Helikase, wa¨hrend die Anzahl in ho¨heren Organismen vari-
ieren kann. Mutationen in drei der fu¨nf menschlichen RecQ-Homologen resultieren in
den seltenen autosomal rezessiven Krankheiten Bloom Syndrom, Werner Syndrom und
Rothmund-Thompson Syndrom. Diese Krankheiten zeichnen sich alle durch genomis-
che Instabilita¨t und hohe Krebsdisposition aus. Jedoch zeigen Syndrome Unterschiede
bezu¨glich der genetischen Vera¨nderungen, Art der Tumore und klinischen Befunden.
Die biochemischen Eigenschaften der humanen RecQ DNS Helikasen sind auch ver-
schieden, auf deren unterschiedlichen Aufgaben in verschiedenen Ketten und Rollen in
Gewa¨hrleistung der genomischen Stabilita¨t hin weisend.
Das Ziel meiner Dissertation war es, die Funktionen der RecQ Homologen BLM,
WRN und besonders die des bis dahin spa¨rlich charakterisierten RECQ5 zu erforschen
mit speziellem Augenmerk auf die Identifikation funktioneller Doma¨nen, biochemische
Eigenschaften und Reaktionsmechanismen.
Um die Doma¨norganisationsstruktur des BLM Proteins zu definieren, haben Janscak
et al. (1) eine Deletionsvariante von BLM, das Peptid der Aminosa¨uren 642-1290, nach
¨Uberexpression in E. coli aufgereinigt und biochemisch charakterisiert. Die Variante
entha¨lt die DEAH Helikasen-, die RecQ-Ct und die HRDC Doma¨nen. Dieses Fragment
zeigte DNS-stimulierte ATPase Aktvita¨t mit derselben Substratspezifita¨t wie das Pro-
tein der ganzen La¨nge. Durch Gel-filtrationsexperimente konnte gezeigt werden, dass
das Protein in Lo¨sung frei und in DNS gebundener Form als Monomer vorlag, was
nicht durch die Pra¨senz von Mg2+ sowie von ATPγS beeinflusst wurde. In einem λ Spi-
Versuch hat sich gezeigt, dass BLM642-1290 partiell die illegitime Rekombination in E.
ColiRecQ- unterdru¨cken konnte. Des Weiteren wurde die RecQ-Ct Doma¨ne als eine
fu¨r die Aktivita¨t des Proteins essentielle Region und die HRDC Doma¨ne als auxilia¨re
Bindungsdoma¨ne identifiziert werden.
Durch meine Arbeit mit RECQ5β, konnte ich die erste biochemische Charakter-
isierung dieser RecQ-a¨hnlichen DNS Helikase zeigen (2). Nach ¨Uberexprimierung in E.
coli habe ich das Protein zu hoher Homogenita¨t aufgereinigt und es mittels klassischen
Helikasenversuchen charakterisiert. Das Protein hat die vorausgesagte ATP-abha¨ngige
v3’-5’ Helikasenaktivita¨t gezeigt, und vermochte auch Holliday Strukturen zu migrieren.
Erstaunlicherweise zeigte dieses Protein eine DNS-Paarungsaktivita¨t im C-terminalen
Teil, welche durch RPA inhibiert werden konnte. Die Inhibition der Paarungsaktivita¨t
konnte ebenfalls durch das schwach hydrolysierbare ATPγS beobachtet werden, was
wiederum duch Mutationen im ATP-Bindungsmotiv aufgehoben wurde, darauf hindeu-
tend, dass das Protein in ATP-gebundener Form nicht in der Lage ist, DNS Stra¨nge
aneinanderzufu¨hren.
BLM und WRN sind als SF2 Helikasen klassifiziert und zeigen ATPase Aktivita¨ten mit
einzelstra¨ngiger sowie doppelstra¨ngiger DNS als Effektoren, auf einen Translokations-
mechanismus deutend, welcher durch Kontakte mit dem Phosphodiestergeru¨st bew-
erkstelligt wird. SF1 Helikasen wie PcrA aus B. stearothermophilus gehen Kontakte mit
den Basen ein, was eine Rotationsflexibilita¨t der DNS beno¨tigt. Ich konnte zeigen, dass
die Helikasenaktivita¨t von BLM und WRN durch den Einbau von Vinylphosphonaten,
welche die Rotationsflexibilita¨t des Phosphodiestergeru¨sts der DNS vermindern, inhi-
biert wurde; ein Effekt, der auch mit PcrA beobachtet wurde (3). Im Gegensatz zu PcrA
konnte der inhibitorische Effekt durch das humane einzelstrangbindende RPA aufge-
hoben werden, auf mechanistische Unterschiede zwischen SF1 und SF2 Helikasen
hindeutend (3).
Eine der Funktionen von BLM ist, Rekombinationsintermediate mit doppel Holliday
Strukturen zusammen mit TOPOIIIα aufzulo¨sen (4) um die Entstehung von ”cross-over”-
Produkten zu verhindern. Wu et al. (5) haben gezeigt, dass diese Reaktion, im Englis-
chen ”double Holliday junction dissolution” genannt, hochspezifisch fu¨r BLM ist unter
den humanen RecQ Helikasen und dass die HRDC Doma¨ne von BLM beno¨tigt. Wir
konnten des Weiteren zeigen, dass die HRDC Doma¨ne von BLM essenziell fuer die
Bindung an und Aufwindung von doppel Holliday Strukturen ist. Das Aufschmelzen
simpler DNS Duplexe ist nicht eine Aktivita¨t, welche fu¨r diese Reaktion beno¨tigt wird.
Lysin 1270 in BLM ist wichtig fuer die effiziente Dissolution und scheint einen wichtigen
Beitrag zur Interaktion mit der DNS zu leisten.
Cheok et al. haben gezeigt, dass BLM, zusa¨tzlich zu der hochkonservierten He-
likasenaktivtita¨t, eine DNS-Basenpaarungsaktivita¨t besitzt. Diese durch BLM bewerk-
stelligte Basenpaarung ist Mg2+-unabha¨ngig, wird durch einzelstra¨ngige DNS inhibiert
und ist von der DNS-La¨nge abha¨ngig. Durch Deletionsanalyse konnte gezeigt werden,
dass die C-Terminale Doma¨ne dafu¨r essenziell ist, und 60 Aminosa¨uren davon fu¨r die
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Bindung einzelstra¨ngiger DNS und fu¨r die Basenpaarung wichtig ist (6).
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1 Helicases - Classification and Mode of Action
Helicases are ubiquitous enzymes that use the free energy from NTP hydrolysis to sep-
arate the two component strands of double-stranded nucleic acids (DNA-DNA, RNA-
DNA, RNA-RNA). These enzymes play essential roles in all aspects of nucleic acid
metabolism (7).
Helicases are classified according to sequence homology and directionality. The
directionality is defined with respect to the nucleic acid strand on which the enzyme
translocates (3’-5’ or 5’-3’) (8). Based on amino acid sequence homology, helicases are
classified into five majour groups, denoted superfamilies 1-5 (SF1-5) (Table 1). SF1 and
SF2 are the largest and are characterised by a set of similar amino acid motifs called Q,
I, Ia and II-VI (Figure 1). SF3 helicases harbour only three different conserved helicase
motifs called A, B and C and the SF4 helicases are known to have the five motifs called
1, 1a and 2-4 (9). The motifs of the SF5 members have not been well described.
Superfamily Helicase Organism nucleic acid Reference
SF1 Rep E. coli DNA (10; 11)
PcrA B. stearother-
mophilus
DNA (10; 12)
UvrD E. coli DNA (10)
SF2 RecQ E. coli DNA (10)
NS3 Hepatitis C Virus RNA (10; 13)
SF3 T antigen SV40 papo-
vavirus
DNA/RNA (10)
SF4 DnaB E. coli DNA (10)
SF5 Rho E. coli DNA/RNA (10)
Table 1: Classification of Helicases based on sequence homology, with some examples.
N CAXXGXG T HRIGRXXRRGXDFVNTSATVLPTRELA TPGRGFZZPOSI
Q(0) I Ia Ib II III IV V VI
Walker A
ATPase A
Walker B
ATPaseB
Figure 1: Schematic representation of the domain organisation of the DEAD box helicases. boxes represent conserved helicase
motifs showing consensus sequences by single-letter amino acid code. (Z=D, E, H, K, R; O=S, T; X=any aa). Adapted from Ref.
(14).
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In Figure 1, the domain organisation of DEAD box helicases is schematically de-
picted. The Q-motif is characteristic of the DEAD box family (15; 16). It contains a
highly conserved glutamine which is also present in the ”0” motif of the RecQ helicases
that belong to the DExH helicase family. In E. coli RecQ the conserved glutamine has
been shown to bind to the adenine moiety of the ATP cofactor (17). For a number of
helicases it has been shown by mutational anlalysis that this conserved residue is es-
sential for ATPase and helicase activity of the enzyme. Moreover, a missense mutation
at the equivalent residue of the BLM helicase is sufficient to cause the Bloom syndrome
(18). Motif I is also referred to as the Walker A motif found in ATPases (19). This domain
is also essential for ATP binding; a conserved lysine residue makes contacts with the
β and the γ phosphates of the ATP molecule (20). The motif Ia has been shown to
contribute to ssDNA binding in the UL9 helicase from the Herpes Simplex Virus (HSV)
and is present in many SF1 and SF2 helicases (21). In the DEAD and DExH heli-
cases an additional motif named Ib motif is found with a consensus sequence of TxGx
(14). Motif II is equivalent to Walker B motif also found in other ATPases. Based on
the sequence of this motif, helicases are further classified into the DExH and the DEAD
families. The highly conserved aspartate residue in Motif I (D of DE) coordinates Mg2+,
and is required for ATP hydrolysis but not binding (20). Motif III is very likely to be im-
portant for coupling ATPase to helicase activity (22). Motif IV seems to be essential
for the later steps of the ATPase reaction as it binds ADP. Motif V is likely to serve as
an additional domain for binding DNA, since it has been shown to make contacts with
the sugar-phosphate backbone (9). The motif VI has been proposed to be required for
the helicase to move along the DNA substrate by mediating conformational changes
associated with nucleotide binding (14).
For the mode of action of helicases, several models have been proposed and are
depicted schematically in Figure 2. In the inchworm model, the enzyme binds to ssDNA
and translocates along the strand until it reaches the duplex which is then invaded and
unwound (23). The modified inchworm model has been proposed for the monomeric
UvrD helicase. The enzyme consists of two DNA binding subdomains, a leading do-
main that binds to ssDNA and dsDNA and a trailing domain that only binds to ssDNA.
ATP binding induces a closed conformation of the enzyme by pulling the trailing do-
main towards the leading domain. Upon ATP hydrolysis, the trailing domain remains on
ssDNA and the leading domain is moved forward into the duplex and mediates strand
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separation (24; 25). In the active rolling model, the helicase consists of two identical
subunits that can both bind to ssDNA and dsDNA. One subunit stays bound on ssDNA
and the subunit behind will detach from the DNA and rotate around the bound sub-
unit to bind dsDNA. A conformational change upon ATP hydrolysis will then lead to the
separation of the duplex (26).
A
B
C
Figure 2: Models for DNA helicase translocation and unwinding. (A) Inchworm model. (B) Modified inchworm model. Leading
domain in green, trailing domain in blue. (C) Active rolling model. Two identical subunits in green and purple.
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2 The RecQ Family of DNA Helicases
2.1 General Features and Structural Organisation
The RecQ helicases, named after the DNA helicase RecQ of Escherichia coli, are highly
conserved from bacteria to man. Defective functions of these proteins lead to genomic
instability that generally manifests as hyperrecombination. In humans, defects in the
BLM , WRN and RTS/RECQ4 genes are associated with the autosomal recessive,
cancer-prone diseases Bloom syndrome (BS) (27; 28), Werner syndrome (WS) (29; 30)
and Rothmund Thompson syndrome (RTS) (31; 32; 33), respectively. Higher organisms
contain several RecQ homologues, with five homologues identified in humans. These
proteins presumably play specialised roles in genome maintenance since distinctions
in the clinical as well as the cellular manifestations of BS, WS and RTS have been ob-
served. Furthermore, the multiple RecQ homologues also display differences at the bio-
chemical level with overlapping, but also very distinct substrate specificities mostly due
to the presence of various additional functional domains. The diverse protein interaction
partners observed further implicate different human RecQ homologues in different DNA
transactions. It seems that the cellular functions of the sole RecQ homologues in uni-
cellular organisms are divided up into and extended on several homologues in higher
organisms.
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RECQ5β
RecQ
WRN Exonuclease
RECQ1
BLM
RECQ4/RTS
Sgs1
Rqh1
RecQ5α
RecQ5β
BLM
Escherichia coli
Saccharomyces cervisiae
Schizosaccharomyces pombe
Drosophila melanogaster
Homo sapiens
Helicase Zn
2+
WH HRDC
NLS
NLS
NLS
NLS
610 aa
1447 aa
1328 aa
1487 aa
468 aa
1057 aa
659 aa
1417 aa
1432 aa
1208 aa
991 aa
Figure 3: Schematic representation of the RecQ helicases of selected organisms. The domains of the RecQ from E. coli are
labelled; helicase domains in red and blue, Zinc-binding domain in yellow, the winged helix domain in green and the HRDC domain
in purple, according to the crystal structure of the E. coli RecQ helicase (34). The putative nuclear localisation signals (NLS) are
marked by red boxes. WRN contains an additional exonuclease domain and a direct repeat (blue triangles). The lengths of the
proteins are given to the right in number of amino acids.
In Figure 3, selected RecQ helicases are drawn schematically. All RecQ members
contain the helicase domains characteristic of the DEAH subgroup of SF2 helicases
(10). The adjacent Zn2+ binding domain has been found in all RecQ helicases exam-
ined, except for RECQ4. Another characteristic of the RecQ members is the winged
helix (WH) domain, which has only been found to be absent in the human RECQ4 and
RECQ5 and their orthologues. Furthermore, distal to the WH domain, the Helicase
and RNAse D C-terminal (HRDC) domain is found. This domain is absent in RECQ1,
RECQ4 and REQ5. The WRN helicase contains an additional 3’-5’ exonuclease at the
aminoterminus of the protein and a 27 amino acid repeat between the exonuclease and
the helicase domains. All unicellular organisms examined contain a single RecQ homo-
logue that harbours all the common conserved motifs, such as the helicase domains,
the Zn2+ binding domain, the WH domain and the HRDC domain (34).
Some biochemical characteristics of selected members of the RecQ family are listed
in Table 2. Figure 4 schematically shows some substrates that have been used to study
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the substrate specificities of RecQ helicases in Table 2.
5'
5'
3'
3'
5'
5'
3'
3'
5'3'
5' 3'
5'
5'
3'
3'
5'
5'
3'
3'
5'
5'
5'
3'
3'
3'
3'
3'
3'
5'
5'
5'
5'
5' 3'
5'
3'
Blunt-ended duplex
Enzymes that require a free ssDNA tail or load
to a specific structure do normally not unwind
such a structure by themselves.
5‘- tailed duplex
A substrate for 5’-3‘ helicases that load on free
ssDNA or to the ssDNA/dsDNA interface. 
3‘- tailed duplex
A substrate for 3’-5‘ helicases that load on free
ssDNA or to the ssDNA/dsDNA interface. 
Duplex containing a bubble
This substrate mimicks a duplex with a distor-
tion of the helix or DNA containing a loop.
Splayed arm or forked duplex
5'-3' and 3'-5' helicases that require free ssDNA
or load on this specific junction will unwind such
a substrate.
A classic helicase substrate
Large circular ssDNA containing a partial
duplex. This substrate has been mostly pre-
pared from M13 ssDNA annealed to a synthetic
oligonucleotide
D-loop structure
This substrate mimicks an intermediate from
homologous recombination, a ssDNA strand
invades the duplex to form this structure. Dis-
ruption of D-loops can be monitored if the
enzyme does not unwind from blunt ends.
Holliday junction or 4-way junction
A synthetic Holliday junction resulting from
annealing of four oligonucleotides. Used to test
for Holliday junction branch migration. A pre-
ferred substrate for BLM.
G4 DNA, also called G quadruplex DNA.
G-rich sequences, especially at telomeres, can
form such a structure through Hogsteen-bonds
between Gs. This structure is biochemically
formed from one oligonucleotide and is stable at
room-temperature. A preferred structure for
BLM, WRN and Sgs1. 
Figure 4: Various DNA substrates used to biochemically assay DNA helicases and explanatory to Table 2.
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Substrate RECQ1 BLM WRN Sgs1 E. coli RecQ
Blunt-ended duplex - (35) - (36; 37) - (36; 38; 39) + (40; 41; 42)
5’-tailed duplex - (35) - (36; 37) - (39) - (43) + (42)
3’-tailed duplex + (35; 44) -+ (36) -+ (36; 45) + (43) + (42)
Splayed arm + (44) + (36; 46; 47; 48) + (36; 46; 47; 49) + (43; 50; 51) + (42; 52)
Bubble-substrate 4nt - (36)
Bubble-substrate 8nt
and larger
-+ (35) + (36) ++ (36; 38)
D-loop + (44) + (37) + (53)
circular ssDNA/partial
duplex 17-30 bp
+ (35) + (54; 55) + (56; 57; 58; 59) + (60)
circular ssDNA/partial
duplex 42-100 bp
+ (61) + (54; 37; 55; 62) - (56; 58; 63; 64) + (60) + (40; 65)
Holliday junction + (44) ++ (36; 66) + (36) + (43; 66) + (42)
G4 DNA 3’ tail ++ (36; 48; 66) ++ (36) ++ (50; 51; 66) + (52)
G4 DNA blunt - (48) - (36; 67) - (50)
G4 DNA 5’ tail + (67)
Table 2: Substrate specificities for some RecQ helicases. + indicates unwinding ability, - no unwinding observed, ++ strong
activity, -+ weak activity. The substrates are explained in Figure 4
.
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2.2 The Escherichia coli RecQ
2.2.1 Genetics
The RecQ protein from Escherichia coli is the founding member of the RecQ DNA he-
licase family and was discovered in 1984 by Nakayama et al. in a screen for mutations
that confer resistance to thymineless death (68; 69). RecQ acts in the RecF pathway of
homologous recombination that operates in the repair of stalled replication forks. RecQ
mutations in a recBC sbcB background lead to an enhanced UV sensitivity and lower
the efficiency of conjugal recombination (68). RecQ and RecJ are required for lagging
strand degradation at stalled replication forks. (70; 71; 72). RecQ is involved in the su-
pression of illegitimate recombination, which is enhanced 30-300 fold in recQ− mutants
(73). A recent study shows that RecQ is needed for the fast degradation of the LexA
repressor in response to UV irradiation to induce the SOS response (74), reviewed in
Ref. (75). The SOS response is a mechanism of bacteria strongly enhanced by the for-
mation of RecA filaments and induces the expression of roughly 30 DNA repair genes
as a response to DNA damage (76).
2.2.2 Biochemical Properties of RecQ
The RecQ gene codes for a 610 amino acids long protein that is an ATP-dependent 3’-5’
helicase. In an initial biochemical characterisation of RecQ, Umezu et al. observed that
the protein is able of unwinding partial duplexes as long as 143 bp in an ATP-dependent
manner (40). Harmon and Kowalczykowski found that RecQ is capable of unwinding a
wide variety of abnormal DNA structures including D-loops, indicative of a role in sup-
pressing illegitimate recombination by disrupting aberrant recombination intermediates
(42). Furthermore, RecQ was shown to unwind a covalently closed double-stranded
DNA substrate which can activate the strand-passage activity of DNA topoisomerase III
(77). Further biochemical properties are in another chapter (Chapter 2).
2.2.3 Models for RecQ-mediated DNA Transactions
Based on genetic and biochemical evidences, four roles for RecQ in the maintenance of
genomic stability in E. coli have been proposed (Figure 5): In a model for the initiation
of recombination, RecQ unwinds DNA at gaps (in wt cells) or double-strand breaks
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(in recBC- cells) allowing RecA filament formation to initiate recombination and D-loop
formation (42). In the anti-recombination model, RecQ can disrupt D-loops formed by
RecA (42). RecQ is very likely to perform the double Holliday junction (DHJ) dissolution,
as it has been shown that RecQ in concert with Topo III can catenate/decatenate duplex
DNA (77), and that BLM together TOPOIIIα can perform the DHJ dissolution (4) it is
likely that RecQ can, together with Topo III perform this reaction as well in vivo. In
the SOS model of Hishida et al. (74), RecQ binds a gap on the leading strand of a
stalled replication fork and unwinds the duplex template ahead of the fork, in a 3’-5’
direction. The ensuing topological stress may be relieved by the combined action with
a type I topoisomerase such as Topo III. Subsequently, RecQ switches to the lagging
strand template, generating a single-stranded DNA gap on the lagging strand, on which
a RecA filament is assembled in the 3’ direction, leading to SOS induction. Subsequent
repair of the blocking lesion, trans-lesion synthesis, or recombinational restart may lead
to the resumption of DNA replication.
Figure 5: Roles of the RecQ DNA helicase in genomic maintenance. Adapted from Ref. (75) (A) Initiation of recombination. (B)
Anti-recombination. (C) DHJ dissolution. (D) The SOS model.
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2.2.4 Structure of RecQ
Bernstein and Keck have crystallized the catalytic core of the E. coli RecQ protein and
resolved its structure (34). The crystal structure of RecQ is shown in Figure 6. In this
work, the authors show that C-terminally adjacent to the helicase domains, there are
two additional structural motifs that are not present in other helicases: The Zn2+-binding
domain contains four highly conserved cysteines which coordinate a zinc ion. Adjacent
to that lies the winged helix (WH) domain forming a helix-turn-helix fold, found to act as a
DNA binding motif in many proteins (78). The HRDC was not present on the polypeptide
crystallized and its function is not yet fully elucidated. Liu et al. have resolved the 3-
dimensional structure of the HRDC of Sgs1 from Saccharomyces cervisiae, but were
not able to draw functional conclusions from this work (79).
Recently, Liu et al. have characterised the importance of the Zn2+-binding domain.
They show that the highly conserved cysteines form a complex with the Zn2+. This
complex is essential for DNA binding and helicase activity, but not for ATP binding.
Furthermore, they show that this zinc finger binding motif is important in maintaining the
integrity of the protein structure. They further discuss that this Zn2+ finger is unique to
the RecQ family (80).
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Figure 6: The structure of the RecQ catalytic core. Adapted from Ref. (34). (A) Schematic diagram of E. coli. Three conserved
regions, helicase, RecQ-conserved (RecQ-Ct), and Helicase-and-RNase-D-C-terminal (HRDC) (81), are labelled. The catalytic
core of E. coli RecQ (RecQ∆C) includes only the helicase and RecQ-Ct regions, and comprises four apparent subdomains in the
structure: residues 1-208 in red, 209-340 in blue, 341-406 in yellow and 407-516 in green. (B) Sequence and secondary structure
of RecQ∆C. Helices (boxes) and β-strands (arrows) are shown above the sequence and labelled sequentially. Colour coding is
the same as in (A). Conserved helicase motifs (motifs 0-VI) are labelled and enclosed in boxes. Residues that are invariant among
65 bacterial RecQ proteins are underlined, and residues that are invariant or highly conserved with a subset of eukaryotic RecQ
proteins (human WRN, BLM, and S.cervisiae) are highlighted in purple or light-blue boxes, respectively. (C) Orthogonal views of a
ribbon diagram of the crystal structure of RecQ∆C, colour-coded as in (A). A bound Zn2+ ion is shown as a magenta sphere.
2 THE RECQ FAMILY OF DNA HELICASES 12
2.3 Saccharomyces cervisiae Sgs1
2.3.1 Sgs1 Cellular Phenotype
Sgs1 was identified as a suppressor of the slow growth phenotype of top3 mutants
(Chapter 2.3.3). sgs1 mutant budding yeast cells show a 40% decrease in lifespan
compared to wild-type cells (82; 83). McVey et al. have shown that sgs1 mutants
in fact arrest in G2 or in G1 (84). sgs1 mutants do not show differences in telomere
lenghts, compared to wild-type cells (85), but the double mutants sgs1 tlc1 and sgs1
est2 show an elevated rate of telomere shortening compared to the single tlc1 mutant,
indicating a role in telomere maintenance (86). sgs1 cells show increased sensitivity to
treatment with MMS (87; 88), UV light (89; 90) and HU (91), but not to γ-radiation (91).
At the chromosomal level, sgs1 mutants display a wide variety of defects as marker loss
(85; 92), an elevated rate of sister chromatid exchanges (SCE) (93), gross chromosomal
rearrangements (94; 95), a higher rate of loss of heterozygosity (96) and an increased
level of illegitimate recombination (97). MMS-induced interchromosomal recombination
was found to be reduced in sgs1 cells and UV light exposure of these mutants only
induced little of those events (92).
2.3.2 Biochemical Properties of Sgs1
Sgs1 codes for a protein of 1447 amino acids and has not been purified at the full
length yet. Biochemical assays were performed with a deletion variant Sgs1400-1268,
which is as the other RecQ helicases an ATP-dependent 3’-5’ helicase being able to
unwind a wide variety of abnormal DNA structures including Holliday junctions (HJ) and
D-loops (Chapter 2). Not only is Sgs1 able to unwind DNA duplexes, it can also disrupt
RNA/DNA hybrid molecules (60).
The abundance of Sgs1 is cell-cycle regulated, with low levels in M and G1, a peak
in S and degradation in G2. Sgs1 forms S-phase specific nuclear foci which partially
co-localise with Rad53 and the origin recognition complex (82). Sinclair et al. have
reported Sgs1 to localise into the nucleolus (82), while Frei and Gasser did not observe
this (91).
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2.3.3 Interaction Partners and Models for DNA Transactions
Topoisomerases
DNA topoisomerases are enzymes that alter the state of supercoiling of DNA by a
strand-passage mechanism involving transient DNA breaks. According to their mode of
action, they are classified into the type I topoisomerases which generate ssDNA breaks
and into type II topoisomerases that create dsDNA breaks to mediate strand-passage.
The S. cervisiae Sgs1 was identified by three different groups independently, but al-
ways in the context of either a topoisomerase gene or protein. Gangloff et al. discovered
Sgs1 in a screen for suppressors of the top3 slow-growth phenotype (98). Watt et al.
identified Sgs1 in a search for interaction partners of Top2 (99) and Lu et al. found
Sgs1 because of genetic interaction with Top1 (Type I) (100). Sgs1 interacts physically
and genetically with all three nuclear topoisomerases. Yeast Top1 is required for DNA
replication (101), mitotic chromosome condensation (102) and general transcriptional
repression in stationary phase (103). Under normal conditions, a deletion of top1 has
no effect on growth. Top1 has been reported to interact with Sgs1, but the role of this
complex has not been identified yet (99; 82). Top2 (Type II) is required for the resolu-
tion of intertwined chromosomes during mitosis and meiosis and is an essential gene
(104; 105; 106). Genetically, Top2 and Sgs1 have been reported to be epistatic with
regard to reducing chromosome non-disjunction, suggesting that they are involved in
the same pathway for chromosome segregation (85).
Top3 mutants grow poorly (107; 108), are sensitive to DNA damaging agents (109;
110), have severe meiotic defects (111; 112) and exhibit hyper-recombination between
repetitive sequences such as telomeres and rDNA (101; 108; 111). The G2 delay, ele-
vated frequency of marker loss and altered morpholgy of a top3 mutant are suppressed
by mutations in the Sgs1 gene (98; 113). Recombinant Top3 (Type I) only acts on
negatively supercoiled dsDNA (107). Ira et al. have shown that the deletion of Sgs1 in-
creases crossovers in yeast cells 2-3 fold. The overexpression of Srs2 nearly eliminates
crossovers, whereas overexpression of Rad51 in srs2 cells almost completely elimi-
nates the noncrossover recombination products. It is very likely that Sgs1 in concert
with Top3 performs the same reaction as BLM/TOPOIIIα on DHJs.
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Sgs1 and Homologous Recombination
Srs2 is a 3’-5’ helicase showing only limited homolgy to the E. coli UvrD helicase and
no homology to any known human protein (114). Srs2 suppresses homologous recom-
bination (HR) through disrupting Rad51 ssDNA filaments (115; 116). Recently, Pfander
et al. have demonstrated that SUMO-modified PCNA recruits Srs2 in S phase to pre-
vent unwanted recombination events at replicating chromosomes (117). Furthermore,
the sgs1 srs2 double mutant shows a severe growth which is alleviated upon blocking
recombination by mutating Rad51, Rad52, Rad55 or Rad57 (89). A recent study from
Liberi et al. shows that in sgs1 mutants, recombination-dependent DNA intermediates
accumulate at damaged forks, a phenomenon that requires the Rad51 protein, which is
counteracted by the Srs2 protein and does not prevent fork movement (118). Sgs1, but
not Srs2, promotes the resolution of these recombination intermediates. The integrity of
these DNA structures at sister chromatid junctions is protected by the Rad53 checkpoint
kinase. They also show that top3 and top3 sgs1 mutants accumulate the same struc-
tures as sgs1 cells, arising from defective maturation of the recombination intermediates
(118). The accumulation of HJs arising from fork reversal in rad53 mutants has been
shown by Sogo et al. (119).
Sgs1 in Checkpoint Activation and Replication Fork Maintenance
Frei and Gasser have observed that the deletion of Sgs1 partially compromises the intra-
S-phase checkpoint, which is largely mediated by the Rad53 kinase (91). Bjergbaek et
al. later found that Sgs1 functions independently of both Top3 and Rad51 to stimulate
the checkpoint kinase Rad53 upon replication fork stalling in response to HU treatment.
This checkpoint activation is not dependent on the helicase activity of Sgs1 which cor-
relates with the finding of direct interaction with Rad53. Furthermore, Sgs1 and Mrc1,
which serves as mediator or adaptor for Rad53 activation, act in the same pathway for
checkpoint activation. Moreover, they find that Top3 and Rad51 are required for DNA
polα and DNA pol ² stabilisation at stalled replication forks and that Sgs1 and Mrc1 act
synergistically to stabilise DNA polα and DNA pol ² at stalled forks (120; 121) . The
authors conclude that the checkpoint kinase activation requires Sgs1 as a noncatalytic
Rad53-binding site, while the Top3/Sgs1 resolvase contributes to recovery of stalled
replication forks (121). Fabre et al. have further shown that Sgs1 may be involved in the
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repair of single-stranded gaps arising from replication (122).
The SLX genes and Mus81/Mms4
In a screen for mutations that show synthetic lethality in an sgs1 background, Mullen et
al. have found a group of genes that were named SLX (123; 124). A synthetic lethality
was also found between the slx mutants and top3, indicative of a function in pathways
parallel to that of Sgs1/Top3. SLX6 was shown to be allelic to Srs2. Slx5 and Slx8 are
putative RING/finger domain proteins that form a complex and are required for efficient
sporulation. Slx1 and Slx4 also form a complex and Slx2 and Slx3 were demonstrated to
be the two subunits of the Mus81-Mms4 heterodimeric complex that acts as a structure-
specific nuclease (123; 124). Fabre et al. have later proposed that the single stranded
DNA resulting from the stalling of replication forks can be processed by two competing
mechanisms: Either recombination or nonrecombinational translesion synthesis. Srs2
would channel recombination intermediates back into the translesion synthesis pathway,
whereas Sgs1/Top3 and Mus81/Mms4 interact in recombination and/or replication to
allow replication restart (122).
RAD16
Saffi et al. have shown that Sgs1 is epistatic to the repair protein Rad16 with respect to
cell survival after treatments with UVC, 4-NQO and H2O2 and that the defect in helicase
activity of Sgs1 is essential for most aspects of the sgs1 mutation phenotype (90; 109).
Rad16 has been shown to function in global genome repair of the nucleotide excision
repair (125).
RMI1/NCE4
In a recent study, Chang et al. show that Rmi1 (RecQ-mediated genome instability,
also known as NCE4) physically interacts with Sgs1 and Top3 (126). Cells lacking RMI1
activate the Rad53 checkpoint kinase, undergo a mitotic delay, and display increased re-
localisation of the recombination repair protein Rad52, indicating the presence of spon-
taneous DNA damage. Consistent with a role for RMI1 in maintaining genome integrity,
rmi1 cells exhibit increased recombination frequency and increased frequency of gross
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chromosomal rearrangements. In addition, rmi1 strains fail to fully activate Rad53 upon
exposure to DNA-damaging agents, suggesting that Rmi1 is also an important part of
the Rad53-dependent DNA damage response (126).
Another recent study identified Rmi1/Nce4 as potential component of the Sgs1/Top3
pathway, based on the observation that strains lacking any one of these genes require
Mus81 and Mms4 for viability. sgs1 and rmi1 mutants display the same spectrum of
synthetic lethal interactions, including the requirements for Slx1, Slx4, Slx5, and Slx8.
Like sgs1 mus81, the rmi1 mus81 synthetic lethality is dependent on HR. On their own,
mutations in Rmi1 result in phenotypes that mimic those of sgs1 or top3 strains including
slow growth, hyperrecombination, DNA damage sensitivity and reduced sporulation.
And like top3 strains, most rmi1 phenotypes are suppressed by mutations in Sgs1. They
further show that Rmi1 forms a heteromeric complex with Sgs1-Top3 in vitro and in vivo.
The Rmi1-Top3 complex is stable in the absence of the Sgs1 helicase, but the loss of
either Rmi1 or Top3 in yeast compromises the interaction of the other with Sgs1. Further
biochemical studies demonstrated that Rmi1 is a structure-specific DNA binding protein
with a preference for cruciform structures suggesting that the DNA binding specificity of
Rmi1 plays a role in targeting Sgs1-Top3 to appropriate substrates (127).
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2.4 RECQ1
RECQ1, sometimes called RECQL or helicase Q1, is the smallest of the human RecQ
helicases (see Figure 3) and was originally cloned independently by two groups (128;
129). The human RECQ1 gene is located on chromosome 12p11-12 (128; 130). Zhang
and Xi have described two variants resulting from alternative splicing (131). Interest-
ingly, although a defect in RECQ1 has not been associated with a human disease yet,
this chromosomal location has been found to coincide with cytogenetic alterations in
testicular germ-cell tumours (132).
The first biochemical charaterisation of RECQ1 was performed before its cDNA was
cloned. Yanagisawa et al. purified DNA-dependent ATPases from HeLa cells and xero-
derma pigmentosum (XP) cells to identify the cause of the disease and found that the
ATPases purified from XP cells differed from those from HeLa cells (133). A 73 kDa AT-
Pase, called ATPase Q1, was isolated and found to display 3’-5’ helicase activity (134).
The identified ATPase Q1 failed to complement XP-cell extracts from XP-C complemen-
tion group cells for DNA repair defects (129). The XPC helicase defective in these XP-C
complementation group cells was identified in another work (135).
The purified RECQ1 was shown by Cui et al. to form dimers in the presence and
absence of ssDNA, with an apparent molecular mass of 158 kDa (35; 61). Also, the
kinetic studies on RECQ1-mediated unwinding suggested that the enzyme functions as
a dimer (35).
RECQ1 is by itself a rather poor helicase, capable of displacing short partial duplexes.
However, it displays an enhanced processivity upon interaction with human replication
protein A (RPA) being able to unwind duplexes as long as 501 bp. This interaction is
specific, as the E. coli single strand binding protein (ESSB) did not stimulate RECQ1-
mediated unwinding of long duplexes (61). Therefore, the enhancement of processivity
is not achieved through merely coating the single stranded DNA, but rather through a
specific protein-protein interaction facilitating the loading of the helicase onto the ss-
DNA/dsDNA interface. Furthermore, RECQ1 has recently been shown to unwind HJs,
D-loops and to promote annealing of short oligonucleotides (44).
In a yeast two-hybrid screen, Seki et al. have identified RECQ1 to interact with Qip1
and Rch1, which are two of the three human importin α homologues involved in nuclear-
cytoplasmic transport (136). This interaction was confirmed by the finding that Qip1 was
2 THE RECQ FAMILY OF DNA HELICASES 18
able to mediate nuclear transport of BSA when conjugated to the full RECQ1 nuclear
localisation signal (NLS) (137).
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2.5 BLM - The Bloom Syndrome Helicase
2.5.1 The Bloom Syndrome
The Bloom syndrome (BS) is a rare autosomal recessive disorder with a high predis-
position to cancer development. BS was first observed in 1954 (138) and is caused by
defects in the BLM gene, located on chromosome 15q26.1 (28). BS is characterised
by a stunted growth, including disproportional growth, manifested in a small head and
unusual facial and skull growths. Furthermore, male infertility and immunodeficiency,
characterised by a decrease in IgA and IgM levels is observed in BS patients. Figure 7
shows a young BS patient who suffers from severe facial telangiectatic erythema. BS
patients suffer from a 150-300 fold increase in the risk of developing malignancies of all
types.
Figure 7: A BS patient. Adapted from Ref. (139). His sun sensitive telangiectatic erythema cover almost all his face.
2.5.2 BS Cellular Phenotype
The hallmark of cell lines derived from BS patients is the elevated rate of sister chro-
matid exchanges (SCEs) to about 10 fold. SCEs represent HR events between sister
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chromatids during S phase or G2 resulting in crossovers. In Figure 8, an example for
elevated SCE levels in BS cells is shown. Similarly, ES cells as well as lymphocytes,
primary or immortalised fibroblasts of Blm knockout mice (140; 141), murine Blm knock-
out ES cells (142) and DT40 BLM-/- chicken B-cells (143; 144) show an elevated rate of
SCEs.
Figure 8: SCE analysis. Adapted from (145). To the left, chromosomes from a normal cell. To the right, chromosomes from a
BS cell. Sister chromatids are distinguished through an assay based on differential labelling by BrdU.
It has been observed that BS cells as well as fibroblasts from BLM-/+ carriers show a
tendency for the accumulation of micronuclei (146; 147) or to bud out micronuclei at an
abnormally high rate (148). Furthermore, a comparatively high number of gaps, breaks
and rearranged chromosomes can be observed in BS cells (149; 150; 143). Moreover,
BS cells have been reported to display a significantly lower rate of chain elongation
during DNA synthesis (151; 152). BS cells are sensitive to UV radiation (153; 144) and
to the ribonucleotide reductase inhibitor hydroxyurea (HU) (154; 155).
2.5.3 BLM - The Protein
The BS protein (BLM) is 1417 amino acids long, was cloned (18) and purified and char-
acterised (62), where it was found that the protein displays ATP-dependent 3’-5’ helicase
activity. Furthermore, BLM has been found through gel-exclusion chromatography and
electron microscopy to form ring-oligomeric structures with hexamers being the most
prominent forms (156). BLM is able to unwind a wide variety of structures as depicted
in Table 2 with a preference for quadruplex DNA and HJs (48; 157). The most important
biochemical finding on BLM to date is, that in conjunction with TOPOIIIα, it is able to
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resolve DHJs via a strand passage mechanism that prevents exchanges between flank-
ing sequences (4). This reaction is called DHJ dissolution and is illustrated in Figure
9. DHJs have been described to be intermediates in meiotic recombination (158) and
are predicted to form in mitotic cells during repair of DSBs by HR. As BS cells are not
hypersensitive to ionizing radiation, BLM presumably does not carry an essential role
in DSB repair (159). It is thought that the non-meiotic DHJs arise from HR-dependent
repair of daughter strand gaps formed during replication (159; 4). The DHJ dissolution
reaction explains many of the phenotypes of BS cells, but most importantly, the cause
of the elevated rate of SCEs is revealed. In addition, BLM has also been reported to
mediate strand exchange in vitro by Machwe et al. (160).
The expression of BLM cells is cell-cycle dependent; The protein level peaks in S,
persists in G2/M and is degraded in G1, consistent with its role in S and G2. BLM is
a phosphoprotein and is phosphorylated during mitosis (154; 161) and in response to
γ-radiation (162; 163; 155). The kinase responsible for this posphorylation seems to be
ATM (Chapter 2.5.4). Also, BLM can be sumolyated (Chapter 2.5.4). Furthermore, BLM
is a downstream target of the ATR-Chk1 pathway.
Dissolution
BLM/TOPOIIIα
14 bp
Figure 9: The DHJ dissolution reaction. Adapted from (4). BLM and TOPOIIIα together dissolute the structure depicted to the
right into its components. In the experimental setup, one of the component oligonucleotides is labelled radioactively and will be
detected as single species upon visualisation of radioactivity.
2.5.4 Interaction Partners of BLM
Many of the interaction partners of BLM listed below indicate that BLM is recruited to and
activated at sites of recombination, probably to ensure the correct resolution of aberrant
structures without cross-overs.
ATM, ATR and DNA Damage Response
In cells from ataxia telangiectasia (AT) patients - they lack the ataxia telangiectasia
mutated protein (ATM) - the mitotic and the γ-radiation-induced phosphorylation of BLM
are absent (153; 164; 163), but the ATR-dependent phosphorylation of BLM in response
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to HU or UVC treatment is not altered (153; 164). ATM appears to be activated primarily
by ionizing radiation or radiomimetic drugs that generate double-strand breaks (165).
BLM has been reported to interact with ATM by Beamish et al. (154). Also, BLM interacts
with ATR and evidences have lead to the suggestion that BLM is also a downstream
target of ATR (164). It was shown that BLM forms foci with γH2AX at broken replication
forks and that these foci recruit BRCA1 and NBS1 (166). Later, it was found that BLM
localises into nuclear foci with phosphorylated γH2Ax and RAD51 and proposed that
this is a response to restore productive DNA replication following S-phase arrest (155).
BLM is very likely to be required at these cites to resolve the arising recombination
intermediates.
Sengupta et al. have observed that BLM co-localised with the DNA damage response
proteins 53BP1 and H2AX. Furthermore, BLM facilitated the the physical interaction be-
tween p53 and 53BP1, but 53BP1 was required for the efficient accumulation of BLM
and p53 at sites of stalled replication. The formation of BLM/53BP1-foci was indepen-
dent of γ-H2AX. The Chk1 active kinase was essential for the focal co-localisation of
BLM and 53BP1 and for the consequent stabilisation of BLM. The authors propose that
BLM functions in repair processes upon receipt of the signals mediated by 53BP1 and
from ATR/Chk1 from replicational stress (167).
The BASC complex
Wang et al. have identified a high-order complex consisting of many DNA repair fac-
tors, BLM amongst them, and called it BASC, standing for BRCA1-associated genome
surveillance complex (168). The complex includes tumour supressors and DNA dam-
age repair proteins: BRCA1, BLM, MSH2, MSH6, MLH1, ATM, RAD50-MRE11-Nbs1
(MRN complex) and RFC. Especially, it was found that BRCA1, BLM and the MRN
complex form large nuclear foci containing PCNA upon treatment with DNA-synthesis
inhibiting agents.
The BRAFT Complex
Upon immunoprecipitation of BLM from HeLa cells, Meetei et al. identified by masspec-
trometric methods a complex that includes BLM, TOPOIIIα, RPA and the five core Fan-
coni anemia (FA) proteins FANCA, FANCC, FANCE, FANCF and FANCG and called this
2 THE RECQ FAMILY OF DNA HELICASES 23
complex BRAFT. BLM is responsible for the unwinding activity in this complex (169).
Pichierri et al. have shown that BLM and FANCD2 colocalise and co-immunoprecipitate
upon treatment with DNA crosslinkers or agents inducing replication fork arrest, again
indicating a functional interaction (170). The features of the BS are very different to
those of the FA, but some aspects of genomic instability in these diseases are similar.
For a review on the Fanconi anemia proteins, see Ref. (171).
CAF-1
Jiao et al. found that BLM interacts with hp150, the largest subunit of the chromatin as-
sembly factor 1 (CAF-1) in vivo and in vitro. The two proteins were found to co-localise
at nuclear foci at sites of DNA synthesis. The fraction of co-localising foci was increased
upon DNA damage or replication inhibition. BLM could inhibit CAF-1-mediated chro-
matin assembly in vitro. The activity of CAF-1 was not affected in BLM deficient cells,
CAF-1 could not be mobilized in the nucleus upon hydroxyurea treatment. The authors
suggested that BLM and CAF-1 function in a coordinated way to promote survival in
response to DNA damage and/or replication blockage (172).
PML
The premyelocytic leukemia protein (PML), is a tumour supressor and has been found
to localise into specific structures called PML bodies, where many proteins involved in
DNA metabolism localise to (173; 174; 175). BLM trafficks into PML bodies in a manner
dependent on SUMO modification (176).
MutSα - the MSH2/MSH6 heterodimer
Marsischky et al. observed, that the S. cervisiae MSH2/MSH6 heterodimer (MutSα)
interacts with HJs and may help resolving them (177), providing a first evidence for a
possible role of DNA mismatch repair (MMR) proteins in HR. Later, it was found that
BLM associated with the human MutSα through direct interaction with hMSH6 in vivo.
BLM and MSH6 co-localise at nuclear foci upon exposure to ionizing radiation. The
authors did not observe an effect of MutSα on unwinding activity of BLM (178). Yang
et al. have further investigated this interaction and found that the purified MutSα could
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stimulate the BLM-mediated HJ branch migration in vitro and that this interaction could
be regulated by p53. Furthermore, hMSH6 co-localised with BLM and p53 phosphory-
lated at Ser-15 in hydroxyurea-induced RAD51 foci. Moreover, they showed hMSH2 and
hMSH6 to coimmunoprecipitate with BLM, p53 and RAD51. Moreover, they observed
that the number of RAD51 foci and the amount of the BLM-p53-RAD51 complex was
increased in cells deficient in hMSH2 or hMSH6 (179). The authors deduct from these
data that MutSα forms a complex with BLM-p53-RAD51 in response to the damage of
DNA replication forks to promote DSB repair. This assumption may not quite explain
why the mismatch-sensor complex MutSα would be required at these sites. An intrigu-
ing model would be that the MutSα/BLM interaction serves for preventing homeologous
recombination (HR between not perfectly homologous sequences). For a review on
MMR, see Ref. (180).
MLH1
MLH1, one of the eukaryotic homologues of the MutL from E. coli, is part of the het-
erodimeric complex MutLα consisting of MLH1 and PMS2 that is recruited to sites of
DNA-mismatch-specific bound MutSα or MutSβ complexes during MMR (181). BLM
and MLH1 have been found to interact in vivo and in vitro. Furthermore, BLM and
MLH1 co-localise in untreated as well as in aphidicoline-treated cells (182). As BLM
deficiency does not result in a MMR defect, BLM is very unlikely to play a role in this
reaction (182; 183).
p53
Wang et al. found that BLM and p53 are likely to regulate apoptosis since they observed
that the ectopic expression of p53 induces apoptosis in normal cells but not in BS cells.
As BS cells show normal Fas-induced apoptosis, this effect seems specific for the p53
apoptotic pathway (184). However, Davalos and Campisi claim that p53-induced apop-
tosis also occurs in BS cells (166)
In vivo, BLM and p53 phosphorylated on Ser-15 partially co-localise (185). BLM and
p53 also co-immunoprecipitate from cell extracts (184; 185) and have been shown to
physically interact in vitro (186). p53 is able to inhibit the unwinding activity of BLM
on HJs, but not on standard oligonucleotide substrates. p53 may therefore be involved
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in the regulation of HR through modulating the interaction of BLM with recombination
intermediates (185). Furthermore, Garkavtsev et al. have observed that the ectopic
expression of BLM causes an anti-proliferative effect in p53 wild-type cells, but not in
p53-deficient cells. Moreover, the p53-mediated transactivation is attenuated in primary
BS fibroblasts (186).
Rad51
The eukaryotic Rad51 protein and its paralogs are orthologues of the bacterial RecA
protein which is involved in HR and DNA repair. Rad51 forms a nucleoprotein filament
on ssDNA to mediate strand exchange. BLM and the human Rad51 have been shown
to interact both in vivo and in vitro. In some untreated cells, BLM and Rad51 co-localise
in late S-phase, and this is enhanced upon γ-radiation and aphidicolin treatment (187;
162). Rad51 and BLM have also been observed to co-localise in early meiotic cells at
sites of interhomologue-DNA transactions (188).
RPA
The replication protein A (RPA) is a human single-stranded DNA binding protein that
exists as a heterotrimer formed by subunits of 14, 32 and 70 kDa. BLM interacts physi-
cally with RPA through the p70 subunit (54; 183) and co-localises with the p34 and p70
subunits of RPA at nuclear foci in normal fibroblasts (189). In vitro, BLM is able to un-
wind partial duplexes of up to 100 bp, whereas, in a reaction together with RPA, partial
duplexes as long as 259 bp can be unwound. This enhancement of helicase activity is
not achieved through stimulation of ATPase activity (54; 47).
TOPOIIIα
The type I topoisomerase TOPOIIIα co-localise with BLM at nuclear foci in growing, nor-
mal fibroblasts as well as in transformed human fibroblasts (190) and interacts directly
with BLM in the dissolution of DHJs in a non-crossover manner (Chapter 2.5.3) (4).
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TRF2
In telomerase-negative cells that maintain their telomeres by a different mechanism
called alternative lengthening of telomeres (ALT), BLM colocalises with the telomere re-
peat binding factor 2 (TRF2) in atypical, telomere-associated PML bodies. Also, TRF2
and BLM could be co-immunoprecipitated, suggesting an in vivo role of this association
(191). TRF2 also interacts with BLM physically and stimulates its helicase activity on
forked duplexes with or without two telomeric repeats. TRF2 is unable to bind these
structures, as it requires more telomeric repeats (47).
WRN
WRN and BLM have been reported to interact directly in vivo and in vitro and that this
interaction has a functional consequence in regulating the exonuclease activity of WRN
(63). This interaction is certainly not the only way for the two proteins to function, as
only a small portion of WRN could be co-immunoprecipitated with BLM (63), and BS is
quite different from the Werner syndrome.
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2.6 WRN - The Werner Syndrome Helicase
2.6.1 The Werner Syndrome
Like BS, the Werner syndrome (WS) is a rare autosomal disorder associated with high
predisposition to cancer. It has been described for the first time in the PhD thesis of Otto
Werner in 1904 (29). This syndrome arises from defects in the WRN gene. Only by the
work of Thannhauser (192) this disease was clearly distinguished from the Rothmund-
Thompson syndrome (Chapter 2.7). WS starts to be apparent in adolescence where
the usual growth spurt does not take place, leading to a short stature. As also seen with
BS patients, the facial features are thin and appear bird-like as a result of the stunted
growth. The skin is affected by unusual pigmentation patterns, and hyperkeratoses
appear at bony areas of the skin, such as for example at the limbs, and often acquires
ulcers at such places. The earliest and clearest signs of WS is the early onset of various
features of ageing such as hair greying and thinning, osteoporosis and soft tissue cal-
cification. Furthermore, diabetes mellitus at an unusual early stage can evolve as well
as arteriosclerosis, hypermelanosis and cerebral cortical atrophy. WS is not only char-
acterised by premature ageing but also a higher incident of malignancies is observed
(193). These malignancies, unlike the ones observed in BS, are mostly of epithelial
and mesenchymal origin. Therefore, WS patients have a predisposition to develop soft
tissue sarcomas, osteosarcomas, acral lentigenous melanomas, meningiomas and thy-
roid carcinomas (194). In contrast to the ageing symptoms, it has been observed that
WS patients have a lower incidence of Alzheimer-like neuropathologies (195). Figure
10 shows a typical WS patient.
2 THE RECQ FAMILY OF DNA HELICASES 28
Figure 10: A Japanese-American WS patient as a teenager (left) and at the age of 48 (right). She was patient number 1 in the
study of Epstein et al. and deceased at the age of 57, a high age for WS patients. Adapted from Ref. (193).
2.6.2 WS Cellular Phenotype
The WRN gene has been positionally cloned and is located in the p11-p12 region on
chromosome 8, spanning 180 kb (30; 196). In culture, WS cells have been shown to
undergo replicative senescence at a faster rate than normal cells which is considered
to be the hallmark of WS cells with an average lifespan of only 27% of normal cells
(197). A recent study shows that the WS cells are defective in lagging strand synthesis
of telomeres and therefore will suffer from a single telomere loss and further argues for
WRN being involved in replication, presumably by disrupting quadruplex DNA that may
form on the G-rich lagging strand template (198). Furthermore, the growth defects of
WS cells are retained after transformation (199). The expression of telomerase hTERT
reverses the poor growth and the entry into premature senescence phenotypes of WS
cells but seems not quite sufficient to immortalise the cells (200; 199). WS cells have
been reported to be sensitive to 4-nitroquinoline 1-oxide (4NQO) (144; 201; 202). This
effect can be reverted by expressing hTERT in SV40-transformed WS cells (203). WS
cells have further been reported to be sensitive to DNA cross-linking drugs such as
mitomicin C and cisplatin (199; 202; 204). Furthermore, WRN-deficient human and
murine cells are sensitive to camptothecin, an inhibitor of Topoisomerase I (205; 206).
Sensitivity to γ-radiation and radiomimetic drugs is debated, since several groups have
shown different responses of WS cells to these treatments (144; 199; 201; 207).
The hallmark of WS cells at the chromosomal level is the elevated rate of extensive
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somatic deletions and translocations which can vary in different clones (208; 209). Fur-
thermore, WS cells display a higher number of RAD51 foci than normal cells, which
probably indicates the persistence of unprocessed recombination intermediates (210).
Unlike in BS cells, no increase in SCE-frequency is seen in WS cells (144; 211; 212).
WRN seems not to be involved in homologous recombination. Instead, its strong
interaction with Ku rather suggests a role in non-homologous end-joining, in a manner
that Ku regulates the WRN exonuclease in resection of DNA at non-homologous ends
(Chapter 2.6.4). This action is likely not to be the sole on DNA ends, as WS cells do not
show an obvious DNA double strand break (DSB) repair defect.
2.6.3 WRN - The Protein
The WRN protein is 1432 amino acids long and contains two functional domains: the
central helicase domain and the N-terminal exonuclease domain. Furthermore, it carries
an unusual direct repeat of 27 amino acids located between the exonuclease and the
helicase domains (Figure 3).
WRN displays an ATP-dependent 3’-5’ helicase activity. As most other RecQ heli-
cases, it is able to unwind D-loops, G-quadruplex DNA and to migrate Holliday junctions
(Table 2). The N-terminal nuclease domain displays 3’-5’ polarity and shows low pro-
cessivity (213). Orren et al. have observed that WRN in vitro will as helicase unwind
the duplex of the invading strand in a D-loop structure and as 3’-5’ exonuclease digest
the invading strand (53). WRN has also been reported to mediate strand exchange in
vitro (160), but the activity observed may be debated as the reaction conditions were far
from physiological.
The cellular WRN protein levels are elevated during cytologic transformation of B-
cells and fibroblasts and decreased when fibroblasts in culture reach confluency, in-
dicative of a role of in proliferating cells (214). The expression of WRN is cell-cycle
regulated, with the concentration peaking in the G2/M phases (215). WRN is present in
the nucleolus and migrates from nucleoli to nuclear foci upon treatment with HU, aphidi-
colin, 4NQO or camptothecin (216; 217; 218; 219; 220).
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2.6.4 Interaction Partners of WRN
DNA-PK complex
The DNA-PK complex consists of DNA-PKcs and the Ku70/Ku80 heterodimer. It has
been shown that WRN interacts with both the Ku heterodimer (221; 222; 223; 224;
225; 226) and DNA-PKcs (207). WRN is phosphorylated in vivo and in vitro by DNA-
PK (207). The Ku70/Ku80 heterodimer strongly stimulates the exonuclease activity of
WRN (223; 224; 207; 227), which is alleviated by poly(ADP-ribosyl)ation of Ku70/Ku80
(228). Not only does the Ku70/Ku80 stimulate the exonuclease activity of WRN, but it
also extends the substrate specificity, so that WRN is able to degrade 3’ protruding or
blunt ends (223). Moreover, the inhibition of WRN exonuclease activity by 8-oxoG and
8-oxoA is alleviated by Ku70/Ku80 (229; 222).
DNA polymerase β
DNA polymerase β (polβ) is a key polymerase in both short and long-patch base ex-
cision repair (BER) (for a review on BER, see Ref. (230)). WRN has been shown
to physically interact with polβ and to stimulate strand-displacement DNA synthesis of
polβ (231). Furthermore a truncated variant consisting mainly of the helicase domain
was sufficient to stimulate polβ (231).
DNA polymerase δ
Kamath-Loeb et al. could show that WRN interacts with DNA polymerase δ (polδ), a
polymerase required for DNA replication and repair. WRN increases the nucleotide in-
corporation by polδ in the absence of PCNA but not that of the polymerases α or ² (232).
The same group further showed that this interaction specifically facilitates the polδ-
mediated DNA replication of templates forming secondary structures like quadruplex
DNA and/or DNA repair (233). This hypothesis correlates with the observed S-phase
defects in WS cells, namely defective lagging strand synthesis at telomeres observed
after WRN depletion in HeLa cells (198).
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EXO1
The human exonuclease 1 (EXO1) is a 5’-3’ exonuclease and a 5’-flap-specific endonu-
clease and it has been proposed to function in DNA recombination and MMR. The
exonucleolytic and the endonucleolytic activities have both been shown to be stimulated
by WRN (234). Moreover, EXO1 and WRN interact physically in vivo and in vitro (234).
FEN1
The flap-endonuclease 1 (FEN1) is a protein that acts in DNA replication to remove the
5’ overhang that arises at Okazaki fragments (235) and is also responsible for the re-
moval of 5’ overhangs arising in strand displacement synthesis during base excision re-
pair (236). Brosh et al. have shown that WRN interacts with FEN1 and greatly stimulates
the FEN1 nuclease activity (46). Sharma et al. further show by FRET (fluorescence res-
onance energy transfer) that WRN and FEN1 form a complex in vivo that co-localises
with foci associated with arrested replication forks. WRN stimulates FEN1 cleavage of
branch-migrating double-flap structures (237). Moreover, they show that in vitro, WRN
unwinds Holliday junctions and stimulates FEN1 to cleave the unwound product (237).
MYC
MYC is an oncoprotein and acts as a transcription factor coordinating cell growth and
division. When overproduced, it has been found to sensitize cells to agents stimulating
apoptosis (238). Grandori et al. reported that MYC directly stimulates transcription of
WRN and that the overexpression of MYC in WS fibroblasts or after WRN depletion
from control fibroblasts led to rapid cellular senescence that could not be suppressed
by hTERT expression. They proposed that WRN up-regulation by MYC may promote
MYC-driven tumorigenesis by preventing cellular senescence (239). A discussion of the
link between MYC and WRN in tumourigenesis is laid out by the same group in Ref.
(240).
p53
The tumour suppressor protein p53 interacts physically with WRN both in vitro and in
vivo (241; 185; 217). Yang et al. have further shown that this interaction modulates the
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activities of both partners. p53 inhibits WRN-mediated unwinding of Holliday junctions,
but only if it is not phosphorylated at Ser-378 and is also able to inhibit the exonuclease
activity of WRN (217). WRN enhances the transcription of p53-responsive promoters in
transfection assays. Ectopic expression of WRN also leads to higher p21 protein levels
(241).
RNA polymerase II transcription
Balajee et al. found that in permeabilised WS cells the efficiency of transcription of a
plasmid template containing the RNA polymerase II- dependent adenovirus major late
promoter is reduced to 40-60% compared to normal cells. This reduction in transcription
efficiency is reverted by the addition of the WRN protein. This effect seems to be medi-
ated by the direct repeat of 27 amino acids ahead of the helicase motifs, as the authors
show that a WRN mutant lacking the direct repeat fails to stimulate the low RNA pol II
transcription rate of WS cells (242).
RPA
WRN alone can only unwind partial duplexes up to 40 bp, but in the presence of RPA
it is able to unwind partial duplexes as long as 849 bp without an increase in ATPase
activity (243). RPA does not effect the exonuclease activity of WRN (222). The physical
interaction between WRN and RPA has been shown in vitro (243).
TRF2
In telomerase-negative cells that maintain their telomeres through the ALT pathway,
WRN co-localises with TRF1, TRF2, PML, RAD52 and NBS1 in nuclear structures
called ALT-specific, atypical PML bodies. In HeLa cells, where the telomerase is present,
WRN localises to the nucleolus (86). As observed with BLM, TRF2 interacts with WRN
physically and stimulates the helicase activity of WRN on forked duplexes with or with-
out two telomeric repeats (47). The exonuclease activity of WRN is not affected by
this interaction (47). Opresko et. al further showed that WRN associates with telom-
eres when dissociation of telomeric D-loops is likely during replication and recombina-
tion. They observed that most TRF1/PCNA co-localising nuclear foci contain WRN in S
2 THE RECQ FAMILY OF DNA HELICASES 33
phase ALT cells but not in telomerase-proficient HeLa cells. TRF1 and TRF2 limits the
WRN-mediated disruption of D-loops (244). WRN is thus very likely to be involved in
ALT.
WHIP
The Werner helicase interacting protein (WHIP) is a protein of 660 amino acids with
homology to the replication factor C (RFC) family proteins. WHIP interacts with WRN,
but not with BLM or RECQ1. The function of this protein is unknown to date (245).
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2.7 RECQ4/RTS- The Rothmund-Thomson Syndrome Protein
2.7.1 The Rothmund-Thomson Syndrome
The Rothmund-Thomson syndrome (RTS) is a rare autosomal recessive disorder with
roughly 200 reported patients worldwide. RTS has first been described in 1868 by Roth-
mund, a german ophtalmologist. Patients from a german family suffered from unusual
skin degeneration and cataracts, a condition where the lens of the eye gradually turns
opaque and results in a blurred view (31). 68 years later, Thomson, a British dermatolo-
gist described a syndrome with skin abnormalities and skeletal malformations and called
it Poikiloderma congenitale (32). In 1957, Taylor recognised that the two syndromes are
manifestations of the same disease and called it therefore RTS (33).
Through a number of patient studies it is known that RTS confers a high incidence
of malignancies, mainly osteosarcomas (246; 247; 248; 249; 250; 251; 252; 253). Pa-
tients suffer from retarded postnatal growth and skin abnormalities that manifest as poik-
iloderma and sun-sensitive rash. Most patients also have sparse hair and eyebrows.
Furthermore, diverse skeletal abnormalities arise, such as a decrease in bone density
(osteopenia), pathological fractures, dislocations and metaphysis. In many cases, the
so-called ”radial ray defect” is immediately apparent, which manifests as appendages of
the thumb or small, missing or bifid thumbs. Often, cataracts appear, whereas mental
or gonadal problems are varying from patient to patient. RTS has been found in some
cases to be associated with a defect in the RECQ4 gene (254). Wang et al. have
later classified RTS into RTS type I, which represents RTS without a predisposition to
osteosarcomas and with an intact RECQ4, and into RTS II that is characterised by a
defective RECQ4 and a high predisposition to osteosarcomas (250). Figure 11 shows
a female RTS patient.
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Figure 11: A female RTS patient. Adapted from Ref. (255). The picture to the left shows the usual strong manifestation
of poikiloderma, also the hair is sparse and the eyebrows are missing. The patient’s arm suffers from eczematous lesions and
bulla formation. The skeletal development of the hand appeares normal. The patient further suffered from severe infections of the
respiratory tract.
Another disease associated with a defective RECQ4 gene has been recently identi-
fied: the RAPADILINO syndrome, characterised by radial hypoplasia, patella hypoplasia
and cleft or arched palate, diarrhea and dislocated joints, little size and limb malforma-
tion, nose slender and normal intelligence. Unlike the RTS, RAPADILINO does not
display the same high predisposition for malignancies (256).
Interestingly, the distinction between the two syndromes is also seen at the genetic
level, as RTS patients with a defective RECQ4 gene are mainly compound heterozy-
gotes of nonsense or frameshift mutations, resulting in a RECQ4 polypeptide lacking a
large part of the helicase domains (248; 254; 257), whereas most of the RAPADILINO
patients are compound heterozygotes in which at least one of two defective RECQ4
alleles contains a deletion that causes, upon pre-mRNA splicing, the skipping of exon
7 without frameshift leading to a polypeptide with an intact putative helicase domain of
RECQ4 (256).
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2.7.2 RTS Cellular Phenotype
RTS cells have been reported to be genetically unstable, displaying a high frequency
of chromosomal abnormalities such as translocations and trisomies (258; 259; 260;
261; 262). Cultured cells from RTS patients show normal sensitivity to mitomicin C,
bleomycin, vincristine, methotrexate (248), cisplatin and adriamycin (263). The rate of
sister chromatid exchanges is also normal in RTS cells (248). However, RTS cells show
an increased sensitivity to ionizing radiation (263; 264; 265), probably due to a reduced
level of DNA repair synthesis and an abnormally low rate of the removal of radiation-
induced DNA lesions (264). The low DNA repair capacity is also an explanation for the
UV sensitivity and reduced unscheduled DNA synthesis after UVC exposure observed
in RTS cells (266).
2.7.3 RTS/RECQ4 - The Protein
The RECQ4 gene has been cloned by Kitao et al. before it was known to be associated
with RTS (215). It lies on the p-arm of chromosome 8 at 24.3 spanning 6.5 kb and
includes 21 exons (267). The RECQ4 protein of 1208 amino acids harbours the helicase
domains, but seems to lack the Zn2+-binding domain as well as the WH and HRDC
domains.
The RECQ4 protein is present in all phases of the cell cycle, but apparently peaks
in S and G2, again indicating replicative or postreplicative roles of RECQ4(267). Yin et
al. have recently shown that the RECQ4 protein is present in the nucleus as well as
in the cytoplasm of HeLa cells and preliminarly characterised biochemical activities of
the immunoprecipitated protein. They could observe an ATPase activity with ssDNA or
dsDNA as co-effectors but the protein failed to displace synthetic DNA duplexes (268) or
to melt a triple helix. The authors conclude that RECQ4 may be similar to the SWI/SNF
chromatin-remodelling factors, members of the SF2 family that show ATPase activity but
not helicase activity in vitro. The absence of the Zn2+ binding domain remains enigmatic
even in this context.
Using Xenopus laevis as a model system, Sangrithi et al. have found that xRTS, the
X. laevis homologue of RECQ4, is essential for DNA replication in egg extracts (269).
They observed that xRTS accumulates on chromatin during replication initiation after
establishment of the prereplication-complex but before the recruitment of replicative
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polymerases. Furthermore, xRTS depletion suppressed the loading of RPA that marks
unwound origins before polymerase recruitment. The authors conclude that xRTS func-
tions after the formation of the prereplication-complex to promote loading of replication
factors, an activity previously unrecongnised but apparently necessary for initiation of
replication (269). This role in replication initiation may explain the cause of chromoso-
mal abberations of type II RTS cells.
2.7.4 Interaction Partners of RECQ4
UBR1 and UBR2
UBR1 and UBR2 are very similar proteins that are the components of ubiquitin (Ub)
ligases (E3) of the N-end rule pathway, one pathway of the Ub-proteasome system. Yin
et al. could isolate a protein complex consisting of RECQ4 UBR1 and UBR2 mainly
from the cytoplasm and observed that this complex displayed DNA-stimulated ATPase
activity, but failed to display helicase or translocase activities. Furthermore, they showed
that RECQ4 is not ubiquitylated in vivo and is a long-lived protein in HeLa cells (268).
p53
Recently, p53 has been shown to repress the transcription of RECQ4 in G1-arrested
cells, both in the absence and presence of DNA damage. Tumour-derived mutant forms
of p53 were not able to repress the transcription of RECQ4. Arresting the cells by the
topoisomerase-inhibitors etoposide (arrest in G2) or camptothecin (arrest in S) led to fur-
ther accumulation of p53 and concomitant decrease in the amount of RECQ4. Histone
deacetylase 1 (HDAC1) was shown to be normally recruited to the RECQ4 and p21 pro-
moter. Trichostatin A (TSA), an inhibitor of all histone deacetylases (HDACs) inhibited
the p53-mediated repression of the RECQ4 promoter, probably due to a conformational
change of HDAC1 as it was observed that it was no longer bound to the promoter upon
camptothecin treatment. The authors of this work proposed that the p53-mediated re-
pression of RECQ4 transcription during DNA damage results from the modulation of the
RECQ4 promoter occupancy by transcription activators and repressors (270).
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2.8 RECQ5
2.8.1 Discovery of RECQ5
RECQ5 is the fifth human homologue of the E. coli RecQ and has not been associated
with any syndrome yet. Kitao et al. identified a small isoform of RECQ5, which was
later denoted RECQ5α (215). In this work, they cloned a cDNA with homology of 48%
to the helicase domain of RecQ. The cloned gene encoded for a 410 amino acids long
polypeptide. Because of the relatively small size compared to the other human RecQ
homologues, the authors classified this RECQ5 variant as a member of a small group.
FISH analysis revealed the corresponding gene to be located on on the q arm of chro-
mosome 17 at the 25 region. The gene was found to be expressed ubiquitously with the
highest levels in testis and ovary (215).
A year later, Sekelsky et al. reported their work on cloning the Drosophila melanogaster
RecQ5 (DmRecQ5) (271). The discovery of the DmRecQ5 was coincidental, as they
found it while cloning an unrelated cell-cycle checkpoint gene by screening a Drosophila
embryo cDNA library. They found two RECQ5 isoforms of 54 kDa and 121 kDa gener-
ated by alternative splicing. The shorter one consists of the conserved helicase domains
and is similar to the previously reported human RECQ5 protein and the longer one, in
addition to the helicase region, contains a long C-terminal part bearing many charged
residues without homology to any other RecQ helicase. Furthermore, they showed that
the long isoform of DmRecQ5 localises to the nucleus. The authors also extended their
study to the human RECQ5 and observed that the cDNA from Kitao et al. was incom-
plete at the 5’ end and used this clone to screen a brain cDNA library. They found
a cDNA coding for a protein of 49 kDa, which would be a bit longer than the 46 kDa
protein identified by Kitao et al. As both cDNAs contained a polyadenylation signal at
the 3’ end, it was assured that both constructs were from genuine coding mRNA. Al-
though the two cDNAs were almost identical, the one identified by Sekelsky et al. was
slightly longer than the other at the 3’ end. It was concluded that the resulting protein
would be generated from a different alternative splicing to yield a protein containing ad-
ditional 25 amino acids. The protein variant Sekelsky et al. had discovered in this work
was actually later denoted RECQ5γ. Furthermore, they speculated on the existence of
two additional variants, of which one was later cloned and named RECQ5β (see be-
low) (271). Another attempt to clone RECQ5 DNA from human testis mRNA revealed
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three different splice variants named α, β and γ. The structure of these transcripts are
shown in Figure 12 (272). Furthermore, it has been shown that RECQ5β localises to
the nucleus, whereas the short isoforms RECQ5α and RECQ5γ are only present in the
cytoplasm. The authors also report an interaction of RECQ5β with the topoisomerases
IIIα and IIIβ (272).
Figure 12: Structure of the RECQ5 gene and the encoded RECQ5 proteins. Adapted from Ref. (272). (a) Genomic structure
of the RECQ5 gene and the exon organisations of three RECQ5 mRNA isomers, RECQ5α, RECQ5β and RECQ5γ. (b) Schematic
representation of the RECQ5 isomers, the sizes are given on the right. The darkened areas indicate the locations of the helicase
domains shared by the RecQ helicase family. The hatched areas indicate the extended homologous region to E.coli RecQ helicase
and correspond to the Zn2+-binding domain. RECQ5γ contains RECQ5α plus an additional 25 unconserved amino acids resulting
in 435 amino acids.
2.8.2 Drosophila melanogaster RECQ5
Ozsoy et al. have performed the first biochemical characterisation of DmRecQ5b, the
small Drosophila melanogaster RECQ5 isoform of 54 kDa. They subjected it to classical
helicase assays and observed that the protein displayed 3’-5’ ATP (dATP)- dependent
helicase activity on partial duplexes as long as 93 bp. Furthermore, they observed
that the protein shows higher helicase activity with dATP than with ATP, with turnover
rates of 1380 min-1 and 900 min-1, respectively (273). In a later work, the same group
2 THE RECQ FAMILY OF DNA HELICASES 40
extended the biochemical characterisation of DmRecQ5b and found that it is a structure-
specific helicase like the other RecQ helicases. The protein unwound 3’-flaps, three-way
junctions and synthetic forks more efficient than 5’-flaps and 12 nt-bubble substrates.
DmRecQ5 also unwound synthetic Holliday junctions. Moreover, they observed that
the protein shows a preference for unwinding the ”lagging-strand arm” in a synthetic
structure resembling a replication fork pointing to a role of DmRecQ5 in the recovery of
stalled replication forks (274).
Kawasaki et al. expressed the large DmRecQ5c isoform of 121 kDa in the baculovirus
system and subjected it to various in vitro assays. In gel filtration experiments, they ob-
served that the proteins forms oligomers. Furthermore, they observed that DmRecQ5
hydrolyses GTP more efficiently than ATP in the presence of ssDNA. However, the heli-
case activity of DmRecQ5c was promoted by ATP and not by GTP. Nevertheless, GTP
had a stimulatory effect on ATP-driven DNA unwinding (275).
To explore the cellular role of Drosophila melanogaster RECQ5, Nakayama et al.
expressed the DmRECQ5 in an sgs1 yeast mutant. DmRECQ5 was able to comple-
ment the sgs1 phenotypes of the synthetic growth defect with srs2, the hypersensitivity
to hydroxyurea and to MMS and also the elevated rate of sister chromatid exchanges
(SCEs), but only poorly complemented the suppression of slow growth in top3. They fur-
ther show that the helicase domain and helicase activity of DmRecQ5 was required to
complement both the sgs1 srs2 and the sgs1 top3 phenotypes. The C-terminus of Dm-
RECQ5 was dispensable for complementig the sgs1 srs2 phenotype, but was required
for complementation of sgs1 top3. These data further imply that the RecQ functions are
highly conserved. It is still unclear, why the elevated rate of SCEs was complemented,
but the slow growth of the top3 could not be reverted (276).
2.8.3 RECQ5 and SCEs
Wang et al. used the chicken B-cell line DT40 to study the consequences of knocking-
out the chicken orthologues of alone or in different combinations (277). The DT40 cells
are a popular system to study gene knock-outs as the high rate of homologous re-
combination observed in these cells allows to knock out genes by gene targeting. In
this work, the authors generated the following mutants: RECQ1-/-, RECQ5-/-, BLM-/-,
RECQ1-/-/RECQ5-/-, RECQ1-/-/BLM-/- and RECQ5-/-/BLM-/- and tested them for the sen-
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sitivities to MMC, MMS and UV-light treatments, and also monitored the rate of spon-
taneous or MMC-induced SCEs. They found that both the RECQ1-/- BLM-/- and the
RECQ5-/- BLM-/- mutants grew slower than the BLM-/- cells due to the increase in the
number of dead cells, suggesting a role for RECQ5 and RECQ1 in cell viability in the ab-
sence of BLM. Moreover, the RECQ5-/- BLM-/- mutant showed an elevated rate of SCEs
compared to BLM-/- cells, whereas this effect was not seen with the RECQ1-/- BLM-/-
mutant. The authors failed to observe a change in sensitivity to UV upon inactivating
RECQ5 in a BLM-/- background. Finally, the RECQ1-/- and the RECQ5-/- single and
double mutants did not show a significant difference from the wild-type cells in growth,
sensitivity to DNA-damaging agents and frequency of SCE (277). This suggests that the
absence of BLM creates substrates for RECQ5 that do not appear in normal cells. This
work shows a first implication of RECQ5 in suppressing SCEs, but the chicken B-cell
line DT40 may not be an ideal model system for the elucidation of the role of the human
RECQ5 protein as the chicken orthologue is only 649 amino acids long.
Recently, Hu et al. have taken the issue of RECQ5 being implicated in suppressing
SCEs further into murine ES cells (142). They observed that in RECQ5+/- murine ES
cells, that grew normally, the level of SCEs is the same as in wild-type cells, whereas
in real RECQ5-/- cells, which also grew normally, the rate of SCEs is elevated approx-
imately three-fold compared to wild-type or heterozygous cells. A further confirmation
of this phenotype was obtained with mouse embryonic fibroblasts (MEFS) derived from
the ES cells. This elevated rate of SCEs is comparable to that of BLM-deficient cells.
Upon creating the double knock-out RECQ5-/-/BLM-/-, the authors could observe a nor-
mal growth rate, but a further increase in the rate of SCEs, compared to the single
knockouts. Their data imply that RECQ5 and BLM have nonredundant roles in sup-
pressing SCEs. It is not clear, however, in what kind of pathway RECQ5 would function
to suppress SCEs (142). These results differ somewhat from those obtained from the
chicken DT40 B-cell line, but probably mouse cells are a better model, as the murine
and the human RECQ5 share 79% homology.
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Abbreviations
Abbreviation Explanation
4NQO 4-nitroquinoline 1-oxide
ALT Alternative lengthening of telomeres
ATP Adenosine-triphosphate
BER Base excision repair
BLM Bloom syndrome protein
bp Base pairs
BS Bloom syndrome
eto Etoposide
DHJ Double Holliday junction
DSB Double strand break
dsDNA Double-stranded DNA
ES cells Embryonic stem cells
FA Fanconi anemia
FRET Fluorescence resonance energy transfer
GTP Guanosine-triphosphate
HJ Hollday junction
HSV Herpes simplex virus
HU Hydroxyurea
HDAC Histone deacteylase
HRDC Helicase and Rnase D C-terminal domain
IgA Immunoglobulin A
IgM Immunoglobulin M
MMC Mitomycin C
MMS Methyl methanosulfonate
MMR Mismatch repair
MRN The MRE11/RAD50/NBS1 complex
MutSα The MSH2/MSH6 heterodimer
MutSβ The MSH2/MSH3 heterodimer
MutLα The MLH1/PMS2 heterodimer
NLS Nuclear localisation signal
nt Nucleotides
NTP Nucleoside-triphosphate
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PCNA Proliferating cell nuclear antigen
PML Premyelocytic leukemia protein
RFC Replication factor C
RPA Replication protein A
RTS Rothmund-Thomson syndrome
SCE Sister-chromatid exchange
SF Superfamily
ssDNA Single-stranded DNA
SUMO Small ubiquitin-like modifier
TSA Trichostatin A
Ub Ubiquitin
UV Ultraviolet
WH Winged helix
WHIP Werner helicase interacting protein
WRN Werner syndrome protein
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Bloom syndrome protein forms an oligomeric ring structure and belongs
to a group of DNA helicases showing extensive homology to the Escheri-
chia coli DNA helicase RecQ, a suppressor of illegitimate recombination.
After over-production in E. coli, we have purified the RecQ core of BLM
consisting of the DEAH, RecQ-Ct and HRDC domains (amino acid resi-
dues 642–1290). The BLM642–1290 fragment could function as a DNA-
stimulated ATPase and as a DNA helicase, displaying the same substrate
specificity as the full-size protein. Gel-filtration experiments revealed that
BLM642–1290 exists as a monomer both in solution and in its single-stranded
DNA-bound form, even in the presence of Mg2þ and ATPgS. Rates of ATP
hydrolysis and DNA unwinding by BLM642–1290 showed a hyperbolic
dependence on ATP concentration, excluding a co-operative interaction
between ATP-binding sites. Using a l Spi2 assay, we have found that the
BLM642–1290 fragment is able to partially substitute for the RecQ helicase
in suppressing illegitimate recombination in E. coli. A deletion of 182 C-
terminal amino acid residues of BLM642–1290, including the HRDC domain,
resulted in helicase and single-stranded DNA-binding defects, whereas
kinetic parameters for ATP hydrolysis of this mutant were close to the
BLM642–1290 values. This confirms the prediction that the HRDC domain
serves as an auxiliary DNA-binding domain. Mutations at several con-
served residues within the RecQ-Ct domain of BLM reduced ATPase and
helicase activities severely as well as single-stranded DNA-binding of the
enzyme. Together, these data define a minimal helicase domain of BLM
and demonstrate its ability to act as a suppressor of illegitimate
recombination.
q 2003 Elsevier Science Ltd. All rights reserved
Keywords: Bloom syndrome; DNA helicase; genomic instability;
illegitimate recombination; mutagenesis*Corresponding author
Introduction
Helicases are motor proteins that are character-
ized by the ability to unwind nucleic acid duplexes
(DNA–DNA, DNA–RNA and RNA–RNA) in a
reaction coupled to the hydrolysis of NTPs.1–4
Helicases perform a variety of important tasks in
nucleic acid metabolism, ranging from a simple
strand separation at the replication fork to more
sophisticated processes, such as migration of Holli-
day junctions.5,6
Mechanistically, there are two classes of heli-
cases: those that translocate along a nucleic acid
strand in a 30 to 50 direction; and those that operate
with the opposite polarity. Based on amino acid
sequence homology, helicases have been grouped
into five superfamilies (SF1–SF5).7 Most 30-50 DNA
helicases are members of SF1 or SF2. These two
superfamilies have similar sets of conserved
motifs, and the proteins are generally considered
to be monomeric. However, the oligomeric state of
0022-2836/03/$ - see front matter q 2003 Elsevier Science Ltd. All rights reserved
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Abbreviations used: ATPgS, adenosine 50-O-(3-thio-
triphosphate); BS, Bloom syndrome; CBD, chitin-binding
domain; DSB, double-strand break; dsDNA, double-
stranded DNA; EMSA, electrophoretic mobility-shift
assay; HRDC, helicase and RNAseD C-terminal; Pi,
inorganic phosphate; RecQ-Ct, RecQ C-terminal; SCE,
sister chromatid exchanges; ssDNA, single-stranded
DNA; WS, Werner syndrome.
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the functional form of these enzymes has been
debated, with both monomeric and oligomeric
models being proposed.8–12 The 50-30 DNA heli-
cases belong to SF4 and SF5. They are character-
ized by fewer conserved motifs and generally
form hexameric rings.13
The RecQ helicase family belongs to SF2 and
includes enzymes that have extensive homology
to the 30-50 DNA helicase RecQ of Escherichia coli.
This enzyme is involved in processing nascent
DNA at blocked replication forks prior to the
resumption of DNA synthesis and in suppressing
illegitimate recombination.14,15 Interestingly, pro-
karyotes and unicellular eukaryotes possess only a
single RecQ helicase, while several RecQ homo-
logues are present in multi-cellular organisms.16 In
humans, five RecQ homologues have been identi-
fied thus far. Mutations in three of them have
been shown to be associated with autosomal reces-
sive disorders characterized by genomic instability
and cancer predisposition. Mutations in BLM
result in Bloom syndrome (BS); mutations in WRN
result in Werner syndrome (WS); and mutations in
RecQL4 result in Rothmund–Thomson syndrome
(RTS).17–19 Genomic instability in BS is evidenced
by chromosome breaks, gaps and, most typically,
by high rate of sister chromatid exchanges (SCE).20
Cells from WS and RTS individuals display an
increased rate of gross chromosomal rearrange-
ments.20 Mutations in RecQ homologues in other
eukaryotic organisms also are associated with
increased rates of chromosomal abnormalities.21,22
Although cellular phenotypes of mutants
suggest that RecQ DNA helicases act as suppres-
sors of illegitimate recombination, exact DNA
transactions mediated by these enzymes to main-
tain genomic stability remain elusive. Illegitimate
recombination takes place between sequences of
little or no homology exposed upon exonucleolytic
processing of DNA double-strand breaks (DSBs)
and it results in DNA rearrangement such as
deletions, translocations, duplications or
inversions.23,24 The observations that several RecQ
helicases could promote branch migration of Holli-
day junctions led to the proposal that these
enzymes remove Holliday junctions formed at
stalled replication forks and thus suppress induc-
tion of DSBs through the action of a resolvase.6
WRN was shown to facilitate copying of tetraplex
and hairpin structures of the d(CGG) trinucleotide
repeat sequence by DNA polymerase d, suggesting
another mechanism that would minimize for-
mation of DSBs at replication forks stalled by
unusual DNA secondary structures.25 Furthermore,
there is evidence suggesting that RecQ DNA
helicases promote non-mutagenic repair of DSBs,
perhaps by inhibiting extensive exonucleolytic pro-
cessing of DSBs or by dissociating intermediates of
illegitimate recombination produced by single-
strand annealing at sites of micro-homology.24,26,27
All RecQ family members contain a DEAH heli-
case domain characterized by a set of seven amino
acid sequence motifs that are present in other SF2
helicases. Mutagenesis and structural studies of a
number of SF1 and SF2 helicases demonstrated
that these motifs are responsible for coupling of
ATP hydrolysis to DNA binding, translocation
and unwinding.8,28–31 In addition, all RecQ heli-
cases contain a C-terminal extension that can be
divided into two domains.32 The proximal domain,
called the RecQ-Ct (RecQ C-terminal) domain, is
unique to the family. The distal domain is present
also in RNAseD and its eukaryotic homologues,
and is called the HRDC (helicase and RNAseD
C-terminal) domain. A recent NMR structure of
the HRDC domain of Sgs1 (the single RecQ homo-
logue in Saccharomyces cerevisiae) suggested that
this domain might function as an auxiliary DNA-
binding domain in a manner similar to that of its
structural homologue, domain 1B in PcrA.33 The
role of the RecQ-Ct domain in the helicase function
remains to be determined. The eukaryotic mem-
bers of the RecQ family usually have additional N
and C-terminal domains that flank the RecQ core,
which show little or no sequence homology and
vary considerably in size between different RecQ
members.34 These divergent domains are involved
in interactions with other proteins and thus most
probably serve to differentiate functionally
between the multiple RecQ helicases present in
higher eukaryotes.34
Size-exclusion chromatography and electron
microscopic examination of BLM indicated that it
forms predominantly a hexameric ring structure.35
BLM oligomerization is mediated by the N-term-
inal part of the protein.36 Similarly, a purified N-
terminal exonuclease domain of the WRN protein
was found to exist in a trimer/hexamer equili-
brium, which was shifted towards the hexameric
species upon addition of a DNA substrate.37 This
suggests that the full-size WRN protein may also
form a hexamer. Moreover, steady-state kinetic
analysis of the helicase activity of the E. coli RecQ
helicase suggested that the enzyme may act as an
oligomer, perhaps a trimer.38
Here, we report biochemical characteristics of a
recombinant fragment of the Bloom syndrome pro-
tein encompassing the amino acid residues 642–
1290, which includes the entire RecQ homology
region of BLM. We have found that this fragment
exists as a monomer both in solution and in a
form bound to a 30mer oligonucleotide, even in
the presence of adenosine 50-O-(3-thiotriphosphate)
(ATPgS) and Mg2þ, and can function as a DNA-
stimulated ATPase as well as a DNA helicase, dis-
playing the same substrate specificity as the full-
size protein. This indicates that the oligomeric
ring structure formed by BLM is not essential for
the helicase activity of the enzyme. Using a l Spi2
assay, we have found that expression of BLM642–1290
in an E. coli strain carrying a recQ mutation par-
tially reduced the elevated illegitimate recombina-
tion observed in this strain, suggesting that the
RecQ function to suppress illegitimate recombina-
tion has been conserved throughout evolution.
Furthermore, we have investigated the roles of the
30 Mutational Analysis of BLM
3 RESULTS 57
RecQ-Ct and HRDC domains of BLM in helicase
activity of the enzyme by mutational analysis. Our
data suggest that the RecQ-Ct domain may be
involved in coupling of DNA binding to ATP
hydrolysis, whereas the HRDC domain may serve
as an auxiliary DNA-binding domain.
Results
Expression, purification and determination of
the oligomeric state of BLM642–1290
The region of the BLM cDNA encoding the RecQ
portion of BLM (amino acid residues 642–1290,
Figure 1(a)) was cloned in the pTXB3 vector to con-
struct a translational fusion of this fragment with a
C-terminal Mxe intein and chitin-binding domain,
which serves as a self-cleaving affinity tag.
Expression of this construct in the BL21-CodonPlus
(DE3)-RIL strain yielded large amounts of the
fusion protein in soluble form (Figure 1(b)). Usage
of the RIL codon plus strain significantly increased
the level of protein expression when compared to
BL21(DE3) (data not shown). The BLM642–1290 pro-
tein was purified to more than 95% homogeneity
by combining affinity purification on a chitin col-
umn with subsequent chromatography on heparin
and CM-Sepharose columns (see Materials and
Methods). This procedure yielded typically 1–
1.5 mg of pure protein per 1 g of cell paste.
In order to characterize the oligomeric state of
BLM642–1290, we carried out size-exclusion chroma-
tography using a Superdex 200 column. We deter-
mined apparent molecular masses of BLM642–1290
in solution and in a form bound to a 30mer oligo-
nucleotide both in the absence and presence of the
poorly hydrolyzable analogue of ATP, ATPgS, and
Mg2þ (Table 1). The BLM642–1290 protein alone was
found to elute in a single peak corresponding to a
molecular mass of 66.8 kDa and in the presence of
ATPgS/Mg2þ in a peak corresponding to 69.3 kDa.
As the predicted molecular mass of BLM642–1290 is
74.1 kDa, these data suggest that BLM642–1290 exists
as a monomer in solution. Addition of a 30mer oli-
gonucleotide to BLM642–1290 (at a BLM to DNA
molar ratio of 6) in the absence and in the presence
of ATPgS/Mg2þ resulted in peaks corresponding to
molecular masses of 103.3 kDa and 104.6 kDa,
respectively. Since the 30mer oligonucleotide alone
eluted from the column at a molecular mass of
33 kDa, these data suggest that BLM642–1290 exists
as monomer in its single-stranded DNA (ssDNA)-
bound form.
Biochemical characterization of the
BLM642–1290 fragment
The purified BLM642–1290 fragment was first
tested for its ability to hydrolyze ATP in the pre-
sence of various DNA effectors, including circular
M13mp18 ssDNA, synthetic 43mer oligonucleotide
and plasmid double-stranded DNA (dsDNA).
ATPase activity was monitored by measuring the
production of inorganic phosphate (Pi) using a
malachite green assay (see Materials and
Methods). As shown in Figure 2(a), BLM642–1290
exhibited a strong DNA-dependent ATPase
activity. The rate of ATP hydrolysis in the presence
of ssDNA was higher than that in the presence of
plasmid dsDNA. Only a weak ATPase activity
was observed in the absence of a DNA effector.
The ATPase reaction catalyzed by BLM642–1290 in
the presence of circular M13mp18 ssDNA dis-
played classical Michaelis–Menten kinetics over a
range of ATP concentrations from 10 mM to 2 mM
(Figure 2(b)). The steady-state kinetic parametersFigure 1. Structure and purification of BLM642–1290.
(a) A schematic of the Bloom syndrome protein demon-
strating the location of the DEAH helicase, RecQ-Ct and
HRDC domains. The locations of the protein–protein
interaction regions for DNA topoisomerase IIIa (TOPO
IIIa), MLH1 and RAD51 are indicated above this scheme
by black lines. A schematic of the BLM642–1290 fragment is
shown below. (b) SDS-PAGE of fractions from purifi-
cation of BLM642–1290. The protein was expressed and
purified as described in Materials and Methods. Samples
were analyzed on a 10% polyacrylamide gel, which was
stained with Coomassie brilliant blue. Lane 1, protein
size markers; lane 2, total cell extract; lane 3, soluble
part of cell extract; lane 4, pooled fractions from chitin
column; lane 5, pooled fractions from heparin column;
lane 5, pooled fractions from a CM-Sepharose column.
Table 1. Molecular masses of free and DNA-bound
forms of BLM642–1290 in the presence and in the absence
of ATPgS/Mg2þ determined by gel-filtration
Sample
Apparent molecular mass
(kDa)
30mer 33.0
BLM 66.8
BLM þ 30mer 103.3
BLM þ Mg2þ þ ATPgS 69.3
BLM þ Mg2þ þ ATPgS þ 30mer 104.6
The predicted molecular mass of BLM642–1290 is 74.1 kDa.
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of the ATPase reaction, kcat and KM, were 22.14 s
21
and 77.3 mM, respectively. The fact that the enzyme
kinetic curve is hyperbolic rather than sigmoidal
suggests that ATP hydrolysis by BLM642–1290 is not
a co-operative reaction.
The helicase activity of BLM642–1290 was first
tested on a partial DNA duplex substrate compris-
ing a 44mer radiolabeled oligonucleotide annealed
to circular M13mp18 ssDNA. This substrate was
incubated with increasing amounts of BLM642–1290
in the presence of ATP, which was followed by
analysis of the reaction products on a non-dena-
turing 15% polyacrylamide gel. Figure 3(a)
shows that BLM642–1290 indeed possesses a DNA-
unwinding activity, resulting in displacement of
the radiolabeled oligonucleotide from M13mp18
ssDNA.
To estimate the affinity of BLM642–1290 helicase for
ATP, the initial rate of BLM642–1290-mediated
unwinding of 25 bp partial M13 duplex was
measured over a range of concentrations of ATP
from 5 mM to 2 mM. The data displayed a hyper-
bolic dependence on ATP concentration with a
K1/2 value of 31.8 mM (Figure 3(b)). The hyperbolic
nature of the curve argues against a co-operativity
in the helicase reaction of BLM642–1290 with respect
to ATP concentration.
To compare the substrate specificity of the
BLM642–1290 fragment to that of the full-size protein,
we have examined the ability of these proteins to
unwind various 50 end-labeled synthetic DNA
structures with a common duplex region sequence,
including blunt-ended duplex, 30 ssDNA-tailed
duplex, forked duplex with two non-complemen-
tary single-stranded arms (splayed arm) and
blunt-ended duplexes containing either a nick or a
50-ssDNA flap (20 nt) in the central part of the
DNA molecule. The last two DNA molecules have
not been tested as substrates for BLM thus far.
Like the full-size BLM protein, the BLM642–1290 frag-
ment could unwind both 30-ssDNA-tail duplex and
splayed arm, with the latter being unwound more
efficiently than the former (Figure 3(c)). The blunt-
ended duplex was not unwound by either protein.
In contrast, both proteins could efficiently unwind
the 50 flap structure to extents similar to those of
the splayed arm, releasing the labeled 50 flap oligo-
nucleotide (Figure 3(c)). The nicked duplex was a
much poorer substrate for unwinding by both
enzymes compared to the 50 flap duplex (Figure
3(c)), indicating a role of the 50-ssDNA flap in the
initiation of duplex unwinding.
The BLM helicase was shown to disrupt syn-
thetic immobile four-way DNA junctions, which
resemble Holliday junctions.39 To investigate
whether the BLM642–1290 fragment possesses such
an activity, a four-way junction substrate prepared
by annealing of 50mer oligonucleotides, of which
one was 50 end-labeled, was incubated with increas-
ing amounts of BLM642–1290. Figure 3(d) shows that
BLM642–1290 was able to disrupt four-way junctions
to the component single strands, as is evident from
the appearance of the free radiolabeled oligo-
nucleotide. As observed with the full-size BLM
protein, the unwinding of four-way junctions by
BLM642–1290 resulted in the accumulation of three-
stranded and two-stranded species, suggesting that
these species are reaction intermediates.39 The
presence of traces of these species in untreated
DNA substrate is most probably due to spontaneous
Figure 2. ATPase activity of BLM642–1290. (a) Time-
course of ATP hydrolysis by 20 nM BLM642–1290 in the
presence of various DNA co-factors including M13mp18
ssDNA (circle), pTZ18R plasmid dsDNA (upwards
pointing triangle), 43mer synthetic oligonucleotide
(square) and no DNA (downwards pointing triangle). In
each reaction, DNA was present at a concentration of
25 mg/ml and ATP was 2 mM. (b) Dependence of the
initial rate of ATP hydrolysis by 20 nM BLM642–1290 in
the presence of M13mp18 ssDNA (25 mg/ml) on ATP
concentration. Reactions were carried out in buffer H at
37 8C and quantified as described in Materials and
Methods. The lines in (a) correspond to a fit by an expo-
nential equation:
Y ¼ Ymaxð12 expð2kXÞ
where Y is the concentration of the reaction product, X is
time and k is the rate constant. The line in (b) corre-
sponds to a fit by Michaelis–Menten equation:
Y ¼ YmaxX=ðKM þ XÞ
where Y is the initial reaction rate, X is the concentration
of substrate and KM is the Michaelis–Menten constant.
Each value represents the mean of at least three indepen-
dent measurements.
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dissociation of the four-way structure following
electroelution from polyacrylamide gel.
Together, these data show that the BLM642–1290
fragment can function as an ATP-dependent DNA
helicase with the same substrate specificity as the
full-size protein. Moreover, the lack of co-operativ-
ity in both ATPase and helicase reactions (with
respect to ATP concentration) in combination with
the gel-filtration data argues that the BLM642–1290
helicase may function as a monomer.
The BLM642–1290 helicase can suppress elevated
illegitimate recombination in E. coli
recQ mutant
In order to obtain further functional character-
istics of BLM642–1290, we asked whether it is able to
substitute in vivo for the E. coli RecQ helicase in
suppressing illegitimate recombination. Using the
l Spi2 assay, it has been demonstrated that E. coli
recQ mutations enhance frequency of spontaneous
and UV-induced illegitimate recombination, indi-
cating that RecQ plays a suppressive role in illegiti-
mate recombination.15 In the l Spi2 assay, the
frequency of formation of specialized lbio transdu-
cing phages, which result from abnormal excision
of the chromosome by illegitimate recombination,
is measured.40 Most of the lbio transducing phages
lack the red-gam region of l phage and show the
Spi2 phenotype, which is the ability to form pla-
ques on a lawn of E. coli P2 lysogen. On the other
hand, normal l phages cannot grow in P2 lysogen.
Therefore, the frequency of illegitimate recombina-
tion can be calculated as a ratio of the number of
Spi2 phages to the number of total phages in a
given lysate. To examine whether the BLM642–1290
helicase can suppress the hyper-recombination
phenotype of RecQ-deficient cells, the correspond-
ing region of the BLM cDNA was cloned into
pBluescript SK(þ ) under control of the lac promo-
ter. The resulting plasmid construct was intro-
duced into the HI2776 DrecQ101 lcI857 lysogen
and the frequencies of the l Spi2 phage formation
in this strain prior to and after UV irradiation
were compared with those displayed by the
DrecQ101 mutant transformed with the pBluescript
SK(þ ) vector. We found that BLM642–1290 signifi-
cantly reduced the rate of illegitimate recombina-
tion in the DrecQ101 mutant under both the non-
irradiated (tenfold) and the irradiated (4.1-fold)
conditions, although it did not restore the wild-
type levels completely (Table 2). Interestingly, the
wild-type strain (HI1162 lcI857 lysogen) harboring
the BLM plasmid showed a higher frequency of l
Spi2 phage formation than the wild-type strain
harboring the pBluescript SK(þ ) vector (Table 2),
suggesting that the BLM fragment may also have
a negative effect on the DNA metabolism in E. coli.
Figure 3. DNA helicase activity of BLM642–1290.
(a) Unwinding of 44 bp partial M13 duplexes by
BLM642–1290. Reaction mixtures (10 ml) in buffer H con-
tained 0.5 nM DNA, 2 mM ATP and the indicated
amounts of BLM642–1290. The reactions were initiated
with enzyme and incubated at 37 8C for 30 minutes
prior to termination by adding 0.5 reaction volume of
buffer S. Samples were analyzed by electrophoresis in
non-denaturing 15% polyacrylamide gel followed by
autoradiography. (b) Dependence of the initial rate of
unwinding of 0.5 nM 25 bp partial M13 duplex by
20 nM BLM642–1290 on the concentration of ATP. Reaction
rates were measured in buffer H at 37 8C as described in
Materials and Methods for concentrations of ATP ran-
ging from 10 mM to 2000 mM. Each value represents the
mean of at least three independent measurements. The
line in the graph corresponds to a fit by the Michaelis–
Menten equation (see the legend to Figure 2). (c) Com-
parison of the helicase activities of BLM642–1290 and
BLMFS (full-size BLM) on blunt-ended duplex (lanes
1–4), 30-ssDNA-tailed duplex (lanes 5–8), splayed arm
(lanes 9–12), 50-ssDNA-flap duplex (lanes 13–16) and
nicked duplex (lanes 17–20). Reaction mixtures (10 ml)
in buffer H contained 1 nM DNA substrate, 2 mM ATP
and 20 nM enzyme. Reactions were carried out and
analyzed as described for (a). The triangles mark the
lanes that contain heat-denatured DNA. Note that the
50-flap substrate contains a small fraction of splayed
arm, which is due to incomplete annealing of the C19
oligonucleotide. (d) Unwinding of the synthetic four-
way junction by BLM642–1290. Reaction mixtures (10 ml)
in buffer H contained 1 nM DNA substrate, 2 mM ATP
and the indicated amounts of BLM642–1290. Reactions
were carried out and analyzed as described for (a).
Positions of four-way junction substrate, three-stranded,
two-stranded and single-stranded products are indicated
to the right. DNA substrates were prepared as described
in Materials and Methods. The asterisks (*) indicate the
location of the radioactive label.
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Together, these results indicate that the BLM
fragment can indeed function as a suppressor of
spontaneous and UV-induced illegitimate recombi-
nation in E. coli, although the compensation of the
recQ mutation was partial.
C-terminal deletion mutagenesis of BLM642–1290
As mentioned above, the homology region of
RecQ family members consists of the DEAH heli-
case, RecQ-Ct and HRDC domains. The DEAH
helicase domain contains a set of seven amino
acid sequence motifs that have been studied exten-
sively in other SF1 and SF2 DNA helicases, and
shown to mediate coupling of ATP hydrolysis to
DNA translocation and unwinding.8,28–31 The roles
of the RecQ-Ct and HRDC domains, which are pre-
sent only in the RecQ family of DNA helicases,
remain to be investigated. To address the import-
ance of the RecQ-Ct and HRDC domains of BLM
for the helicase activity of the enzyme, we have
generated a series of C-terminal truncations of
BLM642–1290, including BLM642–1167, BLM642–1108,
BLM642–1056, BLM642–1036 and BLM642–997, by cloning
corresponding regions of the BLM cDNA into
pTXB3 to construct translational fusions with a C-
terminal Mxe intein and a chitin-binding domain.
However, only one of those constructs, lacking the
HRDC domain and a part of the linker connecting
the HRDC and RecQ-Ct domains (BLM642–1108) was
found to produce stable soluble protein when
expressed in the E. coli BL21 (RIL) strain. The
shorter deletion variants lacking a part of or the
entire RecQ-Ct domain were found to be insoluble
when expressed as fusions with Mxe–CBD. The
BLM642–1167 mutant ending at the beginning of the
HRDC domain could not be expressed in E. coli
BL21 (RIL), perhaps due to its sensitivity to
degradation.
The BLM642–1108 variant was subjected to the
same purification procedure as BLM642–1290. How-
ever, it was not bound to the heparin column.
Measuring steady-state parameters for ATP
hydrolysis in the presence of a 43mer oligonucleo-
tide revealed that the BLM642–1108 mutant displayed
nearly the same ssDNA-dependent ATPase activity
as BLM642–1290 (Table 3). In contrast, it showed
about threefold decrease in helicase activity on
25 bp partial M13 duplex substrate with respect to
BLM642–1290 and even more pronounced defect in
the ability to disrupt four-way junctions (Figure
4(a) and (b)). An electrophoretic mobility-shift
assay (EMSA) employing 50 end-labeled 30mer
oligonucleotide (also used for the S200 gel-
filtration experiments) revealed that the
BLM642–1108 mutant had reduced ssDNA binding
activity dramatically as compared to BLM642–1290
(Figure 7).
Thus, the data from biochemical characterization
of BLM642–1108 support the prediction that the
HRDC domain serves as an auxiliary DNA-bind-
ing domain.33
Site-directed mutagenesis of the
RecQ-Ct domain
Because of the insolubility of BLM fragments
lacking the RecQ-Ct domain, we examined the
importance of this region using a site-directed
approach. We altered several residues in this
Table 3. Steady-state kinetic parameters for ssDNA-
dependent ATP hydrolysis by BLM mutants
Protein
kcat
(s21)
kcat decrease
factor
Km
(mm)
Km(wt)/
Km(mut)
Wild-type 25.79 1.00 63.5 1.00
R1038A 1.36 18.96 66.6 1.00
F1045A 4.76 5.42 62.8 0.99
E1047Q 18.62 1.39 59.0 0.93
E1047A 14.72 1.75 148.1 2.33
D1064N 23.48 1.10 74.0 1.17
D1064A 0.12 214.92 58.5 0.92
R1108A 25.97 0.99 51.2 0.81
K1125A 27.01 0.95 54.3 0.86
BLM642–1108 19.63 1.31 51.9 0.82
BLM642–1290 is referred to as wild-type in this table. The point
mutants are derivatives of BLM642–1290. ATPase reactions were
carried out in the presence of 43mer oligonucleotide as
described under Materials and Methods.
Table 2. Effect of BLM642–1290 on spontaneous and UV-induced illegitimate recombination in the wild-type and recQ
mutation background
Strain
UV dose
(J/m2)
l Spi2 phages (1029) per
total l phage (SE)
Relative frequency l Spi2
to control Burst size
Wild-typea [pBluescript SK(þ)] 0 1.0 (0.33) 1 114
Wild-typea [pJP79 (BLMþ)] 0 12 (1.0) 12 91
DrecQ101b [pBluescript SK(þ)] 0 130 (16) 1 52
DrecQ101b [pJP79 (BLMþ)] 0 13 (1.5) 0.1 91
Wild-typea [pBluescript SK(þ)] 25 80 (4.7) 1 95
Wild-typea [pJP79 (BLMþ)] 25 120 (26) 1.5 85
DrecQ101b [pBluescript SK(þ)] 25 1200 (100) 1 53
DrecQ101b [pJP79 (BLMþ)] 25 290 (21) 0.24 98
The frequency of Spi2 phages per total phages was measured as described in Materials and Methods. Values are the average of four
independent measurements. (SE) indicates the standard error of the mean. Burst size is the number of total phages per cell.
a HI1162 lcI857 lysogen.
b HI2776 DrecQ101 < cat lcI857 lysogen.
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domain that are conserved among RecQ family
members (Figure 5(a)) and characterized the bio-
chemical properties of the resulting mutant pro-
teins. The following amino acid residues were
chosen for mutagenesis of the BLM642–1290 frag-
ment: C1036, R1038, F1045, E1047, C1063, D1064
and C1066 (Figure 5(a)). We have created alanine
mutants at all those residues. The acidic residues
E1047 and D1064 were replaced also by a gluta-
mine and an asparagine, respectively. The mutants
were prepared in the same way as the wild-type
enzyme. Under these conditions, all the three
cysteine mutants exhibited a high level of suscepti-
bility to degradation, being degraded almost com-
pletely following purification on the chitin column
and were, therefore, not further analyzed.
Substitutions at all residues were found to
impair the ssDNA-dependent ATPase activity of
BLM642–1290 (Table 3). Interestingly, at position
1064, the value of kcat was found to be related to
the nature of the present residue. While the neutral
D1064A mutant displayed a very poor kcat value,
the polar D1064N mutant had a kcat value similar
to that of the wild-type enzyme. (The same depen-
dence was observed for helicase and ssDNA bind-
ing activities; see below.) All of the mutants had a
KM for ATP similar to that of the wild-type enzyme,
with the exception of the E1047A mutant, which
exhibited about twofold higher value of KM than
the wild-type enzyme (Table 3). The helicase
activity of the mutants was measured using partial
M13 duplex (25 bp) and four-way junction sub-
strates. With the exception of the D1064N mutant,
all mutants had reduced strand displacement
activity on both substrates, with R1038A and
D1064A mutants being affected most dramatically
(Figure 6(a) and (b)). The ability of the BLM
mutants to bind ssDNA was again investigated by
EMSA using a 50 end-labeled 30mer
oligonucleotide. Figure 7 shows that all mutants
displayed a reduction in their affinity for ssDNA
compared to BLM642–1290 from about twofold
decrease (in apparent Kd) for the D1064N mutant
to more than 20-fold decrease for the D1064A
mutant.
Together, these data indicate that the RecQ-Ct
domain of BLM plays an important role in the heli-
case function of the enzyme.
Site-directed mutagenesis of the region
connecting the RecQ-Ct and HRDC domains
of BLM
Multiple sequence alignment of RecQ family
members also reveals a number of conserved resi-
dues in the region connecting the RecQ-Ct and
HRDC domains (Figure 5(b)). To investigate the
importance of this region for helicase activity of
BLM, we have produced single alanine mutants of
BLM642–1290 at R1108 and K1125, two highly con-
served residues in this region. Biochemical charac-
terization of these mutants indicated that they do
not show significant differences from the wild-
type enzyme in ATPase or helicase activities
(Table 3 and Figure 6(b)), or in the ability to bind
ssDNA (not shown). These data suggest that the
defects observed in the BLM642–1108 mutant, which
lacks a large part of this region, are rather due to
the absence of the HRDC domain.
Discussion
In this work, we have characterized a recombi-
nant fragment of the Bloom syndrome protein
including the entire RecQ homology region and
investigated the role of its RecQ-Ct and HRDC
domains in the helicase activity of the enzyme.
Analysis of BLM642–1290 using size-exclusion
chromatography revealed that it exists as a mono-
mer both in solution and in its ssDNA-bound
form (in the presence and in the absence of
ATPgS/Mg2þ) (Table 1). In contrast, the full-size
Figure 4. DNA helicase activity of the BLM642–1108
mutant. Unwinding of (a) 0.5 nM 25 bp partial M13
duplex and (b) 1 nM synthetic four-way junction by
BLM642–1290 (square) and BLM642–1108 (circle) as a function
of protein concentration. DNA substrates were prepared
as described in Materials and Methods. Reactions
(10 ml) were carried out in buffer H containing 2 mM
ATP. After 30 minutes incubation at 37 8C, reaction pro-
ducts were quantified as described in Materials and
Methods. The lines in the graphs are drawn just to
guide the eye. Individual datum points represent the
mean of at least three independent measurements.
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BLM protein forms an oligomeric ring structure in
solution.35 The oligomerization of BLM is mediated
by the N-terminal region of the protein36, which is
absent in the BLM642–1290 fragment. Since
BLM642–1290 retained all the enzymatic activities
found in the full-size protein, including the ability
to function as a structure-specific DNA helicase, it
seems that the ring structure of BLM is probably
required for other functions: perhaps it is involved
in the formation of specific multiprotein–DNA
repair complexes.
The rates of both ATP hydrolysis and DNA
unwinding by BLM642–1290 showed a hyperbolic
dependence on ATP concentration (Figures 2(b)
and 3(b)), which argues against a co-operative
interaction between ATP-binding sites during
unwinding and suggests that the enzyme may act
as a monomer. This assumption may be supported
by a hyperbolic nature of the dependence of DNA
unwinding by BLM642–1290 on enzyme concen-
tration (Figure 4(a) and (b)). As mentioned above,
however, the issue of the functional form of non-
hexameric helicases has been debated over the last
years. Studies of the PcrA (SF1) and RecG (SF2)
helicases have led to suggestions that these
enzymes as well as other SF1 and SF2 members
function as monomeric helicases.8,41 In contrast,
pre-steady-state kinetic studies of DNA unwinding
by the UvrD and Rep helicases, SF1 members, of
which the latter has been shown to be a structural
homologue of PcrA,42 demonstrated that enzyme
oligomers are required to initiate unwinding.10,11
Recent single-molecule studies employing fluor-
escence resonance energy transfer technique to
measure unwinding indicated that a Rep monomer
can use ATP hydrolysis to move towards the junc-
tion between ssDNA and dsDNA (in agreement
with the PcrA model), but then displays confor-
mational fluctuations that do not lead to DNA
unwinding.12 DNA unwinding initiates only when
the translocating enzyme interacts with additional
enzyme molecule(s).12 Similar studies will be
required for RecQ DNA helicases to gain deeper
insight into the mechanism of unwinding by these
enzymes.
RecQ helicases mechanistically belong to the 30-50
class of helicases that generally require the pre-
sence of a 30 single-stranded tail to initiate unwind-
ing of a DNA duplex. However, our experiments
revealed that BLM can unwind efficiently forked
duplexes having 30 arm double-stranded and 50
arm single-stranded (50-ssDNA-flap duplex), indi-
cating that the enzyme does not essentially require
the 30 tail to be single-stranded to initiate DNA
unwinding on a forked duplex (Figure 3(c)).
Recently, the WRN helicase also has been shown
to posses such an activity.43 Moreover, both BLM
and WRN helicases can unwind synthetic four-
way junctions with blunt-ended arms and are able
to promote the movement of a branched point
along a long stretch of dsDNA.6,39,44 Thus, it
appears that the mode of DNA translocation and
unwinding by RecQ helicases is different from
that of the 30-50 helicases such as PcrA which trans-
locate along ssDNA to mediate duplex
unwinding.8 On the basis of similarity in substrate
specificity, one can predict that RecQ helicases
may be mechanistically related to the RecG
Figure 5. Amino acid sequence alignment of several RecQ helicases. The regions corresponding to (a) the RecQ-Ct
domain and (b) the proximal part of the domain connecting the RecQ-Ct and HRDC domains are shown. The multiple
alignment was performed with the program ClustalX and refined manually. The numbers at the end of each sequence
correspond to the position of the last amino acid residue. Highly conserved amino acid residues are shadowed in grey.
Amino acid substitutions generated in BLM642–1290 are shown. The protein accession numbers used by the National
Center for Biotechnology Information are: Sgs1, P35187; Rqh1, Q09811; RecQL1, NP_002898; WRN, NP_000544; BLM,
A57570.
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helicase, which is believed to mediate strand
separation via translocation on dsDNA.45
A deletion of 182 C-terminal amino acid residues
from the BLM642–1290 fragment including the HRDC
domain and a part of the region connecting this
domain with the RecQ-Ct domain substantially
reduced the helicase activity of the enzyme on
both partial duplex and four-way junction sub-
strates (Figure 4(a) and (b)). Detailed analysis of
the BLM642–1108 mutant revealed that it had a severe
defect in the ability to bind ssDNA (Figure 7),
whereas its kinetic parameters for ATP hydrolysis
at saturating concentrations of ssDNA were close
to the BLM642–1290 values (Table 3). Thus, it appears
that the deleted region significantly contributes to
ssDNA binding but plays no direct role in ATP
hydrolysis by the enzyme. The characteristics of
the BLM642–1108 mutant are consistent with the pre-
diction that the HRDC domain serves as an auxili-
ary DNA-binding domain, which was made on
the basis of similarity of the three-dimensional
structure of the Sgs1 HRDC domain to an ssDNA-
binding domain of the human DNA polymerase
b or the domain 1B of PcrA.33 However, the
BLM642–1108 fragment also lacks a large part of the
region connecting the RecQ-Ct and HRDC domain
that contains a number of amino acid residues con-
served among RecQ family members, raising the
possibility that the absence of this region rather
than the absence of the HRDC domain is respon-
sible for the observed defects. Nevertheless, we
have found that single alanine substitutions at two
highly conserved basic residues, R1108 and K1125
of BLM located in this region, had no effect on the
activity of BLM642–1290, supporting the assumption
that the defects of the BLM642–1108 mutant are due
to the absence of the HRDC domain. A recombi-
nant fragment of the Sgs1 helicase ending at the
beginning of the HRDC domain failed to bind to a
synthetic oligonucleotide, although it was able to
function as an ATP-dependent DNA helicase.46
Moreover, the small isoform of the Drosophila
melanogaster RecQ5 helicase containing only the
DEAH and RecQ-Ct domains showed significantly
reduced DNA helicase activity compared to the
large RecQ5 isoform, which contains the entire
RecQ homology region, whereas the ATPase
characteristics of these proteins were quite
similar.47,48 Thus, all these findings suggest that
the HRDC domain of RecQ helicases is involved
in modulating the helicase activity of the enzyme
through ssDNA binding, but is not absolutely
required for the activity.
Biochemical characterization of BLM642–1290
mutants at several conserved amino acid residues
in the RecQ-Ct domain demonstrated that this
domain is essential for the helicase activity of the
enzyme (Figure 6). In particular, the R1038A,
F1045A and D1064A mutants exhibited severe heli-
cases defects. All alanine mutants displayed
reduction in both ATP hydrolysis and ssDNA
binding of magnitudes similar to those of the
reduction in their helicase activity (compare Figure
6, Figure 7 and Table 3). Since DNA-dependent
ATPase activity is a prerequisite of the DNA-
unwinding function of the enzyme, ATPase defects
of these mutants seem to be the cause of their heli-
case defects. It is less likely that the R1038, F1045
and D1064 residues are involved in DNA binding
directly, because in such a scenario mutants would
not exhibit significant ATPase defects under con-
ditions of a saturating concentration of DNA.
Instead, it is possible that the mutations at R1038,
F1045 and D1064 induced local conformational
changes in the protein that impaired coupling
between DNA binding and ATPase activities of
the enzyme or that these residues are involved
directly in coupling of these activities.
Modeling of BLM structure using the crystal
structure of the PcrA helicase as a template
revealed that the DEAH domain of BLM consists
Figure 6. DNA helicase activity of BLM642–1290 point
mutants. (a) Unwinding of 0.5 nM 25 bp partial M13
duplex by wild-type and mutant BLM642–1290 proteins as
a function of protein concentration. (b) Unwinding of
1 nM synthetic four-way junction by wild-type and
mutant BLM642–1290 proteins each at a concentration of
40 nM. DNA substrates were prepared as described in
Materials and Methods. Reactions (10 ml) were carried
out in buffer H containing 2 mM ATP. After 30 minutes
incubation at 37 8C, reaction products were quantified
as described in Materials and Methods. The data shown
represent the mean of at least three independent
measurements.
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of two RecA-like subdomains that are found in all
SF1 and SF2 helicases for which structural infor-
mation is available.49 The cleft between these
domains forms the ATP-binding site, with residues
from seven helicase signature motifs mediating
protein–nucleotide interactions.8,41,42 The structures
showed also that DNA is bound along a groove on
the top of the RecA-like domains and that the cleft
closes and opens in response to ATP binding and
hydrolysis, which suggested a mechanism for how
protein translocates along DNA.8 It has been postu-
lated that the RecA domains of SF1 and SF2 heli-
cases represent the motor capable of translocating
along DNA, and that the additional, diverse
domains are determinants of the specificity of the
enzyme.4 Thus, the domains 1B and 2B of PcrA
are thought to be involved in destabilization of
DNA duplex ahead of the motor translocating
along ssDNA.8 The N-terminal domain of RecG,
forming a large fold that is divided into three sub-
domains linked to the C-terminal RecA-like motor
by a long helix, was shown to bind to a three-way
DNA junction in a manner that would allow
duplex separation.41 Thus, it is tempting to specu-
late that the region C-terminal to the DEAH
domain of RecQ helicases including the RecQ-Ct
and the HRDC domains have such a “specificity”
function. Structural studies of a RecQ family mem-
ber combined with biochemical analysis of mutants
will certainly clarify this issue. The recombinant
fragment of BLM described here seems to be a
good candidate for these studies, since it can be
prepared in large amounts at a high level of purity.
The fact that the BLM642–1290 fragment could
reduce the frequency of the l Spi2 phage formation
in a recQ mutant (Table 2) suggests that the RecQ
function to suppress illegitimate recombination
has been conserved throughout the evolution from
bacteria to humans. In E. coli, RecQ plays a role in
suppression of RecET-mediated illegitimate
recombination.15,24 It has been proposed that the
RecQ helicase may unwind intermediates of the
DNA end-joining reaction that involves annealing
of 30 single-stranded tails, generated by the RecE-
mediated exonucleolytic processing of a DSB, at
sites of microhomology.24 BLM has been shown to
unwind forked DNA duplexes efficiently,39
suggesting that it may indeed act on intermediates
of illegitimate recombination to promote non-
mutagenic repair of DSBs. However, experiments
using mutants in the chicken cell line DT40
suggested that these DNA transactions are
mediated rather by the WRN helicase, whereas
BLM is probably involved in restarting DNA repli-
cation at stalled replication forks, which prevents
generation of DSBs.22 However, recent evidence
from plasmid rejoining assays using BLM profi-
cient and deficient cell extracts demonstrated that
BLM can suppress mutagenic repair of DSBs by
illegitimate recombination,26 suggesting an overlap
between cellular functions of BLM and WRN. Our
data support this assumption.
In contrast to the suppressive effect of the BLM
fragment in a recQ mutant, its over-expression in
the wild-type strain rather enhanced illegitimate
recombination. A similar effect has been observed
following over-expression of the DnaB helicase in
E. coli.50 A model has been proposed for initiation
of illegitimate recombination in which over-pro-
duction of DnaB helicase results in excessive DNA
unwinding at replication forks and induction of
DSBs.50 A similar scenario might happen in the
case of high levels of BLM, as it efficiently unwinds
forked DNA duplexes.39
Figure 7. Electrophoretic mobility-shift assays of wild-type and mutant forms of BLM642–1290. Proteins at the concen-
trations indicated were incubated with 0.5 nM 50 end-labeled, single-stranded 30mer in buffer B at room temperature
for 20 minutes. Bound and free DNAwere separated by electrophoresis through a non-denaturing 15% polyacrylamide
gel and visualized using a PhosphorImager. Positions of free DNA and DNA–protein complexes are indicated on the
right by arrowheads. Asterisks ( p ) indicate the positions of the wells.
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Materials and Methods
DNA manipulations
All restriction and other DNA-modifying enzymes
were purchased from New England Biolabs (NEB). The
pJP71 expression vector was constructed by a PCR
amplification of the region of BLM cDNA comprising
the codons 642–1290 with primers introducing NcoI and
SapI sites, respectively, and inserting the PCR product
after digestion with NcoI and SapI between the NcoI and
SapI sites in pTXB3 (NEB). This resulted in a translational
fusion of BLM642–1290 with a self-cleaving affinity tag
composed of the Mxe intein and a chitin-binding domain
(CBD) present in pTXB3. An additional methionine resi-
due was introduced between the BLM fragment and the
intein according to the manufacturer’s instructions. The
plasmids pJP71S1167, pJP71S1108, pJP71S1056,
pJP71S1036, pJP71S997 producing the C-terminal trun-
cated variants of BLM642–1290: BLM642–1167, BLM642–1108,
BLM642–1056, BLM642–1036 and BLM642–997, respectively, as
Mxe–CBD fusions were constructed in the same way as
pJP71. All constructs were verified by sequencing to
eliminate any possible mutations introduced by PCR.
An origin repair method was employed for site-directed
mutagenesis of BLM.51,52 Mutagenesis was performed
using the plasmid pJP74, a derivative of pGLamB52 in
which the XbaI–BamHI fragment containing the lamB
gene was replaced by the XbaI–BamHI fragment of
pJP71 encoding for the BLM642–1290–intein–CBD fusion.
For production of mutants, the resulting point mutations
were transferred to pJP71 by replacing the XbaI–BamHI
region in this plasmid with the corresponding XbaI–
BamHI fragments from the mutant derivatives of pJP74.
The plasmid pJP79 was constructed by introducing the
XbaI–BsaBI fragment of pJP71 encoding for BLM642–1290
into pBluescript SK(þ) digested with XbaI and BamHI.
The BamHI end of the pBluescript SK(þ ) vector was
filled in using Klenow fragment in this construction. In
pJP79, BLM642–1290 is under control of the lac promoter
and, as in pJP71, contains an additional methionine
codon at the C terminus, which is followed by a TGA
stop codon.
l Spi2 assay
HI2776 DrecQ101 < cat l cI857 lysogen was con-
structed by transduction of HI1162 l cI857 lysogen53
with P1 phage prepared from N1126 DrecQ101 < cat
(kindly provided by Dr J. Kato). The HI1162 and HI2776
strains were transformed with either pBluescript SK(þ )
or pJP79. The frequency of the l Spi2 phages in these
strains was measured as described.40 Briefly, cells were
grown to 2 £ 108 cells/ml at 30 8C in lYP broth contain-
ing 20 mg/ml of ampicillin. If necessary, 2 ml of the cul-
ture was irradiated with a UV lamp (15 W) at a
wavelength of 254 nm. Immediately after UV irradiation,
the thermal induction of l phage was carried out by
incubation at 42 8C for 15 minutes with aeration. The cul-
ture was then incubated at 37 8C for two hours and the
phage lysate was prepared. The titer of Spi2 phage was
measured by plating on E. coli WL95 P2 lysogen. The
titer of total phage was measured by plating on E. coli
Yme I. The frequency of Spi2 phage was obtained by
dividing the titer of Spi2 phage by the titer of total
phage. Burst size was determined by dividing the num-
ber of total l phages in a lysate by the number of total
cells in the culture before heat induction.
Protein purifications
BLM642–1290 was produced as a fusion with a Mxe–
CBD self-cleaving affinity tag in the E. coli BL21-Codon-
Plus-(DE3)-RIL strain (Stratagene) containing the plas-
mid pJP71. Cells were grown at 37 8C in 1 l of LB
medium supplemented with ampicillin and chloramphe-
nicol at concentrations of 150 mg/ml and 25 mg/ml,
respectively. At an A600 of 0.3, the cultivation temperature
was reduced to 18 8C and protein synthesis was induced
by adding isopropyl-b,D-thiogalactopyranoside (IPTG)
to a final concentration of 0.2 mM and subsequent incu-
bation for 16 hours. All protein purification steps were
carried out at 4 8C. Cells were harvested by centrifu-
gation, suspended in 50 ml of buffer CH (50 mM Tris–
HCl (pH 8), 500 mM NaCl, 1 mM EDTA, 10% (v/v) gly-
cerol, 0.1% (v/v) Triton X-100) and disrupted by soni-
cation. The cell extract was clarified by centrifugation in
an SS-34 rotor (Sorvall) at 18,000 rpm for 30 minutes.
The supernatant was loaded onto a 15 ml chitin column
(NEB) at a flow-rate of 12 ml/hour. The column was
washed with 20 column volumes of buffer CH. Cleavage
of BLM642–1290 from the Mxe intein was induced by flush-
ing the column with three column volumes of buffer CH
supplemented with 50 mM DTT, with a subsequent incu-
bation overnight at 4 8C. The protein was eluted with
buffer CH. Fractions containing BLM642–1290 (as judged
from SDS-PAGE) were pooled, diluted 2.5 times with
50 mM Tris–HCl (pH 7.5) and loaded onto a 5 ml High-
Trap heparin cartridge (Amersham Pharmacia Biotech)
equilibrated with buffer HP (50 mM Tris–HCl (pH 7.5),
0.1 mM EDTA, 1 mM DTT, 10% (v/v) glycerol, 200 mM
NaCl). The protein was eluted with a linear concen-
tration gradient of NaCl (0.2 M–0.6 M; 50 ml) in buffer
HP. Fractions containing BLM642–1290 were pooled,
diluted three times with 20 mM Tris–HCl (pH 8) and
loaded onto a 50 ml CM-Sepharose FF column (Amer-
sham Pharmacia Biotech) equilibrated with buffer CM
(20 mM Tris–HCl (pH 8.0), 0.1 mM EDTA, 1 mM DTT,
10% (v/v) glycerol, 150 mM NaCl). The protein was
eluted with a linear concentration gradient of NaCl
(0.15 M–0.35 M; 500 ml) in buffer CM. Fractions contain-
ing BLM642–1290 with .95% homogeneity were pooled
and concentrated by dialysis against storage buffer
(50 mM Tris–HCl (pH 7.5), 200 mM NaCl, 50% (v/v) gly-
cerol, 1 mM DTT). Other BLM variants were produced
and purified according to the same protocol. The
BLM642–1108 protein as well as the R1038A and D1064A
mutants of BLM642–1290 did not bind to the heparin
column under these conditions. However, sufficient
purification of these proteins to more than 90% homo-
geneity could be achieved by combining chromato-
graphies on the chitin and CM-Sepharose FF columns.
Protein concentration was determined from absorption
at 280 nm using molar extinction coefficients derived
from amino acid composition. The full-size BLM protein
was kindly provided by Professor Ian D. Hickson from
the University of Oxford.
Size-exclusion chromatography
Size-exclusion chromatography of BLM642–1290 was
performed at room temperature on a Superdex 200
PC3.2/30 column using a SMART system (Amersham
Pharmacia Biotech). The column was equilibrated with
buffer GF (20 mM Tris–HCl (pH 7.5), 150 mM NaCl,
0.1 mM EDTA, 1 mM DTT). Samples were prepared
by dilution of the protein tenfold in GF buffer to a final
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concentration of 3 mM. Where required, samples were
supplemented with 0.5 mM single-stranded 30mer
oligonucleotide: 50-CCGTCGACTGACCGATATCCTCG
GTACCCC-30, 1 mM ATPgS and 5 mM MgCl2. Samples
were incubated at room temperature for 15 minutes
prior to injection of 50 ml aliquots onto the column. The
column was run at a flow-rate of 40 ml/minute and
absorbance was monitored at 215 nm, 260 nm and
280 nm. The following size markers were used for cali-
bration of the column: thyroglobulin (669 kDa), ferritin
(440 kDa), catalase (232 kDa), aldolase (158 kDa), bovine
serum albumin (67 kDa), ovalbumin (43 kDa) and chy-
motrypsinogen (25 kDa).
DNA helicase assays
DNA helicase activity of BLM and its mutants was
measured using either partial DNA duplexes prepared
by annealing oligonucleotides to circular M13mp18
ssDNA or using various synthetic duplex substrates.
The following oligonucleotides were used for prep-
aration of the partial M13 duplex substrates: 43mer 50-
CTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCC
GGGTACCG-30 and 24mer: 50-CATTAAAGCCAGAATG
GAAAGCGC-30. The oligonucleotides were annealed to
M13mp18 ssDNA at molar ratio of 10:1 by heating at
95 8C for five minutes and then cooling to 30 8C at
0.2 deg.C/second. Non-annealed oligonucleotides were
removed using a QIAquick PCR purification kit (QIA-
GEN). Annealed oligonucleotides were radioactively
labeled at the 30 end by a filling-in reaction catalyzed by
Klenow fragment (NEB) in the presence of [a-32P]ATP
(3000 Ci/mmol; Amersham Pharmacia Biotech) under
standard conditions (NEB). The oligonucleotides A20
(50mer), A0 (30mer), B19 (49mer), B0 (30mer) and C19
(19mer) were used for the generation of the blunt-ended
duplex (A0 þ B0), 30-ssDNA-tailed duplex (A0 þ B19),
splayed arm (A 2 0 þ B 1 9) , 5 0-ssDNA flap duplex
(A20 þ B19 þ C19) and nicked duplex (A0 þ B19 þ C19)
have been described.54 The oligonucleotides A20 and A0
were labeled at the 50 end using [g-32P]ATP (3000 Ci/
mmol; Amersham Pharmacia Biotech) and phage T4
polynucleotide kinase (NEB), and annealed to appropri-
ate complementary strands at a molar ratio of 1:1.25 by
incubation at 95 8C for five minutes and then cooling to
30 8C at 0.2 deg.C/second. The 50mer oligonucleotides
used to prepare the four-way junction substrate have
been described.6 One of the oligonucleotides was radio-
labeled at the 50 end using [g-32P]ATP and T4 polynucleo-
tide kinase. The labeled oligonucleotide was annealed
with the other three strands at a molar ratio of 1:4 by
incubation at 95 8C for five minutes and then cooling to
30 8C at 0.2 deg.C/second. The radiolabeled four-way
junction substrate was separated from other species on
a non-denaturing 15% (w/v) polyacrylamide gel (acryl-
amide to bis-acrylamide, 19:1 (w/w)) run in TBE buffer
(90 mM Tris–borate (pH 8.3), 2 mM EDTA) and recov-
ered from the gel by electroelution.
DNA helicase reactions were carried out at 37 8C in
buffer H (50 mM Tris–HCl (pH 7.5), 50 mM NaCl,
5 mM MgCl2, 50 mg/ml of bovine serum albumin (BSA),
2 mM ATP, 1 mM DTT). DNA substrates were present at
a concentration of 0.5 nM for partial M13 duplexes or
1 nM for synthetic substrates. After two minutes pre-
incubation, reactions were started with enzyme and
later terminated by addition of 0.5 reaction volume of
buffer S (150 mM EDTA, 2% (w/v) SDS, 30% (v/v) gly-
cerol, 0.1% (w/v) bromophenol blue). In protein titration
experiments, reactions were usually carried out in a
volume of 10 ml using various quantities of protein (as
indicated in the Figure legends) and an incubation time
of 30 minutes. To measure the rate of DNA unwinding
by BLM642–1290 as a function of ATP concentration, 50 ml
time-course reactions were carried out for concentrations
of ATP ranging from 10 mM to 2000 mM using 25 bp par-
tial duplex as DNA substrate (0.5 nM) and an enzyme
concentration of 20 nM. Reaction aliquots (10 ml) at
time-points of 0.5, one, two and three minutes were
analyzed.
For all reactions, the displaced radiolabeled oligonu-
cleotide was separated from its annealed form by electro-
phoresis through a non-denaturing 15% polyacrylamide
gel (acrylamide to bis-acrylamide, 37.5:1 (w/w)) run in
TBE buffer at 100 V for two hours. Gels were dried and
subjected to autoradiography and/or quantified using a
PhosphorImager and ImageQuant software (Molecular
Dynamics). The K1/2 value for ATP (concentration of
ATP at which the rate of unwinding was half of the
maximal rate) was derived by fitting data by the Michae-
lis–Menten equation using Prism 2.0 software.
ATPase assays
DNA-dependent ATPase activity was measured using
a malachite green assay based on a colorimetric esti-
mation of inorganic phosphate produced by ATP
hydrolysis.55 Reactions were carried out at 37 8C in buffer
H in the presence of saturating amounts of DNA cofac-
tors, including M13mp18 ssDNA, supercoiled pTZ18R
plasmid DNA and a 43mer oligonucleotide (see above)
as indicated in the Figure and Table legends. Reactions
were initiated by adding ATP. Aliquots (5–20 ml) were
removed from reactions at various time-points (1, 2, 4, 8,
16, and 32 minutes) and mixed with 20 ml of 0.1 M
EDTA to terminate ATP hydrolysis. After appropriate
dilution, samples (40 ml) were subjected to malachite
green assay in a 96-well microplate as described56 along
with a series of KH2PO4 dilutions ranging from 10 mM
to 140 mM that served for calibration. Steady-state kinetic
parameters KM and kcat for ATP were measured at a pro-
tein concentration of 20 nM, with the exception of
D1064A and R1038A mutants, which were present at
concentrations of 40 nM and 100 nM, respectively. The
concentration of ATP was varied from 10 mM to 2 mM
in these measurements. The KM and kcat values were
derived by fitting data by the Michaelis–Menten
equation using Prism 2.0 software.
DNA binding assay
Protein at concentrations ranging from 5 to 640 nM
was incubated with 2.5 nM 30mer oligonucleotide (the
same as in the gel-filtration experiments) labeled at the
50 end using [g-32P]ATP and T4 polynucleotide kinase.
Incubations were carried out at room temperature for
20 minutes in buffer B (50 mM Tris–HCl (pH 7.5), 1 mM
DTT, 50 mM NaCl, 10% (v/v) glycerol). Samples were
subsequently subjected to electrophoresis through a
non-denaturing 15% polyacrylamide gel (acrylamide to
bis-acrylamide, 37.5:1 (w/w)) run in TBE buffer at 100 V
to separate protein–DNA complex from free DNA. Gels
were dried and analyzed by a PhosphorImager. The
apparent dissociation constant (Kd) was determined as
the protein concentration at which 50% of DNA was
bound.
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Human RECQ5β, a protein with DNA helicase and
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Human RECQ5b, a protein with DNA helicase and
strand-annealing activities in a single polypeptide
Patrick L Garcia1, Yilun Liu2, Josef Jiricny1,
Stephen C West2 and Pavel Janscak1,*
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Proteins belonging to the highly conserved RecQ helicase
family are essential for the maintenance of genomic stabi-
lity. Here, we describe the biochemical properties of the
human RECQ5b protein. Like BLM and WRN, RECQ5b is
an ATP-dependent 30–50 DNA helicase that can promote
migration of Holliday junctions. However, RECQ5b re-
quired the single-stranded DNA-binding protein RPA in
order to mediate the efficient unwinding of oligonucleo-
tide-based substrates. Surprisingly, we found that RECQ5b
possesses an intrinsic DNA strand-annealing activity that
is inhibited by RPA. Analysis of deletion variants of
RECQ5b revealed that the DNA helicase activity resides
in the conserved N-terminal portion of the protein,
whereas strand annealing is mediated by the unique C-
terminal domain. Moreover, the strand-annealing activity
of RECQ5b was strongly inhibited by ATPcS, a poorly
hydrolyzable analog of ATP. This effect was alleviated by
mutations in the ATP-binding motif of RECQ5b, indicating
that the ATP-bound form of the protein cannot promote
strand annealing. This is the first demonstration of a DNA
helicase with an intrinsic DNA strand-annealing function
residing in a separate domain.
The EMBO Journal (2004) 23, 2882–2891. doi:10.1038/
sj.emboj.7600301; Published online 8 July 2004
Subject Categories: genome stability & dynamics
Keywords: DNA helicase; genomic instability; Holliday
junctions; RecQ; single-strand annealing
Introduction
Helicases are ubiquitous enzymes that use the free energy of
nucleotide triphosphate hydrolysis to separate nucleic acid
duplexes into the constituent single strands (reviewed in
Lohman and Bjornson, 1996; Hall and Matson, 1999; von
Hippel and Delagoutte, 2001). They play essential roles in
nearly all DNA metabolic processes, including DNA replica-
tion, recombination and repair. Helicases often contain addi-
tional functional domains or interact with other proteins to
mediate complex DNA transactions.
DNA helicases of the RecQ family, named after the 30–50
DNA helicase RecQ of Escherichia coli, unwind a wide variety
of potentially recombinogenic DNA structures, including
four-way junctions, D-loops and G-quadruplex DNA. RecQ
helicases are highly conserved from bacteria to humans, but
while prokaryotes and unicellular eukaryotes such as
Saccharomyces cerevisiae or Schizosaccharomyces pombe pos-
sess only a single RecQ homolog, multicellular organisms
have several (for recent reviews, see Bachrati and Hickson,
2003; Hickson, 2003; Khakhar et al, 2003). In humans, five
RecQ homologs have been identified to date: RECQ1, BLM/
RECQ2, WRN/RECQ3, RECQ4 and RECQ5. In all organisms,
defective RecQ helicase function is associated with genomic
instability, which is generally manifested as an increase in the
frequency of inappropriate recombination events. Mutations
in genes encoding the human RecQ helicases BLM, WRN and
RECQ4 give rise to the hereditary disorders Bloom’s syn-
drome, Werner’s syndrome and Rothmund–Thomson syn-
drome, respectively (Bachrati and Hickson, 2003). These
diseases are associated with cancer predisposition and vari-
able aspects of premature aging. Although the precise DNA
transactions mediated by RecQ helicases remain elusive, the
enzymes have been implicated in the processing of aberrant
DNA structures arising during DNA replication and repair
(Bachrati and Hickson, 2003).
RecQ helicases possess the so-called DExH helicase and
RecQ-Ct (RecQ C-terminal) regions, which form the catalytic
core of the enzyme (Bachrati and Hickson, 2003; Bernstein
and Keck, 2003). The former domain is homologous to the
superfamily 2 helicases, while the latter is unique to the RecQ
family. Recent structural studies on the E. coli RecQ helicase
have shown that the RecQ-Ct region forms two subdomains
(Bernstein et al, 2003). The proximal part of this region folds
into a platform of four helices containing a Zn2þ -binding site
and the distal part forms a specialized helix–turn–helix motif,
called the winged-helix (WH) domain, which serves as a
double-stranded DNA (dsDNA)-binding motif in several pro-
teins including the catabolite gene activator protein
(Bernstein et al, 2003). Some RecQ helicases also contain
the so-called HRDC (Helicase and RNAseD C-terminal) re-
gion, which may serve as an auxiliary DNA-binding domain
(Liu et al, 1999; Bernstein and Keck, 2003). The eukaryotic
members of the RecQ family usually have additional N- and
C-terminal domains flanking the RecQ core, which are in-
volved in protein–protein interactions (Bachrati and Hickson,
2003).
Although defects in WRN, BLM and RECQ4 are associated
with heritable human disease, such an association has not
been demonstrated for RECQ5. Targeted disruption of RECQ5
in chicken DT40 cells, which have proven to be a valuable
model system to study the cellular functions of BLM and
WRN, does not result in genomic instability (Imamura et al,
2002; Wang et al, 2003). However, a RECQ5/ BLM/ DT40
double mutant exhibits much higher levels of sister chroma-
tid exchanges (SCEs) than a BLM/ mutant, suggesting that
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RECQ5 may serve as backup for BLM (Wang et al, 2003).
RECQ5 deficiency in Caenorhabditis elegans reduces lifespan
and increases cellular sensitivity to ionizing radiation (Jeong
et al, 2003). Together, these findings support the notion that
the product of the human RECQ5 gene may be important for
the maintenance of genomic stability.
The human RECQ5 protein exists in at least three different
isoforms, which result from alternative splicing of the RECQ5
transcript (Shimamoto et al, 2000). In addition to the con-
served helicase and RecQ-Ct regions, the largest isoform,
RECQ5b, contains a long C-terminal region that displays no
homology to the other family members (Figure 7A). Also, in
contrast to the other RecQ helicases, RECQ5b lacks the WH
domain. The other two isoforms, RECQ5a and RECQ5g, are
almost identical. RECQ5a terminates inside the RecQ-Ct
region, just upstream of the putative Zn2þ -binding site.
RECQ5g contains 25 additional amino acids at the C-terminus
that are not present in RECQ5b. The RECQ5b isoform loca-
lizes to the nucleus, whereas the two smaller isoforms are
cytoplasmic (Shimamoto et al, 2000).
The biochemical functions of these isoforms are unknown.
To gain an insight into the potential role of RECQ5 in the
maintenance of genomic stability, we have carried out an
extensive biochemical analysis of the RECQ5b protein. We
found that RECQ5b is monomeric and contains two separate
functional domains: the N-terminal half of the protein com-
prising the conserved DExH and Zn2þ -binding domains
functions as a DNA-dependent ATPase and an ATP-dependent
30–50 DNA helicase. The unique C-terminal portion possesses
an efficient DNA strand-annealing activity. To our knowledge,
this is the first demonstration of a DNA helicase with an
intrinsic DNA strand-annealing function residing in a sepa-
rate domain of the same polypeptide.
Results
DNA-dependent ATPase and 3 0–5 0 DNA helicase
activities of RECQ5b
RECQ5b was overproduced in E. coli as a fusion protein with
a self-cleaving affinity tag composed of an intein fragment
and a chitin-binding domain (CBD), and purified to more
than 95% homogeneity (Figure 1A). To determine the
quaternary structure of the RECQ5b protein in solution,
analytical ultracentrifugation experiments were conducted
with 0.5 mM protein. The sedimentation velocity profile of
RECQ5b preparation revealed the presence of a single species
with an S20,W value of 5.6. Sedimentation equilibrium mea-
surements yielded an apparent molecular mass of 134 kDa
indicating that RECQ5b exists as a monomer in solution (the
predicted value for the monomer is 108.9 kDa). Size-exclu-
sion chromatography on a Superdex 200 column revealed no
change in the quaternary structure of the protein upon
addition of a 30-mer oligonucleotide and/or ATPgS-Mg2þ
(data not shown).
The ATPase activity of RECQ5b was analyzed in the
presence of various DNA molecules, including short oligonu-
cleotides, circular single-stranded DNA (ssDNA), linear
dsDNA or supercoiled plasmid DNA. RECQ5b was found to
exhibit robust ATPase activity with both ssDNA and dsDNA,
whereas little ATPase activity was observed in the absence of
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Figure 1 ATPase and DNA helicase activities of RECQ5b. (A) A 10% SDS–polyacrylamide gel showing individual RECQ5b purification steps.
RECQ5b was overproduced in E. coli as a fusion with a self-cleaving affinity tag. Lane 1, molecular size marker; lane 2, soluble fraction of
whole-cell extract (WCE); lane 3, pooled fractions from the chitin column; lane 4, pooled fractions from the heparin column. (B) ATPase
activity of RECQ5b in the presence of the indicated DNA effectors. Reactions were carried out at 371C for 30min and contained 20nM RECQ5b,
2mM ATP and 25mg/ml DNA effector. The amount of inorganic phosphate (Pi) released by ATP hydrolysis was determined as described in
Materials and methods. sc-dsDNA, supercoiled dsDNA; lin-dsDNA, linear dsDNA. (C) Conventional DNA helicase assay using a 44 bp
M13mp18-based duplex radiolabeled at the 30-end. Reactions were carried out at 371C for 30min and contained 0.5 nM DNA, varying
concentrations of RECQ5b and 2mM ATP (or ATPgS) as indicated. The reaction products were analyzed by 10% nondenaturing PAGE.
Radiolabeled species were visualized by autoradiography. The last lane contains heat-denatured substrate. (D) Helicase polarity assay using a
linearized M13mp18-based DNA substrate with partial-duplex termini. Radiolabeled 30-ends in this DNA substrate are indicated by asterisks
(top panel). Reactions were carried out at 371C for 30min and contained 0.5 nM DNA substrate, 40 nM RECQ5b and 2mM ATP. The products
were analyzed as in (C). Lane 1, substrate incubated without enzyme; lane 2, substrate plus enzyme; lane 3, heat-denatured substrate.
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DNA (Figure 1B). In addition to ATP, RECQ5b could hydro-
lyze dATP with a specific activity similar to that observed
with ATP (data not shown). We also found that GTP and
dGTP could be hydrolyzed in the presence of ssDNA and
dsDNA, but the specific activities were approximately 10-fold
lower than that observed with ATP (data not shown). No
significant hydrolytic activity was observed with other nu-
cleotides.
To determine whether RECQ5b possesses a DNA helicase
activity, we first tested its ability to disrupt an M13mp18-
based partial duplex of 44 bp. Using 0.5 nM DNA substrate
and increasing amounts of RECQ5b in the presence of ATP,
we observed that RECQ5b displaced the annealed oligonu-
cleotide in a concentration-dependent manner (Figure 1C). At
a protein concentration of approximately 15–20nM, 50%
strand displacement occurred. DNA helicase activity was
dependent on ATP hydrolysis, as strand displacement was
not observed when ATP was replaced with poorly hydrolyz-
able ATP analog, ATPgS (Figure 1C). We found that dATP
could substitute for ATP, but failed to observe DNA helicase
activity when other nucleotides were used.
To determine the polarity of the RECQ5b helicase, we
employed a linear DNA substrate consisting of M13mp18
ssDNA with short 32P-labeled (17 and 25 bp) duplex regions
at the 50- and 30-ends, respectively (Figure 1D, top panel). We
found that RECQ5b could only displace the 17-mer, indicating
30–50 polarity, which is a general characteristic of the RecQ
helicase family (Figure 1D, lower panel).
RECQ5b requires RPA to unwind oligonucleotide-based
partial duplexes
Further analysis of the DNA helicase activity of RECQ5b
revealed that the unwinding of oligonucleotide-based sub-
strates was poor compared with the M13-based partial du-
plexes. Using a 30-bp forked duplex with single-stranded
splayed arms, we observed that the formation of unwound
products increased proportionally with protein concentra-
tion, peaking at 10 nM with about 20% of the substrate
dissociated (Figure 2A). Interestingly, at higher protein con-
centrations (10–40 nM), the strand displacement activity
dropped below the level of spontaneous dissociation of the
substrate. At even greater protein concentrations (40–
320 nM), the activity again increased gradually with protein
concentration (Figure 2A). The inability of RECQ5b to pro-
mote efficient unwinding of an oligonucleotide-based fork
structure was surprising since other RecQ helicases such as
BLM or WRN exhibit a preference for this substrate
(Mohaghegh et al, 2001).
To explore the possibility that RECQ5b requires additional
factors to mediate unwinding of oligonucleotide-based sub-
strates, we first examined the effect of the human replication
protein A (RPA), an ssDNA-binding protein, on this reaction.
RPA has been shown to enhance specifically the unwinding of
long DNA duplexes by WRN and BLM (Brosh et al, 1999,
2000). We observed that addition of RPA greatly stimulated
RECQ5b-mediated unwinding of the splayed-arm structure in
a concentration-dependent manner (Figure 2B). Time-course
studies, carried out at 1 nM DNA and 20nM RECQ5b, showed
that in the presence of 24 nM RPA (trimer) the unwinding
reaction was completed in o16min (Figure 2C). The E. coli
ssDNA-binding (SSB) protein (120 nM) could partially sub-
stitute for RPA, but the efficiency of unwinding was reduced
(Figure 2C). These results indicate that the stimulatory effect
of RPA may involve specific interactions between RPA and
RECQ5b, in addition to its effect in binding the ssDNA
products.
RECQ5b promotes Holliday junction branch migration
The BLM and WRN proteins interact with Holliday junctions
(HJs) and promote their migration (Constantinou et al, 2000;
Karow et al, 2000). To determine whether RECQ5b could
catalyze similar reactions, we analyzed its activity with the
synthetic HJ substrate X26 that contains a 26-bp core of
homologous sequences flanked by heterologous arm se-
quences. In the presence of ATP, we observed concentra-
tion-dependent branch migration that generated splayed-arm
products (Figure 3A, lanes 2–6). Branch migration was
stimulated by the presence of RPA (Figure 3A, lanes 8–11,
and Figure 3B).
In these reactions, comparatively few three-strand junc-
tions or single-stranded products were observed, indicating
that the primary RECQ5b-mediated reaction involved recog-
nition of the HJ followed by its movement and dissociation
into splayed-arm products. This proposal was supported by
the analysis of RECQ5b-mediated branch migration reactions
in which the DNA substrate was preincubated with E. coli
RuvA, a protein known to bind HJs with high specificity.
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Figure 2 Stimulation of RECQ5b helicase activity on oligonucleo-
tide-based partial duplexes by ssDNA-binding proteins. (A)
Unwinding of 1 nM 30-bp forked duplex, 32P-end labeled in the
50-ssDNA arm, by RECQ5b at concentrations ranging from 0 to
320nM. Reactions were incubated at 371C for 20min, and the
products were analyzed by 10% nondenaturing PAGE.
Radiolabeled species were visualized by autoradiography. (B)
Unwinding of 1 nM 30-bp forked duplex by 20 nM RECQ5b in the
presence of the indicated concentrations of RPA. Reactions were
carried out and analyzed as in (A). (C) Kinetics of unwinding of
1 nM 30-bp forked duplex by 20 nM RECQ5b in the presence of
24 nM RPA, 120 nM E. coli SSB or without any ssDNA-binding
protein. The percentage strand displacement was estimated as
described in Materials and methods.
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We found that the presence of 40 nM RuvA imposed a
complete block to branch migration mediated by 25 nM
RECQ5b (Figure 3C).
The ability of RPA to stimulate branch migration could be a
consequence of its ability to bind the single-stranded arms of
reaction products thereby (i) stimulating the forward reaction
or (ii) blocking a reverse reaction in which the splayed-arm
structures reannealed to reform the HJ structure. To distin-
guish between these possibilities, time-course studies were
carried out in the presence and absence of RPA. Without RPA,
formation of the splayed-arm branch migration products was
greater after 5min than at later time points (Figure 4A, lanes
3–6, and Figure 4B). This surprising result contrasts with data
obtained with reactions carried out in the presence of RPA, in
which splayed-arm products accumulated in a time-depen-
dent manner (Figure 4A, lanes 7–11, and Figure 4B). As
observed in the helicase assays described earlier, SSB could
only partially substitute for RPA (Figure 4C). Taken together,
these results indicate that RPA plays a specific role in the
branch migration reaction, by specifically inhibiting the
reannealing of the splayed-arm products. RPA stimulation
therefore involves inhibition of annealing, rather than stimu-
lation of branch migration.
RECQ5b possesses DNA strand-annealing activity
The finding that the RECQ5b-mediated dissociation of four-
way junctions to splayed-arm products was followed by a
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cated amounts of RECQ5b protein in the presence or absence of
20nM RPA. Reactions were carried out at 371C for 15min, and the
DNA products were analyzed by neutral PAGE. Lane 1, control
reaction with E. coli RuvA (25nM) and RuvB (50 nM). (B)
Quantification of the data shown in (A). The relative concentration
of the dissociated products is expressed as percentage of total DNA.
The dissociated products include three-way junctions, splayed
arms (the products of branch migration) and ssDNA. Background
levels of dissociated species have been subtracted. (C) Inhibition of
RECQ5b branch migration activity by the E. coli HJ-binding protein
RuvA. RuvA was preincubated with the junction in reaction buffer
for 1min prior to the addition of the RECQ5b protein. Incubation
was then continued, and the products were assayed as described
in (A).
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inhibiting DNA reannealing. (A) Time course of branch migration of
0.5 nM X26 mediated by 50nM RECQ5b either in the presence or
absence of 20 nM RPA. Reactions were carried out at 371C, and the
DNA products were analyzed by neutral PAGE. (B) Quantification of
products (three-way junction, splayed-arm branch migration pro-
ducts and single strands) formed during the reactions shown in (A).
The relative concentration of the products is expressed as percen-
tage of total dissociated products. (C) Time course of branch
migration of 0.5 nM X26 mediated by 50nM RECQ5b in the presence
or absence of excess E. coli SSB protein (1 mM). Reactions were
carried out and analyzed as in (A).
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slow reannealing reaction (Figure 4A) encouraged us to test
whether RECQ5b itself possesses the ability to promote the
annealing of complementary single strands. We therefore
incubated two partially complementary oligonucleotides
(those used to make the splayed-arm helicase substrate)
with increasing amounts of RECQ5b in the absence of ATP,
and subsequently analyzed the reaction products by 10%
nondenaturing polyacrylamide gel electrophoresis (PAGE).
We found that RECQ5b promoted an efficient annealing
reaction (Figure 5). Using 1 nM ssDNA, we found that
annealing was dependent on protein concentration, with
the reaction being most efficient at around 40 nM RECQ5b
(Figure 5A). A large excess of RECQ5b over DNA slightly
inhibited single-strand annealing, possibly as a consequence
of protein aggregation (Figure 5A). Time-course experiments
conducted at the optimal concentration of RECQ5b (40 nM)
revealed that the RECQ5b-promoted annealing reaction
was rapid, with 50% of the single-stranded substrate being
converted into the double-stranded product within
2min (Figure 5B). In contrast, spontaneous DNA annealing
was slow, with only 15% of the substrate being converted
to dsDNA after 32min (Figure 5B). These findings
provide an explanation for the apparent poor helicase
activity displayed by RECQ5b on oligonucleotide-based
substrates.
RECQ5b was also tested for its ability to promote the
annealing of a short oligonucleotide to a target sequence in
M13mp18 ssDNA, which contains a large excess of hetero-
logous sequences. In this experiment, a 32P-end-labeled 43-
mer oligonucleotide (also used in the helicase assays shown
in Figure 1C) was preincubated with RECQ5b followed by the
addition of M13mp18 ssDNA. RECQ5b promoted the anneal-
ing of the oligonucleotide to the M13mp18 ssDNA
(Figure 5C). However, the yield of the annealed product in
this reaction was significantly lower than that of the RECQ5b-
promoted annealing of complementary oligonucleotides
(compare Figure 5A and C). This negative effect of hetero-
logous DNA sequences on RECQ5b-mediated strand anneal-
ing correlates with our earlier studies in which it was shown
that RECQ5b efficiently unwinds M13mp18-based partial
duplexes (Figure 1C).
To gain further insight into the mechanism of RECQ5b-
mediated DNA strand annealing, we investigated whether
coating of the oligonucleotides with RPA would affect the
annealing reaction. Assuming that the size of the DNA-
binding site for RPA is about 30 nucleotides (nt) (Kim et al,
1992), we anticipated that the two partially complementary
oligonucleotides (with lengths of 50 and 49 nt) would each be
occupied by 1–2 RPA heterotrimers. The oligonucleotides
(1 nM) were first preincubated with RPA at a concentration
ranging from 0 to 24 nM for 2min. After this DNA-binding
reaction, RECQ5b was added to a final concentration of
40 nM and incubation was continued for 20min. This protein
titration experiment revealed that the presence of RPA at
concentrations above 3 nM completely inhibited the DNA
strand-annealing activity of RECQ5b (Figure 5D). This result
correlates with the observation that RPA enhances the DNA
helicase activity of RECQ5b on the oligonucleotide-based
substrates (Figure 2C) and also blocks the reassociation
of splayed-arm products resulting from RECQ5b-promoted
HJ branch migration on the X26 structure (Figure 4A
and B).
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Figure 5 RECQ5b promotes DNA strand annealing. (A) Formation
of 30-bp forked duplex in the presence of varying concentrations of
RECQ5b. The A20 and B19 complementary oligonucleotides (1 nM),
of which A20 was radiolabeled at its 50-end, were incubated with
the indicated concentrations of RECQ5b for 20min at 371C. The
reaction products were separated by 10% nondenaturing PAGE and
visualized by autoradiography. (B) Kinetics of RECQ5b-mediated
and spontaneous formation of 30-bp forked duplex. Reactions were
carried out at 371C. The component strands A20 and B19 were
present at a concentration of 1 nM and RECQ5b was at a concentra-
tion of 40 nM. Reactions were initiated by the addition of unlabeled
B19 oligonucleotide. The relative concentration of the strand-
annealing product was determined as described in Materials and
methods. (C) Annealing of 1 nM 32P-end-labeled Hel-1 oligonucleo-
tide (43-mer) to 2 nM M13mp18 ssDNA in the absence or presence
of 100 nM RECQ5b. Reactions were carried out at 371C for 20min
and analyzed as in (A). RECQ5b was preincubated with Hel-1 for
2min at room temperature prior to the addition of M13mp18
ssDNA. Lane 1, Hel-1 alone; lane 2, Hel-1 and M13mp18 ssDNA;
lane 3, Hel-1, M13mp18 ssDNA and RECQ5b. (D) Effect of RPA on
RECQ5b-mediated DNA strand annealing. The complementary oli-
gonucleotides A20 and B19 (1 nM), of which A20 was radiolabeled,
were incubated with or without RPA for 5min at room temperature.
RECQ5bwas added to a final concentration of 40 nM and incubation
was continued at 371C for 20min. The reaction products were
analyzed as in (A).
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ATP binding to the helicase domain of RECQ5b
suppresses strand annealing
We next sought to examine the effect of ATP on the strand-
annealing activity of RECQ5b. Since ATP can be hydrolyzed
by RECQ5b under the conditions of the strand-annealing
assay, we also employed the poorly hydrolyzable analog of
ATP, ATPgS, in order to trap RECQ5b in its ATP-bound form.
Using the two partially complementary oligonucleotides, we
found that the presence of ATP or ADP had little or no effect
on the RECQ5b-mediated strand-annealing reaction
(Figure 6A). In contrast, ATPgS dramatically inhibited the
efficient strand-annealing activity of RECQ5b (Figure 6A).
These data imply that the observed inhibitory effect is the
consequence of ATP binding rather than hydrolysis.
We next used a mutational approach to prove that the
inhibitory effect of ATPgS on RECQ5b-mediated strand an-
nealing was due to its binding to the ATP-binding site of the
RECQ5b helicase domain. In the crystal structure of the
complex of the E. coli RecQ catalytic core with ATPgS and
Mn2þ , the adenine moiety forms hydrogen bonds with Gln-
30 of motif 0 while the triphosphate is bound to Lys-53 of
motif I (Bernstein et al, 2003). We therefore generated
mutants in the corresponding residues of RECQ5b, Gln-34
and Lys-58, by replacing them with alanine and arginine,
respectively. Both single and double mutants were generated,
purified essentially as the wild-type enzyme and tested for
their ability to bind and hydrolyze ATP. We found that the
Q34A mutant retained partial ATPase activity (about 50% of
wild type), whereas the K58A mutant and the double mutant
failed to show any significant ATPase activity (Figure 6B).
Using a UV crosslinking assay with [g-32P]ATP, we found that
all three mutants exhibited reduced ATP binding relative to
the wild-type enzyme (Figure 6C).
The partially complementary oligonucleotides were then
used to assess the effect of ATPgS on the strand-annealing
activity of the mutant RECQ5b proteins. We found that, in the
absence of ATPgS, all mutant proteins promoted DNA an-
nealing, although the activities of the K58R mutant and the
double mutant were slightly reduced compared to that of the
wild-type enzyme (Figure 6D). However, in contrast to the
dramatic inhibitory effect seen with the wild-type enzyme,
ATPgS only partially inhibited the strand-annealing activity of
the Q34A mutant and had no effect on the strand-annealing
activities of the K58R and Q34AK58R mutants (Figure 6D).
These results correlate nicely with the observed ATPase
activities of these proteins (Figure 6B), and show that the
ATP-bound form of RECQ5b does not possess the ability to
promote the reannealing of two complementary DNA strands.
DNA strand-annealing activity resides in the C-terminal
region of RECQ5b
To define the region of RECQ5b responsible for the observed
strand-annealing activity, the RECQ51–475 and RECQ5411–991
deletion variants (Figure 7A) were tested for their ability to
promote this reaction. The former mutant consists of the
conserved portion of RECQ5b including the DExH and the
Zn2þ -binding domains while the latter includes the unique C-
terminal half of RECQ5b. In these reactions, we used two
fully complementary 50-mer oligonucleotides. We found that
the annealing activity promoted by RECQ51–475 was only
slightly greater than that observed in the absence of added
protein and 30-fold lower than that of the wild-type enzyme
(Figure 7B). In contrast, RECQ5411–991 displayed a significant
strand-annealing activity although the rate of this reaction
was reduced (four-fold) with respect to the wild-type enzyme
(Figure 7B). From these data, we suggest that the observed
DNA strand-annealing activity resides in the unique C-term-
inal part of the RECQ5b polypeptide, although it is evident
that the helicase domain increases this activity possibly by
enhancing the affinity of the enzyme for ssDNA.
Because RECQ51–475 does not display a significant DNA
strand-annealing activity and contains the entire helicase
catalytic core, we anticipated that it would unwind oligonu-
cleotide substrates more efficiently than the full-size protein.
To address this question, we compared the helicase activities
of RECQ5b and RECQ51–475 on the 30-bp splayed-arm sub-
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Figure 6 The ATP-bound form of RECQ5b does not promote DNA
strand annealing. (A) Effect of ATP, ATPgS and ADP on RECQ5b-
promoted annealing of the A20 and B19 oligonucleotides. Reactions
were carried out at 371C for 20min and contained 40nM RECQ5b,
1 nM DNAs and 2mM nucleotides as indicated. The reaction
products were analyzed by 10% nondenaturing PAGE.
Radiolabeled species were visualized by autoradiography. (B)
Comparative ATPase assay for wild-type, Q34A, K58R and
Q34AK58R RECQ5b. ATPase reactions were carried out essentially
as described in Figure 1B using A20 oligonucleotide as a DNA
effector. (C) Comparative ATP-binding assay for wild-type, Q34A,
K58R and Q34AK58R RECQ5b. ATP binding was measured using
the ATP photo-crosslinking assay described in Materials and meth-
ods. The material was resolved on a 10% SDS–polyacrylamide gel,
stained with Coomassie brilliant blue (bottom panel) and subjected
to autoradiography (top panel). The asterisks indicate the position
of the RECQ5b protein. (D) Effect of ATPgS on DNA strand-anneal-
ing activities of the wild-type, Q34A, K58R and Q34AK58R RECQ5b.
Reaction conditions and analyses were as described in (A).
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strate at a wide range of protein concentrations (0–320 nM).
We found that RECQ51–475 exhibited a significantly greater
DNA helicase activity than the wild-type enzyme at protein
concentrations420nM, at which RECQ5b displayed efficient
strand-annealing activity (compare Figures 5A and 7C). As
mentioned above, the helicase activity of RECQ5b displayed a
biphasic dependence on protein concentration. In contrast,
the helicase activity of RECQ51–475 gradually increased within
the protein concentration range used (Figure 7C). The in-
crease in helicase activity of RECQ5b at enzyme concentra-
tions above 40 nM presumably reflects an inhibitory effect of
ATP on the RECQ5b-mediated reannealing reaction, which
we have observed to become more pronounced at elevated
protein concentrations (data not shown).
We conclude that RECQ5b contains two separate func-
tional domains: a DNA helicase domain and a DNA strand-
annealing domain.
Discussion
In this work, we have defined the biochemical characteristics
of the human RECQ5b protein, a member of the RecQ family
of DNA helicases. Our work revealed that RECQ5b functions
as an ssDNA/dsDNA-dependent ATPase and an ATP-depen-
dent 30–50 DNA helicase with the ability to promote branch
migration of HJs. These characteristics are shared by other
members of the RecQ helicase family (Bachrati and Hickson,
2003). However, in contrast to BLM and WRN that form
oligomeric structures (Karow et al, 1999; Xue et al, 2002), the
RECQ5b helicase exists as a monomer both in free and DNA/
ATP-bound forms. Most importantly, our analyses revealed
that RECQ5b exhibits an efficient DNA strand-annealing
activity, residing in the unique C-terminal half of the protein.
Such a feature has not been seen for any DNA helicase
characterized so far.
The observed inhibition of RECQ5b-mediated DNA strand
annealing by RPA indicates that the annealing mechanism is
likely to be distinct from the mode of action of classical
single-strand-annealing proteins such as RAD52, which in-
volves a cooperative interaction with the complex of the
cognate ssDNA-binding protein and ssDNA (Sugiyama et al,
1998). Moreover, classical strand-annealing proteins are
known to form oligomeric ring structures (Van Dyck et al,
1998; Passy et al, 1999; Stasiak et al, 2000), whereas RECQ5b
protein is monomeric. Structural analyses of the mechanism
of RAD52-mediated strand annealing revealed that multiple
RAD52 rings appear to be the active catalytic species in the
reaction, with ssDNA bound around each ring with the bases
exposed on the surface of the protein (Van Dyck et al, 2001;
Singleton et al, 2002).
The strand-annealing mechanism exhibited by RECQ5b
may be more closely related to that of MRE11, which is also
strongly inhibited by RPA (de Jager et al, 2001). MRE11 is
thought to promote DNA annealing by bridging two comple-
mentary DNA segments such that their close proximity
results in base pairing and duplex DNA formation.
Consistent with this mode of annealing, RECQ5b-mediated
annealing of complementary DNA strands was dramatically
reduced by the presence of a large excess of heterologous
DNA sequence, as found by measuring the annealing of a
short oligonucleotide to the complementary region in
M13mp18 ssDNA.
We also found that the DNA strand-annealing activity of
RECQ5bwas inhibited by the binding of ATPgS to the helicase
domain of the enzyme. Since helicases are known to translo-
cate along DNA in a reaction driven by ATP binding and
hydrolysis, we suggest that ATPgS binding may lead to the
formation of an intermediate DNA–protein complex that is
incapable of DNA translocation. Alternatively, the binding of
ATPgS may induce an allosteric change in RECQ5b leading to
inactivation of the putative DNA strand-annealing domain.
The fact that ATP did not produce a significant inhibitory
effect is presumably due to its hydrolysis by the ssDNA–
enzyme complex that drives protein translocation and release
from the ssDNA template, allowing the strand-annealing
domain to mediate duplex formation. These findings are
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Figure 7 The DNA strand-annealing activity resides in the unique
C-terminal portion of the RECQ5b polypeptide. (A) Schematic
diagrams indicating RECQ5b and the variant proteins used in this
study. The DExH helicase and RecQ-Ct domains conserved among
the members of the RecQ family are shown as dark- and light-gray
boxes, respectively. The location of the putative Zn2þ -binding site
within the RecQ-Ct region is indicated as a checkered box. The
remaining portion represents the region that is not conserved in the
RecQ family. The numbers on the right refer to the primary amino-
acid sequence of RECQ5b. (B) Kinetics of annealing of 1 nM 50-mer
complementary oligonucleotides A20 and B20 (A20 was radioac-
tively labeled at its 50-end) in the presence of 20nM RECQ5b, 20nM
RECQ51–475, 20nM RECQ5411–991 or without protein. Reactions were
carried at 371C. The relative concentration of the strand-annealing
product was determined as described in Materials and methods. (C)
Unwinding of a 30-bp forked duplex by RECQ5b and RECQ51–475 as
a function of enzyme concentration. Reactions were carried out at
371C for 20min and contained 1nM DNA, 2mM ATP and varying
amounts of enzyme. The percentage of unwound DNA was deter-
mined as described in Materials and methods.
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consistent with a model in which the helicase and the strand-
annealing domains of RECQ5b act in a coordinated fashion.
In the case of oligonucleotide-based partial duplexes as
well as four-way junctions, the strand-annealing activity of
RECQ5b dominated over its helicase activity, unless the
annealing reaction was blocked by coating of the displaced
DNA strands with RPA. In contrast, RECQ5b displayed an
efficient DNA helicase activity with the M13-based partial
duplexes. We suggest that the M13-ssDNA substrate may trap
the strand-annealing moiety of RECQ5b, thus effectively
disabling the annealing activity. Under these conditions,
RECQ5b could act as a DNA helicase. With oligonucleotide
substrates, the strand-annealing domain is free to mediate
DNA reannealing during, or immediately after, the strand
displacement reaction.
Previous biochemical analysis of the large RECQ5 isoform
of Drosophila melanogaster (DmRECQ5/QE) did not reveal
the presence of an intrinsic DNA strand-annealing activity
(Kawasaki et al, 2002). However, it should be noted that the
helicase activity of DmRECQ5/QE was tested solely on M13-
based substrates. In addition, the C-terminal half of human
RECQ5b that is responsible for the observed strand-annealing
activity shows extensive amino-acid sequence homology to
the corresponding part of the DmRECQ5/QE polypeptide
(Shimamoto et al, 2000). Therefore, the existence of this
activity in the Drosophila protein cannot be excluded.
At the present time, the biological significance of our
findings cannot be readily assessed because of the lack of
information on the phenotypic consequences of RECQ5 defi-
ciency in human cells. It is known that targeted inactivation
of the chicken RECQ5 homolog results in a dramatic increase
in the frequency of SCEs, albeit solely in a BLM/ back-
ground (Wang et al, 2003). BLM and DNA topoisomerase IIIa
(TOPOIIIa) have been shown to affect the dissolution of
double HJ recombination intermediates using a strand-pas-
sage mechanism. This reaction yields only non-crossover
products, explaining the observed high levels of SCEs in
BLM-deficient cells (Wu and Hickson, 2003). Our observation
that the human RECQ5b protein can promote HJ branch
migration, an essential step in HJ or replication intermediate
processing, in combination with the finding that RECQ5b co-
immunoprecipitates with TOPOIIIa and TOPOIIIb from
human cell extracts (Shimamoto et al, 2000) is consistent
with a model in which RECQ5b serves as a backup for BLM.
However, we show here that RECQ5b has substantially
different biochemical properties compared to those of BLM.
It is therefore plausible that it has alternative and possibly
more specialized cellular roles.
The biochemical properties of RECQ5b led us to suggest
that the protein may be involved in a DNA repair pathway
that requires the coordinated action of DNA helicase and
DNA strand-annealing activities. Depletion of the RECQ5
homolog in C. elegans results in hypersensitivity to g-radia-
tion (Jeong et al, 2003), indicating that RECQ5b may play a
role in the repair of radiation-induced lesions such as DNA
double-strand breaks, or may be active at stalled replication
forks that arise through radiation damage. One attractive
possibility is that the DNA helicase and reannealing activities
of RECQ5b are coordinated to mediate fork regression, such
that the helicase promotes movement of the branch point
while the annealing activity facilitates base pairing of the
newly synthesized strands during the regression reaction. In
agreement with this hypothesis, the small Drosophila RECQ5
isoform was found to unwind preferentially the ‘lagging-
strand arm’ in a synthetic DNA molecule resembling a stalled
replication fork (Ozsoy et al, 2003). Further analysis of the
precise cellular roles of RECQ5b will shed light on the
functions of the RecQ helicases in maintenance of genomic
stability.
Materials and methods
Plasmid construction
The PP1045 cDNA including the RECQ5b codons 411–991 (GenBank
accession no. AF193041, kindly provided by Dr Gu) and the
RECQ5g cDNA (kindly provided by Dr J Sekelsky) were used as PCR
templates to reconstruct the full-size RECQ5b coding region. In the
first step, the 50- and 30-halves of the RECQ5b coding region
overlapping in the codons 403–417 were amplified and the resulting
DNA fragments were fused in a second round of PCR amplification
to yield the entire RECQ5b coding region. The coding region of
RECQ5b was then inserted between the NdeI and SapI sites of the
plasmid pTXB1 (NEB) to construct a translational fusion between
RECQ5b and a self-cleaving affinity tag composed of an Mxe intein
fragment and the CBD. The resulting plasmid was named pPG10.
An additional methionine codon was placed between RECQ5b and
the affinity tag according to the manufacturer’s instructions. The
plasmids pPG16 and pPG19 encoding the deletion variants of
RECQ5b (RECQ5411–991 and RECQ51–475, respectively) were con-
structed in the same way as pPG10. Site-directed mutagenesis of
the ATP-binding motifs of RECQ5b was performed using a
QuickChangeTM site-directed mutagenesis kit (Stratagene) essen-
tially according to the manufacturer’s protocol with pPG10 as
template.
Protein purifications and analysis
The RECQ5b protein and its variants were produced as C-terminal
fusions with the self-cleaving Mxe-CBD affinity tag in the E. coli
BL21-CodonPlus-(DE3)-RIL cells (Stratagene) and purified essen-
tially as previously described for the production and purification of
the BLM642–1290 fragment (Janscak et al, 2003). E. coli RuvA and
RuvB were purified as described (Eggleston et al, 1997) and E. coli
SSB was purchased from USB. Human RPA protein was prepared
essentially as described, but the purification procedure also
included chromatography on an ssDNA–cellulose column (Hen-
ricksen et al, 1994). Concentrations of proteins are expressed in
moles of monomer except for RPA, which is expressed in moles of
trimeric complex.
Gel filtration chromatography on a Superdex 200 PC3.2/30
column was performed using an A¨KTA system (Amersham
Pharmacia Biotech) under the conditions described previously
(Janscak et al, 2003). Sedimentation velocity and sedimentation
equilibrium runs were carried out in a buffer containing 20mM
Tris–HCl (pH 7.5), 75mM NaCl, 0.1mM EDTA and 1mM DTT as
described previously (Janscak et al, 2001).
DNA substrates
All oligonucleotides used in the helicase and strand-annealing
assays were purchased from Microsynth (Switzerland) and purified
by PAGE. The oligonucleotides A20 (50-mer) and B19 (49-mer) are
described elsewhere (Hohl et al, 2003). The 43-mer Hel-1 (50-
CTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGGTACCG-30) is
complementary to the M13mp18 viral strand. The 50-mer B20 (50-
GAGGTCACTCCAGTGAATTCGAGCTCGCAGTGTCTAGGTCGTGACTT
TGA-30) is the complement of A20. The M13mp18-based partial-
duplex substrate for conventional helicase assays was prepared by
annealing the Hel-1 43-mer to circular M13mp18 ssDNA (NEB) and
by extension of this molecule by 1 nt using the Klenow fragment
(NEB) and [a-32P]dATP (Amersham Pharmacia Biotech) as de-
scribed previously (Janscak et al, 2003). The substrate for the
helicase polarity assay was prepared by cutting the 43-bp
M13mp18/Hel-1 partial duplex with AccI to produce a linear ssDNA
molecule with short duplex regions at both ends. All available 30-
ends in this molecule were radioactively labeled using the Klenow
fragment, [a-32P]dATP and [a-32P]dCTP. For oligonucleotide-based
helicase substrates, one of the oligonucleotides was labeled at the
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50-end using T4 polynucleotide kinase (NEB) and [g-32P]ATP, and
annealed to the appropriate complementary strand as described
(Janscak et al, 2003). The synthetic HJ X26, which contains a 26
base pair region of homology flanked by heterologous arms, was
made by annealing four oligonucleotides as described (Constanti-
nou et al, 2001).
ATPase assays
ATPase activity was determined by colorimetric estimation of the
concentration of inorganic phosphate released by ATP hydrolysis
using the malachite green assay in a 96-well microplate setup (Chan
et al, 1986; Janscak et al, 1996). Reactions were carried out at 371C
in a buffer containing 50mM Tris–HCl (pH 7.5), 50mM NaCl, 2mM
MgCl2, 1mM DTT and 50 mg/ml BSA. Reaction mixtures (typically
20 ml) contained 20nM wild-type or mutant RECQ5b in the presence
or absence of saturating concentrations of DNA effectors (25mg/
ml). Supercoiled pGEM-13Zf(þ ) DNA (Stratagene), NdeI-linearized
pGEM-13Zf(þ ) DNA, single-stranded pGEM-13Zf(þ ) DNA, and
45- and 21-mer oligonucleotides were used as DNA effectors.
Reactions were usually initiated by adding ATP to a final
concentration of 2mM and terminated after 30min by adding one
reaction volume of 0.1M EDTA (pH 8.0).
Helicase assays
Helicase reactions were carried out at 371C in buffer HA (20mM
Tris-acetate, pH 7.9, 50mM KOAc, 10mM Mg(OAc)2, 1mM DTT,
50 mg/ml BSA). Reaction mixtures (10 ml) contained either 0.5 nM
M13mp18-based or 1 nM oligonucleotide-based partial duplexes,
2mM ATP and indicated concentrations of RECQ5b (or its mutants).
Where required, RPA or SSB was added at indicated concentrations.
Reactions were started with enzyme and terminated typically after
20min by adding 0.5 reaction volumes of solution S (150mM EDTA,
2% (w/v) SDS, 30% (v/v) glycerol, 0.1% (w/v) bromophenol
blue). In time-course experiments, the reaction volume was 50ml,
and 5ml aliquots were removed at 0.5, 1, 2, 4, 8, 16 and 32min. The
reaction mixtures were resolved using a 10% (w/v) polyacrylamide
gel (acrylamide to bis-acrylamide ratios 19:1 for oligonucleotide
substrates and 37.5:1 for M13mp18-based substrates) run in TBE
buffer (90mM Tris-borate (pH 8.3), 2mM EDTA) at 100V and room
temperature. Radiolabeled DNA species were visualized by auto-
radiography and quantified using a Molecular Dynamics Typhoon
9400 scanner with associated IMAGEQUANT software. The relative
concentration of displaced products was expressed as percentage of
total DNA.
Branch migration assay
Reactions were carried out at 371C in a buffer containing 50mM
Tris–HCl (pH 8.0), 2mM MgCl2, 2mM ATP, 1mM DTT and 100mg/
ml BSA. Reaction mixtures (10ml) contained 0.5 nM 50-32P-labeled
synthetic HJ DNA (X26) and indicated amounts of RECQ5b. RPA
(20 nM) or SSB (1mM) was added as indicated. For the inhibition
experiment, RuvA was preincubated with the HJ in reaction buffer
for 1min at room temperature before the addition of RECQ5b
protein. The DNA products were deproteinized and electrophoresed
through 10% neutral polyacrylamide gels. Control reactions with
RuvAB (25nM RuvA, 50 nM RuvB) were carried out in a buffer
containing 20mM Tris-acetate (pH 7.5), 15mM Mg(OAc)2, 2mM
ATP, 1mM DTT and 100 mg/ml BSA.
DNA strand-annealing assays
The DNA strand-annealing activity of RECQ5b was measured using
complementary synthetic oligonucleotides (each at a concentration
of 1 nM) of which one was labeled at the 50-end using [g-32P]ATP
and T4 polynucleotide kinase. Annealing of a 32P-labeled oligonu-
cleotide (1 nM) to M13mp18 ssDNA (2nM) was also measured.
Annealing reactions (typically 10 ml) were carried out at 371C in
buffer HA and contained the indicated amounts of RECQ5b (or its
mutants). Where required, RPA (0.38–24 nM), ATP (2mM), ATPgS
(2mM) and ADP (2mM) were added. Reactions were usually
initiated by adding the unlabeled DNA strand and were incubated
for 20min. In time-course experiments, 50ml reactions were
initiated and 5ml aliquots were removed at 0.5, 1, 2, 4, 8, 16 and
32min. Reactions were analyzed essentially as the helicase
reactions (see above).
ATP photo-crosslinking
Purified protein (1 mg) was incubated in a volume of 10ml of buffer
HA with 25mM ATP and 2 mCi of [g-32P]ATP (3000Ci/mmol;
Amersham Pharmacia Biotech) for 5min at 371C. Reactions were
spotted onto Parafilm, placed on ice and irradiated for 5min using a
UV-Stratalinker 1800 lamp (Stratagene). The covalent protein–ATP
complex was separated from free ATP by electrophoresis in a 10%
SDS–polyacrylamide gel. Radiolabeled species were visualized by
autoradiography. The gel was subsequently stained with Coomassie
brilliant blue to determine the position of the protein.
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ABSTRACT
Bloom (BLM) and Werner (WRN) syndrome proteins
are members of the RecQ family of SF2 DNA heli-
cases. In this paper, we show that restricting the
rotational DNA backbone flexibility, by introducing
vinylphosphonate internucleotide linkages in the
translocating DNA strand, inhibits efficient duplex
unwinding by these enzymes. The human single-
stranded DNA binding protein replication protein A
(RPA) fully restores the unwinding activity of BLM
and WRN on vinylphosphonate-containing sub-
strates while the heterologous single-stranded DNA
binding protein from Escherichia coli (SSB) restores
the activity only partially. Both RPA and SSB fail to
restore the unwinding activity of the SF1 PcrA heli-
case on modified substrates, implying specific inter-
actions of RPAwith the BLM andWRN helicases. Our
data highlight subtle differences between SF1 and
SF2 helicases and suggest that although RecQ heli-
cases belong to the SF2 family, they are mechanisti-
cally more similar to the SF1 PcrA helicase than to
otherSF2helicases thatarenot affectedbyvinylphos-
phonate modifications.
INTRODUCTION
Helicases are motor proteins that use free energy from nucleo-
tide triphosphate hydrolysis for unwinding of nucleic acid dup-
lexes (1–4). Helicases can be classified as one of two types:
those that translocate along a nucleic acid strand in a 30 to 50
direction and those that operate with the opposite polarity.
Based on amino acid sequence homology, helicases have
been grouped into five superfamilies (SF1–5) (5). Most of
the known 30–50 DNA helicases are members of SF1 or
SF2. These two superfamilies have similar sets of conserved
motifs that are responsible for coupling of ATP hydrolysis to
DNA translocation and unwinding. The SF1 and SF2 proteins
aremostlymonomeric, but theoligomeric state of the functional
form of these enzymes remains to be clarified, since bothmono-
meric and oligomeric models have been proposed (6–11).
Out of various models proposed for DNA unwinding by heli-
cases, the so-called inchworm model (12) seems to be
the most plausible for the SF1 and SF2 enzymes (6,13). This
model is reminiscent of a ‘snowplow’ which is pushed or
pulled along the nucleic acid duplex mechanically forcing
the duplex to dissociate into the constituent strands. Extensive
structural and biochemical studies on the SF1 helicase PcrA
suggested themechanism of how the free energy ofATP hydro-
lysis is converted to the mechanical force required for the
motion. The ATP binding site of the enzyme is located in the
cleft between twoRecA-like domains,with residues fromseven
helicase signaturemotifsmediating protein–nucleotide interac-
tions (6). DNA is bound along a groove on the top of the RecA-
like domain and the cleft closes and opens in response to ATP
bindingandhydrolysis, suggestingamechanismforDNAtrans-
location (6). A similar situation exists also in the other SF1 and
SF2 helicases which have been analyzed to atomic resolution
(14–16). However, it appears that there is amechanistic distinc-
tion between the SF1 and SF2 helicases in the nature of contacts
between the translocating motor and the DNA substrate (4).
Structural studies of the SF1 helicases PcrA and Rep revealed
that they bind to the substrate via hydrophobic interactions with
the bases and thus translocate along single-stranded DNA
(ssDNA). In contrast, structural data available for SF2 helicases
suggest that theseenzymesbindnucleic acids rather via contacts
with the phosphodiester backbone, which would allow the heli-
casemotor to translocateonbothsingle-strandedDNA(ssDNA)
and double-stranded DNA (dsDNA) (4). In agreement with the
structural data, ATP hydrolysis by SF1 helicases is stimulated
only by ssDNA, whereas the ATPase activity of SF2 helicases
is stimulated by both ssDNA and dsDNA (4).
The proposed base-flipping mechanism of ssDNA translo-
cation by PcrA helicase has been examined using DNA sub-
strates containing vinylphosphonate internucleotide linkages,
which confer reduced rotational flexibility to the DNA back-
bone with minimal steric hindrance (17). In agreement with
the model derived from structural studies, vinylphosphonate
linkages have been found to completely inhibit the helicase
activity of PcrA as long as they are situated in the translocating
*To whom correspondence should be addressed. Tel: +41 0 16348941; Fax: +41 0 16348904; Email: pjanscak@imr.unizh.ch
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strand either at the single-strand/double-strand junction or
inside the duplex region (18). The precise mechanism of this
inhibitory effect is not known, but such data are consistent with
unidirectional translocation of the enzyme along ssDNA
mediated via base-stacking interactions between bases and
aromatic residues of the enzyme, which is likely to depend
on rotational flexibility of various bonds in the DNA
backbone.
Here we have examined the effect of vinylphosphonate
internucleotide linkages on DNA unwinding activity of two
human SF2 helicases BLM and WRN. BLM and WRN belong
to the highly-conserved RecQ family of 30–50 helicases that are
essential for maintenance of genomic stability (19). Inherited
mutations in both alleles of the BLM andWRN genes are asso-
ciated with the cancer-prone disorders Bloom and Werner
syndromes, respectively (19). BLM and WRN are DNA-
structure-specific helicases that preferentially unwind G-quad-
ruplex DNA and various branched DNA structures such as
four-way junctions, D-loops and forked duplexes as compared
to 30-ssDNA-tailed duplexes (20). They can also promote
branch migration of Holliday junctions along long stretches
of dsDNA (21,22).
We present evidence that vinylphosphonate internucleotide
linkages inhibit the helicase activity of both BLM and WRN
as long as they are placed on the translocating strand. The
observed inhibitory effect is not as drastic as in the case of
PcrA but nevertheless it is significant. Moreover we show that
the human ssDNA-binding factor replication protein A (RPA)
relieves the inhibitory effect of vinylphosphonate modifica-
tions on BLM- and WRN-mediated unwinding, whereas it
does not affect the PcrA-catalyzed reaction. We conclude
that the rotational backbone flexibility of the DNA substrate
is important for the action of the BLM and WRN helicases.
The mechanism of DNA translocation by these enzymes may
involve some base flipping but it is not based entirely on base-
flipping as is the case of the SF1 PcrA helicase.
MATERIALS AND METHODS
DNA substrates
Unmodified oligonucleotides were purchased from Micro-
synth (Switzerland) and purified by PAGE. The sequences
of the oligonucleotides used were as follows (50 to 30): VP7
(45mer), TCAAAGTCACGACCTAGACAATCCCCAAAA-
AAAAAGCTCGAATTC; VP8 (45mer), TCAAAGTCACG-
ACCTAGACAAGCTCGAATTCGTAATCATGGTCAT; VP9
(59mer), TCAAAGTCACGACCTAGACAATCCCCAA-
AAAAAAAGCTCGAATTCGTAATCATGGTCAT; VP10
(38mer), TCTAGAGGATCCCCAAAAAAAAACGAGCTT-
AAGCATTA;VP11(19mer),TGCATGCCTGCAGGTCGAC;
RB15 (66mer), ATGACCATGATTACGAATTCGAGCTTT-
TTTTTTGGGGATCCTCTAGAGTCGACCTGCAGGCAT-
GCA. A derivative of RB15, named 4mod, containing a
tandem of four vinylphosphonate internucleotide linkages
(ATGACCATGATTACGAATTCGAGCTT*TT*TT*TT*
TGGGGATCCTCTAGAGTCGACCTGCAGGCATGCA;
positions of modifications are indicated by asterisks) was
synthesized using 50-DMTO-T*T-30CEP phosphoramidite
building blocks as described previously (17). It was purified
using ABI OPC cartridges according to the manufacturer’s
instructions. To prepare the splayed-arm DNA substrates
shown in Table 1, the VP7, VP8, VP9 and VP10 oligonucleo-
tides were radioactively labeled at the 50 end using T4 poly-
nucleotide kinase (New England Biolabs) and [g-32P]ATP
(Amersham Pharmacia Biotech), and annealed to either RB15
(unmodified substrates) or 4mod (modified substrates) under
previously described conditions (23).
Protein purifications
BLM642-1290, WRN and PcrA helicases were prepared as pre-
viously described (23–26). Escherichia coli single-stranded
DNA binding (SSB) protein was purchased from Promega.
Human RPA was prepared essentially as described in (27).
Concentrations of proteins are expressed in moles of monomer
except for RPA, which is expressed in moles of heterotrimeric
complex.
Oligonucleotide-displacement assays
Reactions were carried out at 37C in a buffer containing
50 mM Tris–HCl (pH 7.5), 50 mM NaCl, 2 mM MgCl2,
2 mM ATP, 1 mM DTT and 50 mg/ml BSA. Reaction
mixtures contained 1 nM 50 32P-labeled DNA substrate and
20 nM BLM642–1290 or 5 nM WRN. Control reactions with
100 nM PcrA and 0.5 nM DNA substrate were carried out in a
Table 1. DNA substrates used in this study
Sequences of the constituent oligonucleotides are described in Materials and
Methods. A1, B1, C1 and D1 are unmodified substrates. A2, B2, C2 and D2 are
modified substrates. Positions of the four tandem vinylphosphonate modifica-
tions in the schemes of individual substrates are indicated as light gray boxes.
Note that in substratesD1 andD2, a 19mer oligonucleotide,VP11,was annealed
to the 30 end of RB15 and 4mod, respectively, to ensure that the enzymes enters
the duplex only from the splayed-arm side and thereby translocates only along
unmodified strand.
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buffer containing 20 mM Tris (pH 7.5), 10 mM MgCl2,
50 mMNaCl, 4 mMDTT, 2.5 mMATP.Where required, RPA
was added to a concentration of 24 nM and SSB to a con-
centration of 120 nM. Reactions were started with enzyme.
Aliquots of 10 ml were removed at indicated time points and
mixed with 5 ml of stop solution containing 150 mM EDTA,
2% (w/v) SDS, 30% (v/v) glycerol and 0.1% (w/v) bromo-
phenol blue. The reaction mixtures were resolved on 10%
(w/v) polyacrylamide gels (acrylamide to bis-acrylamide
ratio 19:1) run in TBE buffer (90 mM Tris–borate, pH
8.3, and 2 mM EDTA) at 7 V/cm and room temperature.
Radiolabeled DNA species were visualized by autoradio-
graphy and quantified using a Molecular Dynamics Typhoon
9400 scanner with associated IMAGEQUANT software. The
relative concentration of displaced products was expressed as
a percentage of total DNA.
RESULTS
Inhibition of the DNA helicase activity of BLM by
vinylphosphonate internucleotide linkages in the
translocating strand
To investigate the effect of vinylphosphonate internucleotide
linkages on the helicase activity of BLM, we prepared a series
of splayed-arm DNA substrates containing four consecutive
modifications either in the translocating or displaced strands at
varying positions relative to the single-strand/double-strand
junction (Table 1). A fragment of BLM comprising the heli-
case catalytic core (residues 642–1290, BLM642–1290) was
used in these experiments. This variant was found to exhibit
a similar specific activity as the full-size BLM protein on a
number of DNA structures including splayed arm (23). Using a
simple gel-based, oligonucleotide displacement assay, we
observed that the BLM642–1290-mediated unwinding of a
25 bp duplex was inhibited when the modifications were
located inside the duplex region on the translocating strand
(Figure 1A and B). Modifications incorporated just prior to the
duplex on the translocating strand also reduced the helicase
activity of BLM642–1290 though to a much lesser extent than
the modifications inside the duplex (Figure 1C and D). No
inhibitory effect was apparent when the modifications were
present on the displaced strand inside the duplex (Figure 1E).
Overall, these data indicate that restricting the rotational DNA
backbone flexibility in the translocating DNA strand impairs
BLM-mediated DNA unwinding.
RPA relieves the inhibitory effect of vinylphosphonate
internucleotide linkages on BLM-mediated DNA
unwinding
The human RPA has been shown to specifically promote
unwinding of long DNA duplexes by BLM and WRN. This
stimulatory effect is mediated by physical interaction between
RPA and these helicases (28,29). We set up to determine
whether RPA can alleviate the inhibitory effect of vinyl-
phoshonate internucleotide linkages on the helicase activity
of BLM. In these experiments, we used 39 bp forked duplex
substrates with or without four consecutive modifications
on the translocating strand located inside the duplex
(Table 1; substrates C1 and C2). Under the conditions used,
BLM642–1290 alone could only partially unwind the unmodified
substrate and showed no detectable helicase activity on the
modified substrate (Figure 2A; compare lanes 2 and 9). In
contrast, in the presence of RPA, both unmodified and mod-
ified substrates were unwound by BLM642–1290 efficiently
(Figure 2A; lanes 3 and 10). Substitution of RPA with the
E.coli SSB protein also resulted in a stimulation of BLM-
catalyzed unwinding of both modified and unmodified
substrates, but to a lesser extent than in the case of the RPA-
promoted reactions (Figure 2A; lanes 4 and 11). Time-course
experiments revealed that the RPA-promoted unwinding reac-
tion on the modified substrate displayed similar kinetics as
that with unmodified substrate (Figure 2B and C). Thus, these
data indicate that RPA completely relieves the inhibitory
effect of vinylphosphonate internucleotide linkages on BLM-
catalyzed DNA unwinding.
Single-stranded DNA binding proteins do not stimulate
the helicase activity of PcrA on DNA substrates
containing vinylphosphonate linkages
As mentioned above the helicase activity of PcrA has been
shown to be inhibited by vinylphosphonate internucleotide
linkages located in the translocating DNA strand (18). In
agreement with these findings, the 39 bp splayed arm sub-
strate containing modifications inside the duplex region was
not unwound by PcrA, although unmodified substrate was
unwound efficiently (Figure 3A, B and C). In contrast to
BLM, RPA did not alleviate the inhibitory effect of vinylphos-
phonate modifications on PcrA-mediated DNA unwinding
reaction (Figure 3D). In addition, PcrA helicase activity on
modified substrate was not stimulated by E.coli SSB protein
(data not shown). These data provide further evidence that the
RPA-promoted bypass of regions containing vinyphosphonate
internucleotide linkages by BLM is a specific reaction.
Effect of vinylphosphonate internucleotide linkages on
the helicase activity of WRN
Next we sought to examine whether other RecQ DNA heli-
cases display the same characteristics as BLM on DNA sub-
strates containing vinylphosphonate internucleotide linkages.
To this end, we tested the WRN helicase for the ability to
unwind these substrates in the absence and presence of RPA.
Similar to BLM, we found that vinylphosphonate modifica-
tions significantly reduced the helicase activity of WRN if
located in the translocating strand (Figure 4A and B), but
did not produce an inhibitory effect when located on the dis-
placed strand (Figure 4D). In fact, the substrate with modifica-
tions in the displaced strand was unwound by WRN more
efficiently than the corresponding unmodified substrate.
This could be explained partly by an assumption that the
vinylphosphonate modifications decrease somewhat the
stability of the DNA duplex, since DNA melting studies
have revealed that such modifications decrease the melting
temperature of DNA duplexes by 3.5C per modification
(data not shown). In the case of BLM, such striking differences
was not apparent as the reactions were nearly completed at the
first time point analyzed (Figure 1E). It should also be emphas-
ized that these modifications do not affect the overall structure
of normal B-DNA as revealed by NMR studies (18).
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The inhibitory effect of vinylphosphonate modifications on
WRN-catalyzed unwinding was lost upon addition of RPA
(Figure 4C), again highlighting differences between RecQ
helicases and PcrA in the mode of DNA translocation.
DISCUSSION
Based on amino acid sequence homology, the RecQ proteins
belong to the SF2 superfamily of helicases (5). Several crystal
structures of SF2 helicases, including E.coli RecQ (16), HCV
NS3 (15,30), UvrB (31), RecG (13) and eIF4a (32) have been
solved and revealed structural similarities, but also intriguing
differences from the SF1 helicases PcrA (6,33) and Rep (14).
While the SF1 helicases interact with ssDNA using mainly
hydrophobic interactions with the DNA bases, the SF2 heli-
cases seem to interact with the DNA via non-specific
electrostatic interactions with the phosphodiester backbone
(4,34). These differences may reflect mechanistic differences,
with SF1 helicases apparently able to translocate along ssDNA
and the SF2 helicases along both ssDNA and dsDNA.
The translocation mechanism of helicases has been a con-
tentious issue (35), but in the case of PcrA a base-flipping
unidirectional mode of translocation with one ATP molecule
utilized per base translocated has been suggested (6,36). The
base-flipping mechanism requires the DNA base to flip in and
out of certain pockets on the surface of the protein as it moves
along the ssDNA, which is enabled by rotational flexibility of
the DNA backbone. Consistent with this model, restricting
backbone rotational freedom by introducing vinylphosphonate
internucleotide linkages has a detrimental effect on the PcrA
helicase activity (18). Vinylphosphonate backbone modifica-
tions do not affect regular bending and ‘stiffness’ of DNA,
unless there are sharp kinks induced by the translocating
Figure 1. Effect of vinylphosphonate internucleotide linkages on helicase activity of BLM642–1290. (A) Kinetics of unwinding of 1 nMA1 (left panel) and 1 nMA2
(right panel) by 20 nM BLM642–1290. (B) Quantification of the reactions shown in (A). Data points represent mean values from three independent experiments. (C)
Kinetics of unwinding of 1 nM B1 (left panel) and 1 nM B2 (right panel) by 20 nM BLM642–1290. (D) Quantification of the reactions shown in (C). Data points
representmean values from three independent experiments. (E) Kinetics of unwinding of 1 nMD1 (open circles) and 1 nMD2 (filled circles) by 20 nMBLM642–1290.
The graph shows mean values from three independent experiments. All reactions were carried out at 37C and analyzed as described inMaterials andMethods. The
relative concentration of the strand-displacement products is expressed as a percentage of total DNA. Lanes labeled with triangles contain heat-denatured substrate.
DNA substrates are shown in Table 1.
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helicase that also require rotational backbone freedom. There
is no structural or functional evidence that such sharp kinks are
part of the translocation mechanism of any helicase.
Helicases that interact with DNA mainly via the phospho-
diester backbone, such as the SF2 HCV NS3 (Eckhard
Jankowsky, personal communication) and RecG (Robert G.
Lloyd, personal communication), are able to translocate over
vinylphosphonate modifications without apparent problems.
In contrast, here we show that two other SF2 helicases,
BLM and WRN, are inhibited by vinylphosphonate modifica-
tions. As these modifications in the A2 and C2 substrates
reside inside the duplex region, it is unlikely that they will
inhibit the initial binding of BLM and WRN proteins to the
ssDNA/dsDNA junction. Instead, the inhibition must be
related to the actual translocation process. Although the inhib-
itory effect of vinylphosphonate internucleotide linkages on
BLM- andWRN-mediated DNA unwinding is not as drastic as
that observed for PcrA, it is significant, suggesting that rota-
tional DNA backbone freedom is an essential requirement for
efficient helicase activity in these helicases. Therefore, the
translocation mechanism of BLM and WRN seems to involve
some base-flipping aspect, as in PcrA, but it is not entirely
dependent on base-flipping, unlike PcrA (partial inhibition ver-
sus complete inhibition). As mentioned above, other SF2 heli-
cases such as HCV NS3 and RecG are unaffected by vinyl-
phosphonate modifications, suggesting that their mechanism
of translocation does not involve base-flipping and is instead
based upon interaction with the phosphodiester backbone in
agreement with structural studies. Moreover, the SF2 helicase
NPH-II has been recently shown to tolerate abasic sites in the
translocating strand, while it essentially requires physical con-
tinuity of the phosphodiester linkage, again suggesting a
mechanism in which the protein makes contact with the
sugar-phosphate backbone during translocation (37). The
recent crystal structure of the E.coli RecQ revealed a patch of
conserved aromatic and charged residues (residues 156–159,
C-terminal to motif II) mapping to the same relative surface
location as similar residues in PcrA that are used in DNA
binding (residues 257–260, C-terminal to motif III) (16).
This structural feature suggests that E.coli RecQ may utilize
a combination of base-flipping and phosphodiester backbone
interactions to translocate along ssDNA, although the structure
Figure 2. Single-stranded DNA binding proteins promote unwinding of vinylphosphonate-containing DNA substrates by BLM642–1290. (A) Effect of 24 nM human
RPA and 120 nME.coli SSBon unwinding of 1 nMC1 and 1 nMC2 by 20 nMBLM642–1290. Reactionswere incubated for 20min. (B) Kinetics of unwinding of 1 nM
C1 (left panel) and 1 nMC2 (right panel) by 20 nMBLM642–1290 in the presence of 24 nMRPA. In control reactions, 1 nMDNAwas incubated with 24 nMRPA for
16 min. (C) Quantification of the reactions shown in (B). Data points represent mean values from three independent experiments. The relative concentration of
the strand-displacement products is expressed as a percentage of total DNA. All reactions were carried out at 37C and analyzed as described in Materials and
Methods. Lanes labelled with triangles contain heat-denatured substrate. DNA substrates are shown in Table 1.
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Figure 3. RPA does not alleviate inhibitory effect of vinylphosphonate internucleotide linkages on PcrA-catalyzed DNA unwinding. (A) Kinetics of unwinding of
0.5 nMC1 by 100 nM PcrA. (B) Quantification of the reaction shown in (A). Data points represent mean values from two independent experiments. (C) Time course
of the reaction of 100 nMPcrAwith 0.5 nMC2. (D) Time course of the reaction of 100 nMPcrAwith 0.5 nMC2 in the presence of 24 nMRPA.Reactionswere carried
out at 37C and analyzed as described inMaterials andMethods. The relative concentration of the strand-displacement products is expressed as a percentage of total
DNA. Lanes labelled with triangles contain heat-denatured substrate. DNA substrates are shown in Table 1.
Figure 4. Effect of vinylphosphonate internucleotide linkages on helicase activity of WRN in the absence and the presence of RPA. (A) Kinetics of unwinding of
1 nMA1 (open circles) and 1 nMA2 (filled circles) by 5 nMWRN. (B) Kinetics of unwinding of 1 nMB1 (open circles) and 1 nMB2 (filled circles) by 5 nMWRN.
(C) Kinetics of unwinding of 1 nMC1 (open circles) and 1 nMC2 (filled circles) by 5 nMWRN in the presence of 24 nMRPA. (D) Kinetics of unwinding of 1 nMD1
(open circles) and 1 nM D2 (filled circles) by 5 nM WRN. Reactions were carried out at 37C and analyzed as described in Materials and Methods. The relative
concentration of the strand-displacement products is expressed as a percentage of total DNA. Data points represent mean values from three independent experi-
ments. DNA substrates are shown in Table 1.
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of RecQ complexed with DNA is required to confirm these
observations.
The stimulatory effect of RPA on BLM- and WRN-
mediated unwinding of vinylphosphonate-containing DNA
substrates and the failure of RPA to stimulate PcrA imply a
specific interaction between RPA and both BLM and WRN
helicases. This is further supported by the fact that heterolo-
gous SSB from E.coli stimulated BLM and WRN helicases on
modified substrates only marginally. This effect is likely to
reflect a simple non-specific trapping of displaced strands by
SSB. BLM andWRN helicases exhibit a very low processivity
(28,29). RPA has been shown to specifically stimulate BLM-
and WRN-mediated unwinding through direct protein–protein
interactions (28,29). It has been postulated that in addition to
trapping displaced single-strands, RPA may tether the helicase
to the DNA substrate at the single-strand/double-strand junc-
tion to facilitate the progression of the enzyme through rela-
tively long DNA duplex tracts (28,29). Such a mechanism
would explain the observed stimulatory effect of RPA on
BLM- and WRN-mediated unwinding of vinylphosphonate-
linked substrates. Providing that the modifications cause a
pause in enzyme translocation followed by its dissociation
from the DNA substrate, one can assume that tethering
the enzyme to the translocating strand via interaction with
ssDNA-bound RPA would allow it to cope with a more rota-
tionally rigid region in the DNA template during the unwinding
reaction.
Our study provides evidence of subtle differences and simi-
larities between SF1 and SF2 helicases. Although RecQ heli-
cases belong to SF2, they appear to be different from other SF2
helicases such as HCV NS3, RecG and NPH-II. They may
translocate along ssDNA by using a combination of base-
flipping (characteristic of the SF1 PcrA helicase) and non-
specific phosphodiester–backbone interactions (characteristic
of SF2 HCV NS3, RecG and NPH-II helicases). In that sense
RecQ helicases may mechanistically belong to a sub-family of
SF2 helicases.
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Article IV
The HRDC domain of BLM is required for the recognition, processing and dissolution
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The HRDC domain of BLM is required for
the dissolution of double Holliday junctions
Leonard Wu1, Kok Lung Chan1,
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Bloom’s syndrome is a hereditary cancer-predisposition
disorder resulting from mutations in the BLM gene. In
humans, BLM encodes one of five members of the RecQ
helicase family. One function of BLM is to act in concert
with topoisomerase IIIa (TOPO IIIa) to resolve recombina-
tion intermediates containing double Holliday junctions
by a process called double Holliday junction dissolution,
herein termed dissolution. Here, we show that dissolution
is highly specific for BLM among human RecQ helicases
and critically depends upon a functional HRDC domain in
BLM. We show that the HRDC domain confers DNA struc-
ture specificity, and is required for the efficient binding
to and unwinding of double Holliday junctions, but not
for the unwinding of a simple partial duplex substrate.
Furthermore, we show that lysine-1270 of BLM, which
resides in the HRDC domain and is predicted to play a role
in mediating interactions with DNA, is required for effi-
cient dissolution.
The EMBO Journal (2005) 24, 2679–2687. doi:10.1038/
sj.emboj.7600740; Published online 30 June 2005
Subject Categories: genome stability & dynamics
Keywords: Bloom’s syndrome; Holliday junction resolution;
HRDC domain; RecQ DNA helicases; topoisomerase III
Introduction
Mutations in the BLM gene give rise to Bloom’s syndrome
(BS) in humans (Ellis et al, 1995). This rare genetic disorder
is characterized by short stature, sunlight sensitivity, immuno-
deficiency and a predisposition to the development of many
different types of malignancies (Bachrati and Hickson, 2003;
Hickson, 2003). BLM encodes a DNA helicase that belongs to
a highly conserved family, the prototypical member of which
is encoded by the recQ gene of Escherichia coli (Figure 1A)
(Bachrati and Hickson, 2003). Germline mutations in two
other human RecQ family helicase genes also give rise to
cancer-predisposition disorders: WRN mutations give rise to
Werner’s syndrome and RECQ4mutations are associated with
some cases of Rothmund–Thomson syndrome (Yu et al, 1996;
Kitao et al, 1999).
The existence of clinically distinct disorders associated
with inactivation of any of three different RecQ family
helicases indicates that the human RecQ family helicases
have specialized functions in the cell (Oakley and Hickson,
2002; Bachrati and Hickson, 2003; Wang et al, 2003). In the
budding yeast, Saccharomyces cerevisiae,mutation of the sole
RecQ helicase gene, SGS1, results in elevated levels of gen-
ome-wide genetic recombination (Gangloff et al, 1994; Watt
et al, 1996). This role in regulating homologous recombina-
tion levels appears to have been conserved in humans, at
least in the case of BLM, since BS cells also show excessive
levels of genome-wide homologous recombination. This is
particularly apparent for recombination events between sister
chromatids, giving rise to a characteristically elevated level of
sister chromatid exchanges (SCEs) that is sufficiently specific
for BS to be used in the diagnosis of the disorder (Chaganti
et al, 1974). The hyper-recombination phenotype of certain
RecQ helicase mutants is likely due to aberrant processing of
recombination intermediates (Wu and Hickson, 2002b) since
RecQ helicases from several organisms have been purified,
and have been shown to act upon DNA intermediates that
arise during the process of homologous recombination
(Bachrati and Hickson, 2003).
RecQ helicases all contain a conserved helicase domain
that defines the family (Bachrati and Hickson, 2003). There
are, however, additional sequence motifs that flank the
signature helicase domain (Figure 1A). In certain cases,
additional enzymatic activities reside in these flanking do-
mains. In the case of WRN, a 30–50 exonuclease domain is
located in the N-terminal region, whereas the C-terminal
domain of RECQ5b directs a DNA strand annealing function
(Huang et al, 1998; Kamath-Loeb et al, 1998; Garcia et al,
2004) (Figure 1A). Other sequence motifs identified in RecQ
helicases include the RQC domain, which is situated
C-terminal to the helicase domain and appears to be found
exclusively in some RecQ helicases, and the HRDC domain,
which is found C-terminal to the RQC domain of some RecQ
helicases and in RNaseD homologs (Figure 1A and B)
(Bachrati and Hickson, 2003). The structures of the RQC
and HRDC domains have been determined for RecQ and
Sgs1, respectively (Liu et al, 1999; Bernstein et al, 2003).
The RQC domain resembles a so-called winged-helix domain,
which is a member of the helix–turn–helix superfamily, and
plays a role in binding duplex DNA (Bernstein et al, 2003).
Interestingly, in BLM and WRN, the RQC domain has been
implicated also in the orchestration of protein–protein inter-
actions (Brosh et al, 2001; von Kobbe et al, 2002; Bachrati and
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Hickson, 2003). The HRDC domain is thought to function as
an auxiliary DNA-binding domain and, structurally, it resem-
bles domains found in many DNA-metabolizing enzymes
such as helicases, polymerases and recombinases (Morozov
et al, 1997; Liu et al, 1999). How these conserved motifs
impact on the biochemical properties of RecQ helicases and
affect the in vivo function of these enzymes has not been
determined.
In addition to the presence or absence of the aforemen-
tioned functional domains, the different cellular functions of
the various vertebrate RecQ helicases likely depend on their
ability to form specific interactions with different protein
partners. BLM is proposed to act in a complex with replica-
tion protein A and the type IA topoisomerase, topoisomerase
IIIa (hTOPO IIIa) (Brosh et al, 2000; Johnson et al, 2000; Wu
et al, 2000; Meetei et al, 2003). This association with a type IA
topoisomerase is evolutionarily conserved, since Sgs1p also
acts together with Top3p, the only type IA topoisomerase
expressed in budding yeast (Gangloff et al, 1994; Bennett and
Wang, 2001; Fricke et al, 2001). top3 mutant cells have
elevated levels of recombination (Wallis et al, 1989), which
can be suppressed, at least partially, by inactivation of either
Sgs1p or Rad52p, the latter of which is required for all forms
of homologous recombination (Gangloff et al, 1994; Oakley
et al, 2002; Shor et al, 2002). The conserved coupling of a
RecQ helicase and a type IA topoisomerase, therefore, ap-
pears to have a central role in regulating recombination levels
in the cell (Wu and Hickson, 2001). In particular, Sgs1p and
BLM appear to suppress the formation of crossover products
that arise from the resolution of homologous recombination
intermediates containing Holliday junctions (Ira et al, 2003;
Wu and Hickson, 2003). We have recently proposed a
mechanism by which this is achieved by BLM. Together
with hTOPO IIIa, BLM can catalyze double Holliday junction
dissolution (DHJ), a reaction mechanism in which DHJs are
resolved exclusively into non-crossover recombinant pro-
ducts (Wu and Hickson, 2003). Here, we have demonstrated
that BLM cannot by substituted by other RecQ helicases in
dissolution reactions containing hTOPO IIIa. Furthermore, we
reveal the first biochemical function for the HRDC domain of
a RecQ helicase through the demonstration of a requirement
for this domain in the specific recognition, processing and
dissolution of DHJs.
Results
Double Holliday junction dissolution is specific for BLM
Despite the similar biochemical properties of many RecQ
helicases in vitro, and their ability to act upon a wide variety
of DNA structures, an elevated frequency of SCEs is thought
to be a feature unique to BLM-deficient cells among human
RecQ helicase mutants. We set out, therefore, to examine the
apparent contradiction between, on the one hand, the pro-
miscuous and redundant biochemical activities of RecQ
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α3 α4 α5
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WRN
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RECQ1
RECQ5β
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HRDCHelicase R
Exo HRDCHelicase R
Helicase
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HRDCHelicase R
212 641 1268 1417
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Sgs1
(S.cerevisiae)
HRDCHelicase R
BLM 1212 EEMVKKCLGELTEVCKSLGKVFGVHYF.NIFNTVTLKKLAESL 1253
WRN 1150 QETQIVLYGKLVEARQKHANKMDVPPA.ILATNKILVDMAKMR 1191
Sgs1 1272 LNNLRMTYERLRELSLNLGNR.MVPPVGNFMPDSILKKMAAIL 1313
RecQ 530 GNYDRKLFAKLRKLRKSIADESNVPPY.VVFNDATLIEMAEQM 571
BLM 1254 SSDPEVLLQIDGVTEDKLEKYGAEVISVLQKYSEWTSPA 1292
WRN 1192 PTTVENVKRIDGVSEGKAAML.APLLEVIKHFCQTNSVQ 1229
Sgs1 1314 PMNDSAFATL.GTVEDKYRRRFKYFKATIADLSKKRSSE 1351
RecQ 572 PITASEMLSVNGVGMRKLERFGKPFMALIRAHVDGDDEE 610
A
B
Figure 1 (A) Schematic representation of selected members of the RecQ helicase family. All proteins are from humans, except E. coli RecQ and
S. cerevisiae Sgs1, and are aligned about the conserved helicase domain. Also shown are the relative positions of the exonuclease (Exo) and
ssDNA annealing domains of WRN and RECQ5b, respectively, and the RQC (R) and HRDC domains. Nonconserved regions are shaded in gray.
Relevant amino-acid residue positions of truncation mutants used in this study are indicated above BLM and RecQ. See text for details.
(B) Alignment of the HRDC domain of BLM, WRN, Sgs1 and E. coli RecQ. Residues comprising a-helices in the three-dimensional structure
of Sgs1 are indicated by boxes above. Identical or similar residues are shaded in gray. Shown below is the amino-acid substitution K1270V
used in the generation of BLM(K1270V). See text for details. The figure was adapted from Liu et al (1999).
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helicases in vitro and, on the other, the distinct cellular
phenotypes of RecQ helicase mutants. To do this, we ana-
lyzed the ability of three other human RecQ helicases to
catalyze dissolution in conjunction with hTOPO IIIa.
Dissolution was assessed using an oligonucleotide-based
molecule (DHJ) that we had used previously to assay for
dissolution activity (Figure 2) (Fu et al, 1994; Wu and
Hickson, 2003). Using this substrate, we found that WRN,
RECQ1 and RECQ5b could not substitute for BLM in dissolu-
tion reactions with hTOPO IIIa, indicating that the reaction
mechanism of dissolution displays a high degree of specificity
for BLM (Figure 3).
The N-terminal domain of BLM is not required
to catalyze dissolution
The apparently specific ability of BLM to catalyze dissolution
indicated that the BLM protein itself must possess biochem-
ical functions that are not present in the other human RecQ
helicases. To identify structural features of BLM that are
required for catalysis of dissolution, we generated a series
of truncated versions of BLM that all retained the catalytic
core of BLM (Figure 1) and assessed the ability of these BLM
variants to catalyze dissolution. Residues 1–133 of BLM
contain an hTOPO IIIa-interaction domain (Hu et al, 2001).
We therefore wanted to determine if this interaction domain
was required for dissolution. Deletion of residues 1–212 of
BLM, and thus removal of this hTOPO IIIa-interaction do-
main, did not affect the ability of BLM to catalyze dissolution
(Figure 4A). Moreover, a truncated BLM protein generated by
removal of the entire nonconserved N-terminal domain of
BLM (residues 1–641) was still able to catalyze dissolution
(data not shown). Dissolution of DHJ is a symmetrical
reaction and generates two circular products in an ATP-
dependent manner. To eliminate the possibility that both of
the N-terminally truncated proteins catalyze a pseudodisso-
lution reaction by, for instance, asymmetric nicking of the
substrate in the unlabeled oligonucleotide, we monitored the
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Figure 2 Outline of the strategy used in the generation of the DHJ-
containing substrates analyzed in this study, DHJ and DHJ/Rsa1.
DHJ comprises two oligonucleotides (B1 and R1), each of which
contains two regions of complementary sequences giving rise to
two 11 bp internal duplex arms. When incubated together, B1 and
R1 anneal to form a molecule that contains two juxtaposed HJs
separated by two 14 bp heteroduplex regions (Fu et al, 1994; Wu
and Hickson, 2003). These heteroduplexes contain approximately
1.5 helical turns, which results in the catenation of B1 and R1 when
both oligonucleotides are circularized by ligation. Topologically
relevant helical turns are shown. Each oligonucleotide can be
detected individually by the 50 end-labeling of one of the oligo-
nucleotides prior to annealing. In this scheme, oligonucleotide R1
has been labeled, as indicated by the asterisk. Blue arrows indicate
the enzymatic activity each substrate was used to assess and the
detectable product generated from each substrate. Dissolution of
DHJ results in the decatenation of B1 and R1 releasing the two
oligonucleotides as circular DNA species, each of which has a faster
mobility on denaturing PAGE than the DHJ substrate (Wu and
Hickson, 2003). Unwinding of DHJ/Rsa1 by BLM releases linear
R1 and circular B1.
BLM WRN
BLM RECQ1
BLM RECQ5β
−
−
−
Figure 3 Dissolution is specifically catalyzed by BLM. Dissolution
reactions containing a series of two-fold dilutions of BLM (upper
panel, 5, 2.5, 1.25, 0.625, 0.3125, 0.15 and 0.075 nM; the middle
and lower panels did not contain the three and two lowest con-
centrations, respectively), WRN (15, 7.5, 3.75, 1.87, 0.94, 0.47
and 0.24 nM), RECQ1 (100, 50, 25 and 12.5 nM) or RECQ5b (80,
40, 20, 10 and 5nM), as indicated above the panels. Lanes contain-
ing hTOPO IIIa (250nM) are indicated above by black bars.
Positions of the DHJ substrate and the dissolution product are
shown on the left. For simplicity, the intertwining of the strands
of DHJ is omitted.
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fate of both oligonucleotides by performing dissolution reac-
tions on the two forms of DHJ in which either oligonculeotide
R1 or B1 was labeled. The reaction catalyzed by both of the
N-terminal BLM truncation mutants on each DHJ substrate
was indistinguishable from that carried out by full-length
BLM with regard to ATP dependency and the structure of the
reaction products, that is, two intact circular species (Figure
4A and B and data not shown). Together, these data indicate
that the N-terminal domain of BLM, and thus a physical
association of hTOPO IIIa with this portion of BLM, is not
required for the catalysis of dissolution.
The C-terminal domain of BLM is essential
for dissolution
The dispensable nature of the N-terminal domain of BLM for
dissolution led us to examine the role of the C-terminal
domain of BLM using a previously described, truncated
version of BLM that consists of residues 213–1267, herein
designated BLM(213–1267) (Wu and Hickson, 2002a).
Despite being an active helicase, we found that BLM(213–
1267), in contrast to BLM(213–1417), which contains the
natural C-terminus of BLM, was defective in catalyzing dis-
solution (Figure 4C). This indicates that in addition to the
helicase domain, residues 1268–1417 of BLM are required for
dissolution (Figure 4).
The RecQ family HRDC domain is required for the
binding to and unwinding of double Holliday junctions
The deletion of residues 1268–1417 to generate BLM(213–
1267) resulted in truncation of the HRDC domain, which
consists of residues 1210–1290 in BLM (Figure 1A and B). We
reasoned, therefore, that the failure of BLM(213–1267) to
catalyze dissolution might be reflected in a diminished ability
to interact with and/or process DHJs as a result of the
inactivation of the DNA-binding function of the BLM HRDC
domain. To address this, we compared the ability of BLM and
BLM(213–1267) to unwind, in the absence of hTOPO IIIa, a
modified DHJ molecule (DHJ/Rsa1) in which DHJ had been
digested with Rsa1 (Wu and Hickson, 2003). The lineariza-
tion of oligonucleotide R1 by Rsa1 results in the topological
unlinking of the two constituent oligonucleotides of DHJ and
thus creates a substrate that can be disrupted by thermal
denaturation or by a helicase activity (Figure 2) (Wu and
Hickson, 2003). The intact DHJ substrate is resistant to
conventional unwinding due to its covalently closed nature.
While we found that both BLM and BLM(213–1267) were
able to unwind DHJ/Rsa1, BLM(213–1267) displayed an
approximately 10-fold reduction in helicase activity toward
this substrate compared to that of full-length BLM (Figure 5).
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Figure 4 The C- but not the N-terminal domain of BLM is required
for dissolution. (A) Dissolution reactions in the presence or absence
of 5mM ATP and containing hTOPO IIIa and full-length BLM(1–
1417) or BLM(213–1417), as indicated. In the DHJ substrate,
oligonucleotide R1 is labeled. Positions of the DHJ substrate,
dissolution product and products of the indicated restriction digests,
confirming the identity of the labeled oligonucleotide, are shown on
the left. (B) Identical reactions to those shown in (A) were carried
out except that a DHJ molecule was used in which oligonucleotide
B1 was labeled. (C) Dissolution reactions containing a series of two-
fold dilutions of BLM (highest concentration, 5 nM) or BLM(213–
1267) (highest concentration, 7 nM). Lanes containing hTOPO IIIa
(250 nM) are indicated by black bars. Positions of the DHJ substrate
and dissolution product are shown on the left.
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Figure 5 The C-terminal domain of BLM is required for efficient
unwinding of DHJs. Helicase assays using DHJ/Rsa1 and a series
of two-fold dilutions of BLM, BLM(213–1417) or BLM(213–1267)
on DHJ/Rsa1, as indicated. The positions of DHJ/Rsa1 and the
unwound product are shown on the right. The graph shows
quantification of the level of unwound product generated
by BLM (circles), BLM(213–1417) (squares) and BLM(213–1267)
(triangles) on DHJ/Rsa1. Note that the scale on the horizontal axis
is logarithmic.
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This impaired helicase activity was solely due to the loss of
residues 1268–1417 of BLM, since BLM(213–1417), which
lacks only the N-terminal 1–212 residues, displayed helicase
activity on this substrate that was equivalent to that displayed
by full-length BLM (Figure 5).
One possible explanation for the reduced helicase activity
displayed by BLM(213–1267) was that the truncated protein
has a reduced affinity for DHJs. To analyze this, we employed
two independent means to compare the binding affinities of
BLM(213–1417) and BLM(213–1267) for the DHJ substrate:
a filter-binding assay, in which we measured protein-depen-
dent retention of DHJ on a nitrocellulose membrane, and an
electrophoretic mobility shift assay (EMSA), in which poten-
tially different protein/DHJ complexes were visualized as
a result of their reduced electrophoretic mobility compared
to protein-free DHJ. Using the filter-binding assay, we found
that BLM(213–1267) had a significantly reduced ability to
bind DHJ as compared to BLM(213–1417) (Figure 6A). Using
EMSAs, BLM(213–1417) was found to generate two differen-
tially retarded species and a small amount of material that
could not be resolved and was retained in the gel wells
(Figure 6B). The level of all retarded species was dramatically
reduced when BLM(213–1267) replaced BLM(213–1417) in
the EMSA analyses (Figure 6B), thus confirming the conclu-
sion of the filter-binding assay.
Next, we addressed the question of whether the observed
reduction in DNA-binding affinity and helicase activity of
BLM(213–1267) was specific for DHJ structures. To do this,
we compared the helicase activities of BLM, BLM(213–1417)
and BLM(213–1267) on a conventional helicase substrate,
a forked partial duplex. Interestingly, all three proteins dis-
played very similar levels of helicase activity on this substrate
and, in contrast to the results with the DHJ substrate, BLM
and BLM(213–1267) displayed similar binding affinities for
the forked duplex substrate (Figure 7). Together, these data
strongly suggest that the C-terminal domain of BLM contains
a DNA structure-specific binding motif, and implicate resi-
dues 1268–1417 of BLM in the processing of DHJ structures.
To provide further support for the proposal that it is loss of
the HRDC domain that is responsible for the reduced ability
of BLM(213–1267) to unwind DHJ/Rsa1, a comparison was
made between the activities of E. coli RecQ and a truncated
version of this protein (residues 1–523) that lacks the entire
HRDC domain, RecQ(1–523) (Figure 1A and B) (Bernstein
and Keck, 2003). Both proteins were able to unwind DHJ/
Rsa1 to some extent, but RecQ(1–523) had a much reduced
ability to unwind this molecule compared to full-length RecQ
(410-fold reduction; Figure 8). As was the case with BLM,
loss of the RecQ HRDC domain appeared to specifically affect
the helicase activity of RecQ on the DHJ/Rsa1 substrate since
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Figure 6 The C-terminal domain of BLM is required for efficient
binding to DHJs. (A) DNA filter-binding assay using a series of two-
fold dilutions of BLM(213–1417) or BLM(213–1267) on DHJ. The
graph shows the quantification of the relative level of DNA bound to
the filter in reactions containing either BLM(213–1417) (squares) or
BLM(213–1267) (triangles). (B) DNA EMSA using a series of two-
fold dilutions of BLM(213–1417) or BLM(213–1267) on DHJ, as
indicated above the lanes. The positions of the unbound substrate
and protein–DNA complexes (black arrowheads) are indicated on
the right. The graph shows the quantification of the total amount
of DNA bound by BLM(213–1417) (squares) or BLM(213–1267)
(triangles).
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Figure 7 The C-terminal domain of BLM is not required for the
unwinding or binding of forked duplexes. (A) Helicase assays using
a series of two-fold dilutions of BLM, BLM(213–1417) and
BLM(213–1267) on a forked partial duplex substrate. The positions
of the forked duplex and the unwound product are shown on the
right. The graph shows quantification of the amount of unwound
product generated by BLM (circles), BLM(213–1417) (squares) or
BLM(213–1267) (triangles). (B) DNA filter-binding assay using a
series of two-fold dilutions of BLM or BLM(213–1267) on a forked
partial duplex substrate. The graph shows quantification of the
relative amount of DNA bound to the filter in reactions containing
BLM(213–1417) (squares) or BLM(213–1267) (triangles).
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it had no significant effect on its helicase activity on a forked
DNA substrate (Figure 8). These data suggest a conserved
function for the HRDC domain of RecQ family helicases in the
specific processing of DHJs. The fact that the RecQ and BLM
HRDC domains apparently have similar functions in facilitat-
ing the efficient unwinding of DHJ/Rsa1 raised the possibility
that RecQ might also catalyze dissolution together with
bacterial Top3. RecQ and Top3 have been shown to cooperate
in the mediation of a strand passage activity that facilitates
the catenation and decatenation of covalently closed plasmid
DNAs (Harmon et al, 1999). However, we found that RecQ
and Top3 could not catalyze dissolution under conditions that
supported dissolution by BLM and hTOPO IIIa (data not
shown).
Lysine-1270 of BLM is required for efficient dissolution
activity
Thus far, we conclude that the inability of BLM(213–1267) to
catalyze dissolution is likely due to the absence of a func-
tional HRDC domain, which had been inactivated by trunca-
tion. However, to demonstrate this directly and to eliminate
the possibility that the truncation of the C-terminal 150
residues to generate BLM(213–1267) might have had long-
range effects on other portions of the BLM protein and
thereby led to inactivation of non-HRDC-mediated functions,
we sought to abrogate the HRDC domain function in the
context of the full-length protein. The similarity of the pre-
dicted secondary structure of the HRDC domain in RecQ
helicases to motifs in unrelated DNA-metabolizing enzymes
suggests that it is the conserved protein fold of the HRDC
domain that is important for function. We set out, therefore,
specifically to disrupt the conformation of the HRDC domain
in BLM by site-directed mutagenesis. Initial attempts in-
volved either the substitution of proline for the highly con-
served alanine-1250 residue in order to destabilize a-helix 2
of the HRDC domain, or the creation of an internal deletion
removing residues 1251–1262 to truncate a-helix 2 and
remove a-helix 3 (Figure 1B). However, neither of these
proteins could be expressed successfully, indicating that
disruption of the fold of the HRDC domain likely reduces
the solubility and/or stability of BLM. As an alternative, we
chose to mutate highly conserved residues that, in the pre-
dicted three-dimensional structure of the BLM HRDC domain,
reside on the protein surface. We reasoned that such residues
were less likely to be essential for the overall structural
integrity of the HRDC domain, but may be important for
function through the mediation of intermolecular inter-
actions. Lysine-1329 of Sgs1 has been shown to contact
ssDNA, consistent with the role of the HRDC domain as an
auxiliary DNA-binding domain (Liu et al, 1999). This residue
is conserved among RecQ helicases and corresponds to
residue 1270 in BLM (Figure 1B). We therefore mutated the
BLM cDNA to convert lysine-1270 to valine in the full-length
BLM protein to generate BLM(K1270V). BLM(K1270V) could
be expressed and purified to give protein yields that were
comparable to those seen with wild-type BLM (data not
shown). Purified BLM(K1270V) was active as a helicase,
and had a level of activity on a forked partial duplex substrate
that was indistinguishable from that of wild-type BLM
(Figure 9A). The substitution of lysine-1270 to valine, there-
fore, did not appear to have any gross effect on the overall
stability or the helicase activity of BLM. However,
BLM(K1270V) had a substantially reduced ability in compar-
ison with wild-type BLM to support dissolution together with
hTOPO IIIa (Figure 9B). Time-course experiments performed
with a fixed concentration of protein indicated an approxi-
mately eight-fold reduction in the rate of dissolution for
BLM(K1270V) (Figure 9B). Taken together, these data reveal
that lysine-1270 of the HRDC domain in BLM is essential for
the efficient dissolution of DHJ.
Discussion
A cellular marker of BLM deficiency used in the diagnosis of
BS is an abnormally high frequency of spontaneous SCEs. In
normal cells, it has been proposed that SCEs are suppressed
by the ability of BLM, together with hTOPO IIIa, to catalyze
dissolution. This is an alternative mechanism to that of
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endonuclease-mediated resolution of HJs, such as that cata-
lyzed by RuvC, Mus81 or the XRCC3/RAD51C complex (Chen
et al, 2001; Osman et al, 2003; West, 2003; Liu et al, 2004).
Here, we have shown that despite being one of five highly
related human RecQ helicases, BLM could not be substituted
by WRN, RECQ1 or RECQ5b in dissolution reactions contain-
ing hTOPO IIIa. Structurally, proteins of the RecQ helicase
family are modular in nature. Several members, including
BLM, contain, in addition to the signature helicase domain, a
number of identifiable sequence motifs. Previously (and in
this study), we have shown that BLM-mediated dissolution
requires ATP hydrolysis, indicating a requirement for the
helicase domain of BLM in this reaction (Wu and Hickson,
2003). In this study, we have identified the HRDC domain of
BLM as also being required for dissolution. The structural
similarity of the HRDC domain found in RecQ helicases to
domains found in other DNA-metabolizing enzymes strongly
indicates a role in mediating contacts with DNA. However,
the RecQ helicase HRDC domain is clearly not required for
intrinsic helicase activity since we demonstrated that variants
of both BLM and RecQ that lack HRDC domains have a
helicase activity on forked duplexes that is similar to that of
their respective full-length proteins. Rather, we propose that
the HRDC domain found in RecQ helicases performs a more
specialized role in the recognition of alternate DNA struc-
tures, and, more specifically, that it is required for the
efficient unwinding of DHJ structures. In particular, we
have shown that the amino-acid substitution K1270V in
BLM, which is predicted to alter the charge of the DNA-
binding face of the HRDC domain, resulted in a diminished
ability to mediate dissolution. This is the first specific
biochemical function to have been ascribed to the HRDC
domain. We did not attempt to complement the hyper-SCE
phenotype of BS cells by expression of the BLM(K1270V)
cDNA since we and others (Ellis et al, 1999; Hu et al, 2001;
Davies et al, 2004) have made the observation that comple-
mentation with the wild-type BLM cDNA is often only partial
and results in a broad range of SCE frequencies. Therefore,
given that the BLM(K1270V) mutant is only partially defec-
tive for HRDC function and can still catalyze dissolution, to
some extent, we think it is unlikely that any statistically
significant difference between BLM(K1270V) and BLM
to correct the elevated SCEs seen in BS cells will be demon-
strable. However, Yankiwski et al (2001) have shown that
expression of a mutant BLM cDNA, which contains an
internal deletion that removes the whole of the HRDC domain
and thus will be completely defective for HRDC function, is
unable to complement the hyper-SCE phenotype of BS cells.
This observation is consistent with the proposal that there
is a direct link between the dissolution of DHJs and the
suppression of SCEs in vivo.
While the HRDC domain is necessary for BLM to catalyze
dissolution, its presence in other RecQ helicases is not
sufficient to facilitate dissolution. One question that arises
from this study, therefore, is does the HRDC domain function
in a similar manner in those RecQ helicases where it is
present or has it evolved different but related auxiliary
functions that contribute to the functional diversification of
RecQ helicases? Superficially, the BLM and RecQ HRDC
domains appear to have a similar role, in vitro, in the specific
recognition of DHJs. An HRDC domain is also present in
WRN. However, unlike BS cells, Werner syndrome cells do
not show obvious alterations in the levels of genome-wide
recombination, but do have telomere maintenance defects
(Wyllie et al, 2000; Crabbe et al, 2004). Indeed, in murine
models of WS, many of the phenotypes of WS are only
manifested in the presence of a second mutation that inacti-
vates telomerase (Chang et al, 2004; Du et al, 2004).
Therefore, one role for WRN may be in a recombination-
dependent pathway that acts to maintain telomeres in the
absence of telomerase. The HRDC domain of WRN may
therefore have evolved a role in the specific recognition of
recombination structures that arise at telomeres (Opresko
et al, 2004). Structural comparisons of the RecQ and Sgs1
HRDC domains indicate that the domain is a highly versatile
DNA-binding module that can support several different DNA-
binding modes (Liu et al, 1999; DA Bernstein and JL Keck,
unpublished data). Indeed, the distribution of surface charge
of the HRDC domain, to which lysine-1270 of BLM contri-
butes, is quite distinct between Sgs1, BLM and WRN, which
is consistent with the notion that the HRDC domain may have
evolved different roles in different RecQ helicases (Liu et al,
1999, DA Bernstein and JL Keck, unpublished data).
We have demonstrated that the entire N-terminal domain
of BLM is dispensable for dissolution. This result was some-
what surprising since this portion of BLM contains an hTOPO
IIIa-interaction domain that is essential in vivo for the inter-
action with hTOPO IIIa and for the suppression of SCEs (Hu
et al, 2001). Moreover, a similar functional domain organiza-
tion exists in Sgs1, where the N-terminal domain of Sgs1p is
required for the interaction with Top3p (Gangloff et al, 1994;
Bennett et al, 2000; Fricke et al, 2001). One possible explana-
tion for these apparently contradictory in vitro and in vivo
requirements for a physical association of BLM and hTOPO
IIIa is that, in vivo, the physical association between hTOPO
IIIa and the N-terminal domain of BLM may facilitate, not
a biochemical activity, but rather the recruitment of hTOPO
IIIa to its correct subcellular localization. This proposal is
consistent with the mislocalization of hTOPO IIIa observed
in BS cells (Wu et al, 2000).
RecQ and Top3, respectively, constitute the sole RecQ
helicase family member and topoisomerase III enzyme in
E. coli. The fact that these two enzymes were unable to
catalyze DHJ dissolution suggests that the ancestral function
of coupling the activities of a RecQ helicase and topoisome-
rase III may not be to catalyze dissolution. Indeed, in contrast
to BS cells, RecQ mutants have decreased, not increased,
levels of crossovers (Kusano et al, 1994). Dissolution results
exclusively in non-crossover products and therefore sup-
presses the exchange of genetic material between molecules
engaged in the process of homologous recombination. We
propose that this mechanism to resolve recombination inter-
mediates evolved with the advent of diploid organisms with
large genomes containing repetitive sequences. In such
organisms, the suppression of crossover events during
recombinational repair is paramount for the prevention of
mutagenic genomic rearrangements that can arise when the
DNA molecules participating in recombinational repair are
nonsisters. In particular, crossing-over in mammalian cells
between sequences lying on homologous chromosomes can
lead to loss of heterozygosity, a known driver of the tumor-
igenesis process. Notably, Blm-deficient mice show excessive
loss of heterozygosity and accelerated tumor development
(Luo et al, 2000).
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In summary, we have shown that the RecQ helicase family
HRDC domain confers DNA structure specificity and, in BLM,
is required for the dissolution of DHJs. Further analyses to
elucidate how the HRDC domain confers structural specificity
and how it may function differentially in the various RecQ
helicase family members will be crucial in our understanding
of the role played by these enzymes in the maintenance of
genome integrity and the suppression of tumorigenesis
in man.
Materials and methods
Proteins
BLM, BLM (K1270V), BLM(213–1267) and BLM(213–1417) proteins
were expressed in yeast and purified by nickel-chelate affinity
chromatography using methods described previously (Karow et al,
1997). WRN, RECQ1, RECQ5b, RecQ and RecQ(1–523) were
expressed and purified as described previously (Brosh et al, 1999;
Bernstein and Keck, 2003; Bernstein et al, 2003; Cui et al, 2004;
Garcia et al, 2004). The expression construct for BLM(K1270V) was
generated by replacing in the yeast expression vector, pJK1, the
HindIII/BamHI fragment, internal to the BLM cDNA, with a PCR-
generated mutant fragment containing the desired single codon
substitution. hTOPO IIIa was a kind gift from Drs He´le`ne Goulaouic
and Jean-Franc¸ois Riou (Goulaouic et al, 1999).
DNA substrates
DHJ, DHJ/Rsa1 and partial duplex fork substrates were prepared
and purified as described previously (Mohaghegh et al, 2001; Wu
and Hickson, 2003).
Dissolution and unwinding assays
Reactions were carried out in a buffer containing 50mM Hepes–
KOH, pH 7.2, 50mM NaCl, 4mM MgCl2, 5mM ATP, 1mM DTTand
various combinations of proteins and DNA substrates, as indicated
in the figure legends. Reactions were incubated at 371C for 60min,
unless otherwise stated, and stopped by the addition of 1% SDS and
50mM EDTA. Samples were deproteinized by the addition of
proteinase K and a further incubation at 371C for 15min.
Dissolution and unwinding reactions were subjected, respectively,
to 8% denaturing and 10% native PAGE. Gels were dried and
subjected to PhosphorImage analysis using a STORM 840 scanner
and ImageQuant software.
DNA-binding filter assays
DHJ was incubated with varying concentrations of protein, as
indicated in the figure legends, in reaction buffer containing 20mM
triethanolamine–HCl, pH 7.5, 4mM MgCl2, 10 mg/ml BSA, 2mM
ATPgS and 1mM DTT at 371C for 20min. Reactions containing the
forked duplex were performed as described above for the DHJ, with
the exception that the reaction buffer contained 2mM MgCl2.
Reactions were then adsorbed under vacuum onto a nitrocellulose
membrane using a dot-blot manifold apparatus. Each reaction spot
was then washed with 500ml reaction buffer under vacuum before
the membrane was air-died and subjected to PhosphorImage
analysis using a STORM 840 scanner and ImageQuant software.
DNA-binding EMSA
DHJ was incubated with varying concentrations of protein, as
indicated in the figure legends, in reaction buffer containing 20mM
triethanolamine–HCl, pH 7.5, 4mM MgCl2, 10 mg/ml BSA, 2mM
ATPgS and 1mM DTT at 371C for 20min. Samples were then fixed
by the addition of 0.25% glutaraldehyde before being subjected
to 5% PAGE. Gels were dried and subjected to PhosphorImage
analysis using a STORM 840 scanner and ImageQuant software.
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ABSTRACT
The product of the gene mutated in Bloom’s
syndrome, BLM, is a 30–50 DNA helicase belonging
to the highly conserved RecQ family. In addition to
a conventional DNA strand separation activity, BLM
catalyzes both the disruption of non-B-form DNA,
such as G-quadruplexes, and the branch migration
of Holliday junctions. Here, we have characterized
a new activity for BLM: the promotion of single-
stranded DNA (ssDNA) annealing. This activity does
not require Mg21, is inhibited by ssDNA binding
proteins and ATP, and is dependent on DNA length.
Through analysis of various truncation mutants of
BLM, we show that the C-terminal domain is essen-
tial for strand annealing and identify a 60 amino acid
stretch of this domain as being important for both
ssDNA binding and strand annealing. We present
a model in which the ssDNA annealing activity of
BLM facilitates its role in the processing of DNA
intermediates that arise during repair of damaged
replication forks.
INTRODUCTION
Bloom’s syndrome (BS) is a rare genetic disorder associated
with several abnormalities, including proportional dwarfism,
sunlight sensitivity and a predisposition to cancers of most
types. The gene mutated in BS, BLM, encodes a protein com-
prising 1417 amino acids that is a member of the highly con-
served RecQ family (1,2). This family includes Sgs1p of
Saccharomyces cerevisiae, Rqh1p of Schizosaccharomyces
pombe, and the WRN, RECQ1, RECQ4 and RECQ5 proteins
in humans. WRN and RECQ4 are defective in Werner’s and
Rothmund–Thomson syndromes, respectively, which are dis-
orders not only associated with cancer predisposition but also
with some features of premature aging (2). Where tested, all
RecQ family members are DNA helicases that translocate
along DNA strands in the 30–50 direction. A number of studies
have shown that RecQ helicases unwind a wide variety of
different oligonucleotide-based DNA substrates, including
forked duplexes, four-way junctions modeling the Holliday
junction, and simple 30-tailed duplexes. Moreover, RecQ
helicases can even unwind non-B-form DNA structures,
such as G-quadruplexes (3–7).
RecQ helicases are defined by a highly conserved domain
that contains seven signature motifs (hereafter referred to as
the helicase domain) (2). These sequence motifs are also
found, in a related form, in many other RNA or DNA helicases
from different families. Outside of the helicase domain there
is much less sequence similarity between RecQ family
members. Nevertheless, there are two additional identifiable
domains that are found in some, but not all, RecQ family
proteins. One of these, the RQC (RecQ C-terminal) domain,
is apparently unique to the RecQ family and is found in BLM.
Recent X-ray crystallographic analysis of Escherichia coli
RecQ protein indicates that the RQC domain forms a
so-called winged-helix structure that is implicated in the bind-
ing of DNA (8). Indeed, a previous study showed that the RQC
domain of WRN binds several DNA structures, including a
forked duplex and a four-way junction (9). Interestingly, in
some RecQ helicases, the RQC domain also seems to direct
protein–protein interactions (10–12). A second sequence fea-
ture found in certain RecQ helicases, including BLM, is the
HRDC (helicase and RNaseD C-terminal) domain (13). This
domain is poorly conserved at the primary sequence level, but
seemingly has a well-conserved structural fold comprising
five a-helices and a number of basic residues that constitute
a putative DNA binding surface (14). This domain is not
unique to RecQ helicases, being present also in RNaseD
homologs and, in a related form, in some DNA polymerases
and recombinases. In those RecQ helicases where the RQC
and HRDC domains are present, it is possible that interactions
with different DNA substrates are influenced by either or
both of these putative auxiliary DNA binding regions in the
enzyme. Nevertheless, because some RecQ enzymes only
*To whom correspondence should be addressed. Tel: +44 0 1865 222 417; Fax: +44 0 1865 222 431; Email: ian.hickson@cancer.org.uk
 The Author 2005. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
3932–3941 Nucleic Acids Research, 2005, Vol. 33, No. 12
doi:10.1093/nar/gki712
Published online July 15, 2005
3 RESULTS 101
contain the helicase domain, and lack the RQC and HRDC
domains, it seems highly likely that the helicase domain is both
necessary and sufficient for at least some enzymatic activities.
The functional role(s) of the RQC and HRDC domains can
only be the subject of speculation at this stage, but a possible
candidate is to extend the range of alternate DNA structures,
such as G-quadruplexes or Holliday junctions, that can be
recognized by a particular RecQ helicase.
Our studies of the RecQ helicase family are focused on
the BLM protein. We have previously shown that BLM is a
DNA structure-specific helicase that unwinds a wide variety
of DNA molecules, although it is incapable of unwinding a
blunt-ended DNA duplex (3,15). Nevertheless, it can disrupt
a four-way junction modeling the Holliday junction recomb-
ination intermediate even if that substrate has blunt termini
(15). Consistent with this activity being dependent upon
branch migration, BLM has been shown to catalyze branch
migration of bona fide Holliday junctions generated by the
RecA recombinase (15). Here, we report a new activity for
the BLM protein: the promotion of single-stranded DNA
(ssDNA) annealing. We have characterized the biochemical
properties of this strand annealing activity and have identi-
fied a short region of the C-terminal domain of BLM that
is essential for this function. We provide evidence that
strand annealing is influenced by ssDNA binding proteins,
by nucleotide co-factors and by DNA length.
MATERIALS AND METHODS
Plasmids
Plasmids pJP71, pJP74 and pJP75, which were used for the
expression of the truncated BLM variants, BLM642-1290,
BLM642-1417 and BLM642-1350, respectively, were con-
structed as described previously (16). Briefly, the region of
the BLM cDNA encoding residues 642–1290, 642–1350 or
642–1417 was amplified by PCR with primers introducing
NcoI and SapI sites. The PCR product was digested with NcoI
and SapI, and inserted between the NcoI and SapI sites of
pTXB3 (NEB). Constructs for the expression of BLM213-
1417 and BLM213-1267 have been described previously (17).
Protein purification
BLM, BLM213-1417 and BLM213-1267 were expressed as
C-terminally hexahistidine-tagged proteins in the protease-
deficient yeast strain JEL1 (MATa leu2 trp1 ura3-52 prb1-
1122 pep4-3 his3::PGAL10-GAL4) and were purified as
described previously (18). BLM642-1290, BLM642-1350
and BLM642-1417 were produced as C-terminal fusion pro-
teins with the Mxe-CBD affinity tag in the E.coli BL21-
Codonplus-(DE3)-RIL strain (Stratagene) and were purified
as described previously (16). Human replication protein A
(RPA) was kindly provided by Dr A Vindigni. E.coli
ssDNA binding protein (SSB) was purchased from USB.
All concentrations of proteins are given in terms of moles
of monomer.
DNA substrates
All oligonucleotides used in this study were purchased
from Sigma Genosys and were purified by PAGE. X12-1
(50-CGGGTCAACGTGGGCAAAGATGTCCTAGCAATG-
TAATCGTCTATGAGACG-30) and its complement X12-2
(50-GACGCTGCCGAATTCTGGCTTGCTAGGACATCTT-
TGCCCACGTTGACCCG-30) were used for the generation
of the 31 bp forked duplex. DF-1 (50-TGTAATCGTCTAT-
GAGACGCGGGTCAACGTGGACATCTGCAAAGATGT-
CCTAGCAATGTAATCGTCTATGAGACG-30) and its
complement DF-2 (50-GACGCTGCCGAATTCTGGCTTGC-
TAGGACATCTTTGCAGATGTCCACGTTGACCCGGAC-
GCTGCCGAATTCTGGC-30) were used for the generation
of the twin-forked duplex. DS-50-1 (50-GGCAAAGATGTC-
CTAGCAACGGGTCAACGTGGGCAAAGATGTCCTAG-
CAA-30) and its complement DS-50-2 (50-TTGCTAGGAC-
ATCTTTGCCCACGTTGACCCGTTGCTAGGACATCTTT-
GCC-30) were used for the generation of the 50 bp duplex;
DS-31-1 (50-CGGGTCAACGTGGGCAAAGATGTCCTAG-
CAA-30) and its complement DS-31-2 (50-TTGCTAGGA-
CATCTTTGCCCACGTTGACCCG-30) were used for the
generation of 31 bp duplex; DS-15-1 (50-GGCAAAGATG-
TCCTA-30) and its complement DS-15-2 (50-TAGGACA-
TCTTTGCC-30) were used for the generation of the 15 bp
duplex. X12-1, DF-1 DS-50-1, DS-31-1 and DS-15-1 were
labeled at the 50 end using T4 polynucleotide kinase (NEB)
and [g-32P]ATP. The forked duplex used in helicase assays was
generated by the annealing of X12-1 and X12-2. X12-1 was
50-32P-labeled before annealing. All concentrations of DNA
substrates are given in terms of moles of oligonucleotides.
Helicase assays
The 31 bp forked duplex was prepared as described previously
(18). Reactions (20 ml) were carried out at 37C in buffer H
(50 mM Tris–HCl, pH 7.5, 50 mM NaCl, 1 mM DTT and
0.1 mg/ml BSA) supplemented with 2 mM MgCl2 and 2 mM
ATP for 30 min in the presence of the indicated amounts of
BLM and 1 nM of 32P-end-labeled forked duplex substrate.
Where indicated, SSB and RPA were added at a concentration
of 60 and 3 nM, respectively. Reactions were stopped, and
the samples were de-proteinized by the addition of stop buffer
(50 mM EDTA, 1% SDS and 0.1 mg/ml proteinase K) and
incubated at 37C for 10 min. The reaction products were
resolved on a native 10% (w/v) polyacrylamide gel (acrylam-
ide to bis-acrylamide ratios 19:1) run in TBE at 30 mA per gel
for 1 h at 4C. The radiolabeled DNA was visualized using
a PhosphorImager and the percentage DNA unwinding was
quantified using ImageQuant software.
Strand annealing assays
DNA strand annealing activity was measured using fully or
partially complementary oligonucleotides (at a concentration
of 1 nM each), one of which was 50-32P-end-labeled. Reactions
(20 ml) were carried out in buffer H supplemented with 2 mM
MgCl2 unless otherwise indicated for 30 min at 37
C with the
indicated concentrations of BLM. For time-course experi-
ments, an 80 ml reaction was initiated and 10 ml aliquots
were removed at defined time points. Reactions were stopped
by the addition of stop buffer (50 mM EDTA, 1% SDS and
0.1 mg/ml of proteinase K) and incubated for 10 min at 37C.
Where indicated, RPA was added (0.75–48 nM) to the reac-
tion. The reaction products were analyzed as described for the
helicase assay.
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Gel retardation assays
Radiolabeled oligonucleotide (1 nM) was incubated with
BLM or its truncated derivatives in 50 mM triethanolamine,
pH 7.5, 2 mMMgCl2, 2 mMATPgS, 50 mMNaCl, 1 mMDTT
and 0.1 mg/ml BSA for 20 min at 37C. Glutaraldehyde
(0.25%) was then added and the reaction was incubated for
a further 10 min at 37C. The protein–DNA complexes were
resolved on a 5% (w/v) native polyacrylamide gel (acrylamide
to bis-acrylamide ratios 19:1) run in TBE at 150 V for 70 min
at 4C. The radiolabeled DNA was visualized using a Phos-
phorImager and the percentage ssDNA bound was quantified
using ImageQuant software.
RESULTS
During an analysis of the DNA helicase activity of BLM,
we observed that the appearance of the ssDNA product
of unwinding followed an unusual pattern. The extent of
ssDNA product formation increased with increasing enzyme
concentration up to a point, beyond which the level of
unwound product declined substantially. An example of such
a pattern is shown in Figure 1a and quantified in Figure 1d for
a forked DNA duplex substrate. In this particular case, the
level of the ssDNA product of unwinding peaked in reactions
containing 10 nM BLM and then declined significantly until
it was only marginally above background in reactions con-
taining 80 nM BLM (Figure 1a and quantified in Figure 1d).
One explanation for this phenomenon was that high concen-
trations of BLM were able to promote the re-annealing of
the ssDNA products of the unwinding reaction. Consistent
with this was the observation that addition of either E.coli
SSB or human RPA, two unrelated ssDNA binding proteins,
could overcome the apparent decline in helicase activity seen
at high BLM concentrations (Figure 1b–d). Previously, it was
shown that BLM helicase activity is stimulated by RPA (19),
but not by SSB, making it unlikely that the similar effects of
RPA and SSB shown in Figure 1 involved direct stimulation
of BLM helicase activity.
To analyze this putative ssDNA annealing activity of BLM
more directly, we incubated different concentrations of BLM
with the two single-stranded 50mer oligonucleotides (each at
1 nM) that were utilized to create the forked duplex used in the
experiment shown in Figure 1. One of these oligonucleotides
was 50-end-labeled to allow strand annealing to be monitored.
We found that BLM promoted efficient annealing of the two
oligonucleotides. Using BLM concentrations of >20 nM,
90% of the labeled ssDNA was annealed to its complement
(Figure 2a). Analysis of the kinetics of this reaction using a
fixed BLM concentration (20 nM) indicated that 50% of the
labeled oligonucleotide was annealed in <4 min (Figure 2b),
using the reaction conditions described in Materials and
Methods. Consistent with the notion that this reaction reflected
genuine ssDNA annealing, addition of increasing concentra-
tions of RPA progressively diminished the level of the
annealed forked duplex product (Figure 2c). This confirmed
that the ability of RPA to overcome the decline in helicase
activity seen at high BLM concentrations (Figure 1c) was due
to the inhibition of the ssDNA annealing activity of BLM.
BLM requires Mg2+ and ATP to catalyze DNA unwind-
ing (18). We tested whether there was a similar co-factor
requirement for the strand annealing function. As shown in
Figure 3a, strand annealing promoted by BLM did not depend
on the presence of Mg2+. Indeed, the strand annealing activity
was resistant to incubation with 50 mM EDTA (data not
shown). Although there was a slight stimulation of strand
annealing activity at a Mg2+ concentration of 1 mM, Mg2+
concentrations >4 mM caused a mild inhibition of the reaction.
In marked contrast to the absolute requirement for ATP hydro-
lysis in DNA unwinding, increasing ATP concentrations
strongly inhibited the DNA strand annealing reaction
(Figure 3b). A similar, if slightly less dramatic, inhibition was
seen with the poorly hydrolyzable ATP analog, ATPgS. In
contrast, concentrations of ADP up to 20 mM had no detect-
able inhibitory effect on the reaction (Figure 3b). Hence, the
ssDNA annealing reaction promoted by BLM has different
Figure 1. Inhibition of BLM helicase activity occurs at high protein
concentrations, which is relieved by ssDNA binding proteins. (a) Unwinding
of 1 nMof a 31 bp forked duplex catalyzed by different concentrations of BLM,
as indicated above the lanes. (b) Unwinding of 1 nM of a 31 bp forked duplex
catalyzed by BLM in the presence of 60 nM SSB or (c) in the presence of 3 nM
RPA. In (a–c), the positions of the forked duplex and the ssDNA product of
unwinding are indicated on the left. (d) Quantification of the helicase activity of
BLM from the data in (a–c). All reactions were incubated for 30 min at 37C.
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Mg2+ and adenine nucleotide co-factor requirements from
those needed to support BLM helicase activity.
Next, we asked whether oligonucleotide length influenced
the efficiency of BLM-mediated strand annealing (Figure 4).
We found that complementary 15mer oligonucleotides were
not annealed to any detectable extent, while a 31mer pair could
be annealed, albeit very inefficiently, requiring a BLM con-
centration of >40 nM. Increasing the oligonucleotide length
to 50 nt substantially increased the extent of annealing, par-
ticularly in reactions containing a low BLM concentration
(<20 nM). We then asked whether the annealing reaction
required that the two oligonucleotides be fully complement-
ary. To analyze this, we used two related oligonucleotide pairs.
One pair comprised a 31mer complementary region and a
non-complementary 19mer tail, which could form a forked
partial duplex, and the other comprised the same 31mer com-
plementary region flanked by two 19mer non-complementary
regions that could form a twin-forked duplex (Figure 4a).
Both oligonucleotide pairs could be annealed efficiently by
BLM (Figure 4a and b), indicating that the annealing reaction
does not require the oligonucleotides to be fully comple-
mentary, and that the complementary portion of the oligonuc-
leotide need not be located at the ends of the DNA molecule.
Despite containing only 31 nt of complementary sequence,
these oligonucleotides were annealed as efficiently as the
fully complementary 50mers, and far more efficiently than
the fully complementary 31mer pair (Figure 4a and b).
These data indicate that, for a fixed length of complementary
sequence, the overall length of the oligonucleotide strongly
influences the efficiency of the annealing reaction.
Next, we addressed whether the differences in annealing
efficiency noted above for different lengths of ssDNA were
reflected in differences in the ability of BLM to form a stable
complex with each DNA substrate. To achieve this, we used
gel retardation assays with a 15mer, a 31mer and a 50mer
single-stranded oligonucleotide. As shown in Figure 4c and d,
BLM formed a stable complex with the 50mer and, to a much
lesser extent, with the 31mer, but no complex with the 15mer
could be detected. These data suggest that the DNA length-
dependence of the ssDNA annealing reaction may be
a reflection of the relative ability of BLM to bind stably to
DNA molecules of different length.
In order to identify functional domains in BLM required for
the ssDNA annealing reaction, we purified a series of trun-
cated versions of BLM, which are shown diagrammatically
in Figure 5. These variants all contain the central helicase and
Figure 2. BLM promotes annealing of ssDNA. (a) Effect of BLM concentration on the annealing of two ssDNA molecules to generate a forked duplex. Reactions
were incubated for 30 min. (b) Time course of ssDNA annealing in reactions containing 20 nM BLM. (c) Effect of increasing concentrations of RPA on ssDNA
annealing catalyzed by 10 nM BLM. In (a–c), the percentage of ssDNA annealed was quantified and the data are presented graphically on the right of the
corresponding dataset.
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RQC domains, but lack part or all of the N-terminal domain,
and in some cases also part of the C-terminal domain. Initially,
we analyzed whether strand annealing required the N- and
C-terminal portions of BLM. A BLM variant lacking the
N-terminal 212 amino acids (BLM213–1417) was proficient
at strand annealing (Figure 6a and b), as indeed was BLM642–
1417 that lacked the entire N-terminal domain (data not
shown). In contrast, BLM213–1267 was barely able to cata-
lyze strand annealing above the background level seen in
the absence of BLM (Figure 6a and b) and showed a >10-
fold reduced rate of strand annealing in comparison with
BLM213–1417. This difference between these two BLM vari-
ants was specific for the strand annealing function of BLM,
since the intrinsic helicase activity of each protein was com-
parable (Figure 6c). Importantly, these helicase assays were
performed in the presence of SSB in order to prevent ssDNA
annealing.
The results presented thus far would indicate that the
C-terminal domain of BLM between residues 1267 and 1417
is important for its strand annealing function. Given that the
entire N-terminal domain of BLM is dispensable for ssDNA
annealing, we used BLM variants commencing at residue 642
to analyze whether the annealing function could be localized
to a particular region of the C-terminal domain of BLM. We
found that a protein truncated by only 67 C-terminal residues
(BLM642–1350) could promote efficient strand annealing
(Figure 6d). In contrast, removal of an additional 60 residues
(to create BLM642–1290) generated a protein that had no
detectable annealing activity (Figure 6d). The removal of
residues 1291–1350 appear to specifically affect the strand
annealing function of BLM since BLM642–1290 protein is
an active helicase (16).
Since we had shown above that a correlation exists between
DNA binding efficiency and an ability to promote annealing
of different lengths of ssDNA, we next asked if those trun-
cation mutants of BLM that were unable to promote annealing
might have an alteration in their intrinsic ssDNA binding
properties. Using gel retardation assays we found that,
although there was no quantitative difference in the total
amount of ssDNA bound by full-length BLM and its truncated
derivatives, there was a clear qualitative difference in the
nature of the retarded complexes when comparing strand
annealing-proficient and -deficient variants. Using BLM,
BLM213–1417, BLM642–1417 or BLM642–1350 at concen-
trations that promote efficient strand annealing, most of the
retarded DNAs could not be resolved in the gel, indicative of
the formation of large protein–DNA complexes (Figure 7).
In contrast, the retarded species seen in reactions with
the two strand annealing-defective variants, BLM213–1267
and BLM642–1290, were readily resolved within the gel
(Figure 7). Taken together, these data indicate that the first
641 amino acids of BLM are not important for ssDNA bind-
ing or annealing, but that the 60 residues between positions
1290 and 1350 are essential for strand annealing and for the
formation of higher-order protein–DNA complexes.
DISCUSSION
We report a new activity for the BLM helicase in showing that
BLM promotes efficient annealing of complementary ssDNA
molecules. This activity does not require Mg2+ or ATP, the
co-factors essential for BLM to perform its helicase function.
We have shown that significant DNA length dependence
exists for the BLM strand annealing activity, which appears
to derive from differences in the ability of BLM to form stable
complexes with ssDNA of different lengths. Most interest-
ingly, this length dependence does not require that the
annealed strands be fully complementary. This may suggest
that the mechanism by which BLM promotes ssDNA anneal-
ing is for it to bind non-specifically to the two ssDNA
molecules and then to bring them into close proximity via
protein–protein interactions between BLM molecules bound
to the individual oligonucleotides. The length dependence
may, therefore, reflect the number of BLM molecules that
can bind simultaneously to each ssDNA molecule. Using
different BLM variants, we found a strong correlation exists
between ssDNA annealing activity and an ability to form
higher-order protein–DNA complexes that were not resolved
on polyacrylamide gels. In line with the comments above,
we would propose that the formation of these large molecular
Figure 3. Effect of Mg2+ and adenine nucleotide co-factors on ssDNA
annealing. (a) Strand annealing by BLM (10 nM) as a function of increasing
Mg2+ concentration. The reaction shown in the left panel was performed in the
absence of BLM. (b) Strand annealing by BLM (10 nM) as a function of
increasing concentration of ATP, ATPgS or ADP, as indicated. Graph below
shows quantification of the data.
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weight complexes is a function of the binding of multiple
BLM molecules to each ssDNA oligonucleotide.
BLM may promote ssDNA annealing in a manner similar
to that of the RAD52 recombination protein. RAD52 forms
oligomeric rings that bind ssDNA on their outer surface, and
the annealing reaction requires that multiple rings engage
their bound ssDNA in a large complex (20,21). BLM is
oligomeric in solution, and previous studies have identified
Figure 4. Strand annealing of different ssDNA structures byBLM. (a) In each case, different concentrations of BLM (indicated above the lanes) were incubatedwith
the ssDNA species indicated on the left of each autoradiogram. The positions of the unannealed ssDNA and the annealed fully duplex or partial duplex products are
indicated on the left. (b) Quantification of the data in (a). (c) Gel retardation assays with increasing quantities of BLM and the ssDNA oligonucleotides indicated
above the wells. The positions of the ssDNA and the retarded BLM–DNA complexes are shown on the right. (d) Quantification of the data from (c).
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4- and 6-fold symmetric ring structures that can form in the
absence of DNA (22). However, the oligomeric state of the
catalytically active form of BLM remains to be confirmed.
Certain truncated forms of BLM are monomeric in solution
and yet can still perform DNA unwinding (16), suggesting that
the ability to form oligomers is not obligatory for helicase
function. An interesting avenue for future research will be
to address whether oligomerization of BLM is required for
its ssDNA annealing function.
Recent data indicate that BLM is not alone among RecQ
helicases in promoting strand annealing. Garcia et al. (23)
showed that human RECQ5b also possesses a DNA strand
annealing activity that is strongly inhibited by RPA. However,
we have data to indicate that such a strand annealing activity
is not conserved in E.coli RecQ (C.F. Cheok, L. Wu and
I.D. Hickson, unpublished data). This suggests that the anneal-
ing function is unlikely to be intrinsic to the highly conserved
Figure 5. Schematic representation of the full-length BLM (1–1417) and
truncated BLM variants used in this study. Amino acid residue numbers of
each protein are indicated on the left. The positions of the helicase (red),
RQC (yellow), HRDC (gray) domains are indicated. Green boxes denote
poorly conserved regions.
Figure 6. TheC-terminal domain of BLM, between residues 1290 and 1350, is required for ssDNAannealing. (a) Strand annealing as a function of increasing protein
concentration for BLM213–1417 and BLM213–1267. Reactions were incubated for 30 min. The graph below shows quantification of the data. (b) Time course
of ssDNA annealing by 20 nM BLM213–1417 or BLM213–1267. The graph below shows quantification of the data. (c) Comparison of the helicase activity of
BLM213–1417 and BLM213–1267. Assays were as described in Figure 1. Graph below shows quantification of the data. (d) Strand annealing as a function of
increasing protein concentration for BLM642–1290 and BLM642–1350. Graph below shows quantification of the data.
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helicase and RQC domains, but rather is dictated by one of the
poorly conserved N- or C-terminal regions that flank these
domains in BLM. Consistent with this, the C-terminal domains
of BLM and RecQ5b are required for ssDNA annealing activ-
ity. Interestingly, the C-terminal domains of these two
proteins, however, show little sequence similarity. Notably,
the RecQ5b C-terminal domain lacks both the 60 amino acid
region found in the C-terminal domain of BLM, which we
have shown is essential for ssDNA annealing activity, and an
HRDC domain, which in BLM lies adjacent to the critical
Figure 7. The C-terminal domain of BLM is required for the formation of higher-order protein–DNA complexes. (a) Gel retardation assays of BLM1–1417,
BLM213–1417, BLM213–1267 (upper panel), BLM642–1417, BLM642–1350 and BLM642–1290 (lower panel) using a 50mer ssDNA oligonucleotide. The
positions of the gel wells and of BLM–DNA complexes that could be resolved in the gel are indicated on the right. (b) Quantification of total ssDNA bound by BLM
and its truncated derivatives. (c) Quantification of the ssDNA that was retarded in the gel wells. For clarity, the data are represented on two graphs in each case.
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60 amino acid region. Moreover, there are obvious differences
in the effects of nucleotide analogs on the respective activities
of the two proteins. Most notably, the annealing activity of
RECQ5b is inhibited by ATPgS, but not by ATP or ADP,
whereas BLM is inhibited by both ATPgS and ATP. While
this manuscript was in preparation, we became aware of an
electronic paper in press containing findings that overlap with
those presented here. Machwe et al. (24) reported that RecQ
family members, including BLM, promote DNA strand pair-
ing as well as DNA unwinding. Our findings are in general
agreement with those of Machwe et al. (24), except we did not
find that BLM requires Mg2+ for its strand annealing activity.
Moreover, in the present work, we have significantly extended
our knowledge of the strand annealing function of BLM. In
particular, we have mapped a domain in BLM vital for strand
annealing activity and have defined structural features of the
DNA substrates that are required for BLM to mediate this
function.
An important issue to address is why should RecQ helicases
catalyze apparently antagonistic reactions: DNA unwinding
and ssDNA annealing? Although the precise cellular role of
any RecQ helicases is not fully elucidated, our previously
published evidence indicates that BLM co-operates with topoi-
somerase IIIa to resolve DNA intermediates that arise during
recombinational repair of replication forks (25). The ability of
BLM to promote strand annealing of molecules with non-
complementary ends indicates that BLM can promote strand
annealing at internal sites in DNA and may not require DNA
end recognition. One potential role for ssDNA annealing activ-
ity may be to promote the processing of Holliday junctions.
BLM and topoisomerase IIIa together catalyze double
Holliday junction dissolution (25), a process that requires
the juxtaposition of two individual Holliday junctions. As
two Holliday junctions are brought together in close proxim-
ity, the torsional stress generated by the convergence of the
two junctions may be relieved by topoisomerases acting ahead
of each migrating Holliday junction. The strand annealing
activity of BLM acting on the strands behind each junction
may function to overcome the torsional constraints imposed by
two converging Holliday junctions (Figure 8a). Furthermore,
as the two junctions are brought together in close proximity,
steric hindrance may prevent either junction from being able
Branch migration Branch migration
Branch migration Branch migration
Torsional
and steric
constraints
Fork regression via
annealing of nascent
DNA strands
Reverse branch
migration and resetting
of replication fork
Extension of
leading strand
(a)
(b)
Figure 8. Models for the possible role of the strand annealing function of BLM in replication fork maintenance. (a) Branch migration model. Schematic
representation of how torsional stress and steric hindrance may impede the convergence of two Holliday junctions by branch migration. The strand annealing
activity of BLM acting on strands behind each junction may act to overcome these constraints and thereby facilitate the juxtaposition of two Holliday junctions.
See text for details. (b) Fork regressionmodel. Template strands are shown in black and nascent strands in red. The yellow triangle depicts a fork-blocking adduct on
the leading strand template. See text for details.
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to assume the necessary square planar configuration. Rather,
each junction may assume the configuration in which the two
duplexes are stacked, which is inhibitory to classical branch
migration. Under these conditions, the ssDNA annealing activ-
ity of BLM may be required to promote an atypical form
of Holliday junction branch migration in order to generate
a hemicatenane, the presumed substrate for double Holliday
junction dissolution. Our recent data indicate that the two
strand annealing defective derivatives of BLM described
here are also defective in catalyzing Holliday junction dis-
solution (26), although whether there is a mechanistic link
between these two functions is unclear at this stage.
A second possible model (Figure 8b) for the role of the
ssDNA annealing function specifically links BLM function
with repair of damaged replication forks. Lesions on the
leading strand template for DNA replication likely block
fork progression. One proposal is that lesion bypass can
occur via template switching in which the fork regresses
via the annealing of the nascent strands to form a so-called
chicken-foot structure (15,27). After extension of the leading
strand and/or lesion removal, the regressed fork (a four-way
junction) can be reversed by branch migration to re-set an
active fork. We propose that BLM could catalyze both the
fork regression step, by promoting annealing of the nascent
strands, and the reversal of the regressed fork, using its
helicase/branchmigration function. In this way, BLM recruited
to the arrested fork could promote repair and hence restoration
of productive DNA replication. Clearly, further work is needed
to identify whether these models have validity.
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4 Conclusions and Perspectives
The human genome is constantly challenged with endogenous and exogenous DNA
damage and requires a set of mechanisms to preserve its integrity. The human RECQ
helicases seem to play an important role in resolution of aberrant structures that arise
from different repair pathways and are likely to mediate other functions as well. The
fact that there are five different RecQ family members in humans, whereas unicellular
organisms only contain a sole RecQ helicase, points to the evolutionary split-up and ex-
tension of the RecQ-mediated processes. Many groups have contributed to unravelling
the roles of the RecQ helicases but the DNA transactions mediated by these proteins
are diverse and are not fully understood yet.
Yet, to elucidate the roles of the human RecQ helicases, different approaches must
be combined. The observation that BLM and RECQ5 have non-redundant roles in sup-
pressing is further supported by our finding that RECQ5β cannot perform the DHJ dis-
solution in conjunction with TOPOIIIα which is consistent with our finding that the HRDC
domain of BLM - absent in RECQ5β - is essential for efficient binding and unwinding of
DHJs. As we have found that RECQ5β exhibits strand-annealing activity in addition to its
helicase activity, it may be that RECQ5 acts in the recovery of damaged replication forks
by promoting fork regression, whereas BLM suppresses cross-overs that would appear
from the repair of non-meiotic DHJs that arise from HR-dependent repair of daughter
strand gaps formed during replications. To address this possibility, the next steps would
be to knock down the protein levels of RECQ5β in human cells and to characterise the
phenotypic consequence with regard to sensitivities to DNA damaging agents and SCE
frequency. A further evidence for the non-redundant roles of RECQ5β and BLM could
be obtained by knocking down RECQ5β in BS cells and monitoring sensitivity to DNA
damaging agents and the rate of SCEs. Furthermore, with experiments established for
RecA and RecG to assay for fork-regression activity, RECQ5β should be tested for its
potential ability to regress forks.
Surprisingly, the functions of the human RecQ helicases are more global than only
restricted to resolve aberrant DNA structure, as has been shown with RECQ4 that plays
a role in replication initiation. The question arises if the role of RECQ4 in replication
initiation is an evolutionarily acquired function, or if it is conserved in bacteria as well.
Therefore, this aspect may be studied in E. coli and S. cervisiae.
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